Quarterly Report • Sep 7, 2023
Quarterly Report
Open in ViewerOpens in native device viewer

The Phoenix Holdings Ltd. Consolidated Interim Financial Statements as of June 30, 2023 (Unaudited)
השקעות, ביטוח ופיננסים

Benjamin Gabbay - Chairman Ben Langworthy Dr. Ehud Shapira (Independent Director) Eliezer Yones Rachel Levine (External Director) Richard Kaplan (External Director) Roger Abravanel Stella Amar Cohen Itzhak Shukri Cohen

| Part 1 | Report of the Board of Directors on the State of the Corporation's Affairs |
|---|---|
| Part 2 | Consolidated Interim Financial Statements |
| Part 3 | Standalone Financial Data from the Consolidated Interim Financial Statements Attributed to the Company |
| Part 4 | Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure |
| Part 5 | Statements Regarding Controls and Procedures in respect of Disclosure in the Financial Statements of The Phoenix Insurance Company Ltd. |

Report of the Board of Directors on the State of the Corporation's Affairs


| 1. | THE GROUP'S STRUCTURE, ITS AREAS OF ACTIVITY, AND DEVELOPMENTS THEREIN………………………………………………………………………………………….2 |
|---|---|
| 2. | DESCRIPTION OF THE BUSINESS ENVIRONMENT 12 |
| 3. | DEVELOPMENTS IN THE MACROECONOMIC ENVIRONMENT 22 |
| 4. | BUSINESS TARGETS AND STRATEGY 25 |
| 5. | THE BOARD OF DIRECTORS' EXPLANATIONS FOR THE STATE OF THE CORPORATION'S BUSINESS……………………………………………………………26 |
| 6. | DISCLOSURE ON EXPOSURE TO, AND MANAGEMENT OF, MARKET RISKS 54 |
| 7. | LINKAGE BALANCE 55 |
| 8. | CORPORATE GOVERNANCE ASPECTS 58 |
| 9. | DISCLOSURE PROVISIONS RELATING TO THE CORPORATION'S FINANCIAL REPORTING…………………………………………………………………………………….60 |

The Report of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter, "The Phoenix Holdings" or the "Company" or the Corporation") as of June 30, 2023, outlines the principal changes in the Company's operations in the period from January through June 2023 (hereinafter - the "Reporting Period").
The report was prepared in accordance with the Securities Regulations (Periodic and Immediate Reports), 1970. With regard to the insurance, pension, and provident fund operations of the Group, the Report was prepared pursuant to the Supervision of Insurance Business Regulations (Reporting), 1998, and in accordance with the directives issued by the Commissioner of the Capital Market, Insurance and Savings Authority (hereinafter - the "Supervisor" or the "Commissioner"). The report was prepared assuming that the reader also has at his/her disposal the Company's report for first quarter of 2023 as well as the full 2022 periodic report (hereinafter - the "Periodic Report").
The Report of the Board of Directors is an integral part of the quarterly report, and the quarterly report should be read in its entirety, as a single unit (hereinafter - the "Financial Report" or the "Financial Statements").
The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - "Belenus"), which is held indirectly, through a number of companies, by two global funds - Centerbridge Partners LP and Gallatin Point Capital LLC. Centerbridge Partners LP is controlled by CCP III Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by Matthew Botein, Lewis (Lee) Sachs.
In December 2022, the Company reported that a consortium of investors from the United Arab Emirates alongside other international investors are assessing the option of acquiring the control core in the Company from Belenus, and the parties' signing a memorandum of understanding. In July 2023, the Company reported that the parties reached a mutual understanding regarding the cancellation of the memorandum of understanding, and a concurrent execution of a transaction for the sale of shares by Belenus to the consortium, while retaining a stake of at least 30% of its shares on a fully diluted basis.
On August 14, 2023, a transaction for the sale of 2% of the Company's shares to a company controlled by an investor from the United Arab Emirates was completed, and as of the report's publication date Belenus holds 31.15% of the Company's shares.
For further details, please see reports dated December 13, 2022, July 23, 2023 and August 15, 2023 (Ref. Nos.: 2022-01-150541, 2023-01-068953 and 2023-01-075799, respectively).


* In order to separate the financial results between profits attributed to insurance and profits arising from other core activities, the Company splits the "other" segment. The split is made for convenience purposes and the Company views the capital and unattributed segment as a single operating segment.
The Group is engaged in four core areas of activity: insurance, asset management, credit and distribution, which are divided into seven reporting segments in the financial statements (property and casualty insurance, health insurance, life insurance and savings, asset management - pension and provident, asset management - financial services, insurance agencies and credit). As of the report date, the Group has NIS 406 billion in assets under management. In the insurance business, the Company operates through The Phoenix Insurance Company Ltd; in the asset management business, the Company operates through The Phoenix Pension and Provident Ltd., The Phoenix Investment House Ltd.,1 and The Phoenix Advanced Investments Ltd.; in its credit business, the Company operates mainly through Gama Management and Clearing Ltd. a publicly-traded company, whose controlling shareholder is the Company.2 In its distribution activity through The Phoenix Agencies 1989 Ltd., and the agencies owned and held by The Phoenix Agencies.3
Changes in the risk-free interest rate curve and capital market affect The Phoenix Insurance's assets, liabilities, financial performance, and solvency ratio. The Company manages the interest risks of all of its assets and liabilities.
Interest rates - during the reporting period, the Bank of Israel increased its interest rate from 3.25% to 4.75%. Furthermore, in the reporting period, the shekel yield curve increased, and on the other hand the illiquidity premium decreased by 0.16%, which led to a decrease in the discount rate and a negative effect on the financial statements. Changes in the shekel interest rate curve affect both the Company's financial results and The Phoenix Insurance's solvency ratio; in accordance with the provisions for calculating the solvency ratio, the illiquidity premium is not used.
1 Formerly Excellence Investment House.
2 For information about the tender offer for the acquisition of the entire stake in Gama, see Section 1.3.9 below.
3 For further details regarding the res tructuring in The Phoenix Agencies, see Section 1.3.10 below.
The capital market - during the reporting period, there was volatility in financial markets in Israel and across the world. These changes affected both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.
Inflation - during the reporting period, the inflation rate increased by 2.2%. The increase in inflation rates has an adverse effect both on the Company's financial results, and on The Phoenix Insurance's solvency ratio.
In the period subsequent to the reporting date through immediately prior to the financial statements publication date, financial markets in Israel and across the world continued to be volatile, the Bank of Israel did not raise the interest rate, and inflation continued to rise concurrently with expectations of a decrease in inflation in Israel and globally in 2023.
For more information regarding the effects of changes in the interest rate curve, the capital market and inflation rates on the Company's financial results, see Section 4.4.5 in the Description of the Corporation's Business chapter, and Note 41 to the financial statements for 2022. As to the effect of the changes in the shekel yield curve and in capital markets on The Phoenix Insurance's solvency ratio, see Section 2.1.5 below, and Section 8 in The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.
For the purpose if using its financial results, the Company uses a real return of 3% (see Section 5.4.1); in view of that, the changes in the CPI, as stated above, affects the classification of amounts between underwriting profits and investment profits.
In recent months, there has been uncertainty regarding the government's plans to promote changes in the judicial system, and the growing public controversy surrounding this move. During January 2023, the government began promoting a plan to make fundamental changes in the legal system in Israel, which led to controversy and widespread public protests. In July 2023, protesters intensified their protest against the legislation of the Basic Law: The Judiciary (Amendment No. 3) - Abolishing the Standard of Reasonableness, which was passed by the Knesset on July 24, 2023. Against the backdrop of promoting the changes in the judiciary, in April 2023, Moody's - the international rating agency - published Israel's credit rating, leaving the rating unchanged at A1, and changing the credit rating outlook from "positive" to "stable" following its assessments regarding developments that will arise from the implementation of the changes. In May 2023, S&P - the international rating agency published Israel's credit rating. S&P reiterated Israel's AA- rating with a stable outlook, based on the assumption that agreement will be reached regarding the reform in the legal system.
In July 2023, immediately prior to the revocation of the standard of reasonableness, Moody's and S&P published special reports in response to the legislation of the law for the abolishment of the standard of reasonableness, which emphasized the risks and the concerns regarding potential adverse effects on the Israeli economy, which might arise from further unilateral legislation. However, no changes were made to the rating of the State of Israel and/or its rating outlook. In addition, credit rating agency Fitch reiterated Israel's credit rating at A+ and the rating outlook at "stable", but also issued a warning regarding further future developments.
At this stage the Company is unable to assess future developments, or the effect of those events on the Israeli economy in general and the Company's activity in particular.

In August 2021, The Phoenix Insurance issued - through The Phoenix Capital Raising (2009) Ltd. (hereinafter - "The Phoenix Capital Raising") subordinated bonds to institutional entities and to the Company. The subordinated bonds were recognized by the Commissioner as an Additional Tier 1 capital instrument of The Phoenix Insurance, and listed by The Phoenix Capital Raising for trade on the TACT Institutionals trading platform operated by the TASE.
In April 2023, The Phoenix Capital Raising fulfilled the conditions for listing the subordinated bonds on the main list of the TASE, and at the beginning of May 2023 trading of the subordinated bonds on the main list started. In accordance with the provisions of the deed of trust, the interest in respect of the subordinated bonds was reduced by 0.2% from 2.29% to 2.09%.
As part of the listing on the main list, The Phoenix Insurance undertook to publish data in connection with its economic solvency ratio on a quarterly basis in respect of the quarter preceding the reporting date. For further details, please see Section 2.1.3 below.
For more information in connection with the issuance of the subordinated bonds and their listing on the main list, see the Company's immediate reports dated August 2, 2021, August 3, 2021 August 8, 2021, April 24, 2023 and May 3, 2023 (Ref. Nos.: 2021-01-060658, 2021-01-061159, 2021-01-062515, 2023-01-038554 and 2023- 01-040573, respectively).
As of the report date, the Company completed a study regarding costs in connection with long-term health insurance coverage (hereinafter - the "Study"). Following the Study, the Company recorded in its financial statements as of June 30, 2023, a NIS 59 million pre-tax profit; for more information, see Note 8(a)4 to the financial statements.
As from 2011, The Phoenix Insurance and The Phoenix Pension and Provident (hereinafter - the "Companies") operate - together with Saifa Management Services (2013) Ltd. (hereinafter - "Saifa") - the "FNX Private" venture (hereinafter - "FNX Private"), which is engaged in the development, adaptation, marketing and direct marketing (rather than through external insurance agents) of The Phoenix's selfdirected policies and provident funds (IRA). These are customized services and products with unique characteristics, which are mainly suitable to wealthy customers (hereinafter - the "Venture"). Each of the companies' share in the Venture is 50%. In the first quarter of 2023, the Companies and Saifa, entered into an agreement for the incorporation of the Venture as separate legal entities, such that the Companies will continue holding 50% of the joint Venture. In accordance with the Circular on Allocation of Non-Marketable Assets, The Phoenix Insurance carried out a valuation of FNX Private's activity in relation to The Phoenix's self-directed insurance products; the valuation was conducted by an independent external appraiser. In accordance with the valuation, The Phoenix Insurance recognized, during the first quarter of

2023, a pre-tax earning of NIS 113 million from revaluation of excess fair value of the illiquid assets against the LAT reserve in the health insurance segment.
In June 2023, the companies signed an agreement for assuming control over the partnerships of the FNX Private venture; as a result of assuming control over the said venture's partnerships, in the second quarter, the companies recorded a post-tax one-off profit of NIS 129 million; on the other hand, The Phoenix Insurance deducted the profit from revaluation of excess fair value of illiquid assets, which was recognized against the LAT reserve in the first quarter of the reporting period, as stated above.
A. In January 2023, an agreement was signed between KSM Mutual Funds Ltd. (hereinafter - "KSM") and Psagot Mutual Funds Ltd. (hereinafter - "Psagot Funds"), according to which KSM will acquire from Psagot Funds, in an asset transaction, part of its mutual funds activity, with assets under management of NIS 17.1 billion in consideration for NIS 260 million (hereinafter, respectively the "Funds Agreement" and the "Sold Funds").
In July 2023, following discussions regarding the Transaction held with the Israel Competition Authority, the parties received the Israel Competition Authority's position regarding the parties' suggestion to enter into an alternative transaction that includes changes to the sold assets and the consideration compared to the Funds Agreement (hereinafter - the "Alternative Transaction"), whereby the Israel Competition Authority will not demand the filing of merger notices in respect of the Alternative Transaction, and therefore the Competition Commissioner (hereinafter - the "Commissioner") or the Israel Competition Authority will not take enforcement measures in respect of its execution. The total assets under management that will be acquired in the Alternative Transaction shall stand at NIS 11.1 billion, in consideration for NIS 200 million, instead of the total assets under management and consideration under the Funds Agreement. For further information in connection with an agreed order pursuant to Section 50B to the Economic Competition Law, 1998, see immediate report of July 13, 2023 (Ref. No.: 2023-01-066511).
As of the report publication date, the parties completed the alternative transaction.For further details, please see the immediate report dated July 13, 2023 (Ref. No.: 2023-01-066511).
B. Furthermore, The Phoenix Investment House and Psagot Securities Ltd. (hereinafter - "Psagot Securities") signed an agreement, which is independent and unconditional of and separate from the Funds Agreement; under the said agreement, The Phoenix Investment House will acquire the entire portfolio management activity of Psagot Securities, comprising assets under management of approx. NIS 8.1 billion (hereinafter - the "Portfolio Agreement"), in consideration for NIS 50 million. As of the report publication date, the entire consideration in respect of the Portfolio Agreement was paid, and all economic rights and liabilities in respect of the activity were transferred to The Phoenix Investment House. The parties applied to the Israel Competition Authority for its approval of the transaction and filed a motion with the court in accordance with Section 350 to the Companies Law, 1999.

In June 2023, the parties agreed an amendment to the Portfolio Agreement whereby the Court's approval in accordance with Section 350 to the Companies Law, 1999, is not a condition precedent to the completion of the transaction. In view of the above, the Company announces that the conditions precedent set in the Portfolio Agreement were fulfilled and the transaction was completed. The actual transfer of the holding in the assets and liabilities sold under the Portfolio Agreement shall be carried out on the Court's approval date or on the date on which the holding thereof shall be transferred to The Phoenix Investment House by way of independent transfer of the portfolio management customers in accordance with the law.
The consideration in respect of the agreements was funded through a loan advanced by the Company to The Phoenix Investment House, further to the expansion of the Series 6 Bonds, that was carried out in January 2023, and the remaining amount will be funded through a loan KSM will take from a financial institution.
For further details regarding the above, please see immediate reports dated January 19, 2023 and July 2, 2023 (Ref. Nos.: 2023-01-009285 and 2023-01- 061972).
In May 2023, The Phoenix Insurance closed the activity of the retail unit, which employs 120 employees. This move is part of the promotion of the Company's strategy to cut costs on the one hand, and enhance and develop it distribution channels on the other hand.
As part of a strategy for efficient and effective management of the capital at the Group level, in June of 2023 The Phoenix Pension and Provident approved a NIS 330 million loan and a NIS 150 million credit facility from a financial institution in order to refinance an internal debt of The Phoenix Pension and Provident to The Phoenix Insurance and to the Company; the debt arises from the rapid growth in the activity of The Phoenix Pension and Provident. To secure the repayment of the loan and credit facility, the Company provided a guarantee to the financial institution.
In July 2023, The Phoenix Value P2P Limited Partnership (hereinafter - the "Partnership") - a publicly-traded limited partnership, whose general partner is The Phoenix Value P2P General Partner Ltd. - which merged into The Phoenix as part of its merger with Halman Aldubi Investment House Ltd., in which the Company has an indirect stake of 47.5% (hereinafter - the "General Partner"), announced that the General Partner's Board of Directors decided that it is in the best interest of all holders of participation units in the Partnership (hereinafter - the "Investors") to take action to discontinue the Partnership's operations in accordance with the provisions of the partnership agreement, such that the Partnership will stop executing investments in

the form of acquisition of new loans, and other the other hand will take steps to distribute to investors the funds that will be received in respect of the existing loans included in the Partnership's portfolio of assets; the Partnership reported that during the said period no success fees will be collected, and the amount of management fees that will be collected will not exceed the actual amount of expenses incurred by the General Partner. The Partnership's decision was made in view of the macro-economic conditions, their worsening and their impact on the Partnership's activity. The General Partner's decision to discontinue the Partnership's operations in accordance with the provisions of the partnership agreement was made based on the assessment that in the foreseeable period there will be no substantial changes in the macroeconomic conditions in the capital and interest markets across the world, and therefore the Partnership will find it difficult in the future to meet the return targets it has set; this, among other things, taking into account the scope of the cumulative redemption requests received by the Partnership, as well as in view of the continued uncertainty regarding the ability to raise additional funds for the Partnership in order to make new investments.
Accordingly, as from the date on which the decision was made, no new transactions will be executed by the General Partner in connection with the Partnership's portfolio of assets, no further funds will be raised for investment in the Partnership, and the Partnership's assets will be used by the General Partner to make payments in an equitable manner. After the completion of the above process, the Partnership will be wound-up, and accordingly it will stop being a reporting corporation.
In August 2023, The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary of the Company (hereinafter - "The Phoenix Investments") published a full tender offer (whose validity is conditional upon the acquisition of all of the offerees' shares) to acquire all shares of Gama Management and Clearing Ltd. (hereinafter - "Gama").
As of the report's publication date, The Phoenix Investments holds 76.87% of Gama's shares. If the full tender offer will come to fruition, the consideration which The Phoenix Investments is expected to pay will amount to NIS 221 million. It should be clarified that it is uncertain whether the tender offer will, indeed, be completed successfully. For further details, please see the immediate report dated August 10, 2023 (Ref. No. 2023-01-074644).
A. In December 2022, the competent organs of The Phoenix Agencies and Agam Leaderim Holdings (2001) Ltd. (hereinafter - "Agam Holdings"), a company in which The Phoenix Agencies has a 60% stake, approved a merger offer between the two aforesaid companies, in accordance with a merger agreement under which Agam Holdings will be wound up and merged with and into The Phoenix Agencies in consideration for allotment of ordinary shares of The Phoenix Agencies that will be issued to the other shareholders of Agam Holdings, such that after the execution of the merger the Company will hold 80% of the shares of The Phoenix Agencies, and the other shareholders will hold the remaining shares. The merger was completed in June 2023. For more information, see the immediate reports

dated June 11, 2023, and June 28, 2023 (Ref. Nos.: 2023-01-054346 and 2023- 01-060460).
In August 2023, concurrently with the approval of The Phoenix Insurance's Financial Statements as of June 30, 2023, The Phoenix Insurance's Board of Directors decided to distribute a NIS 350 million dividend, at a rate higher than that set in the distribution policy, without detracting from its long-term dividend policy, and given the amount of the distributable profits and the solvency ratio rate of The Phoenix Insurance, and after compliance with the solvency ratio targets and the distribution tests as per the Companies Law.
Furthermore, the Board of Directors of The Phoenix Insurance also passed a decision as to a change in the minimum solvency ratio target, net of the transitional provisions, for purposes of dividend distribution from a 111% rate to a 115% rate.
In August 2023, concurrently with the approval of the Company's Financial Statements as of June 30, 2023, which are included in this report, the Company's Board of Directors decided to distribute a dividend in accordance with the Company's dividend distribution policy, which was revised in March 2022,10 totaling NIS 120 million and NIS 0.5 per share. It shall be clarified that to the extent that options are exercised by employees between the dividend declaration date and the record date, the per-share dividend amount shall be adjusted in accordance with the actual number of outstanding shares on the record date. The Company shall publish, as required, a supplementary report in respect of said adjustment on the record date.
The said distribution is based, among other things, on a dividend distribution from subsidiaries, including from The Phoenix Insurance, as detailed above.
10 Please see the immediate report dated March 29, 2022 (Ref. No. 2022 -01-037000).

In December 2018, the Company adopted an option plan for employees and officers. Pursuant to the option plan, the Company grants, from time to time and without consideration, option warrants (hereinafter - "Options") to employees and officers of the Company and companies under its control.
In June 2023 and August 2023, the Company's Board of Directors approved the award of up to 3,211,588 options to employees and officers of the Company and its subsidiaries, exercisable into ordinary shares of the Company NIS 1.00 par value each, subject to adjustments, without cash consideration. In accordance with the Board of Directors' decision, out of the amount of 3,211,588 options allotted to offerees a total of 57,190 options were allotted to the Company's CEO. The award of options to the Company's CEO was approved in an extraordinary general meeting of the Company on August 2, 2023 (hereinafter - the "Meeting").
As part of the Meeting, the shareholders also approved the allocation of 78,771 (illiquid) options of The Phoenix Investment House Ltd. to the Company's CEO and 63,321 (illiquid) options to the Chairman of the Company's Board of Directors11 in respect of their service as directors in The Phoenix Investment House Ltd. In the Compensation Committee and Board of Directors' reasons for the award of the options to the CEO and the Chairman of the Board of Directors, it is noted, among other things, that the Compensation Committee and Board of Directors believe that the award of the options, which are exercisable into The Phoenix Investment House's shares, and whose vesting depends on the latter's performances, plays an important role in the strengthening of the link between the Company's CEO and Chairman of the Board of Directors in their capacity as directors in The Phoenix Investment House, and the performances of the latter, and constitutes a proper incentive for their continued work and the fulfillment of their role in the future to achieve the objectives, targets and business and strategic plans of The Phoenix Investment House (and consequently also those of the Company). The Board of Directors of The Phoenix Investment House also approved the award of options to other officers and employees of The Phoenix group, which influence and contribute to the activity of The Phoenix Investment House. For further details, please see the immediate reports dated June 28, 2023, July 26, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060307, 2023-01-060334, 2023-01-072205513 and 2023-01-088974, respectively).
The Company continues to prepare for applying IFRS 17, in the Financial Statements of the Company and The Phoenix Insurance. During the second quarter, the Capital Markets Authority published a revised roadmap - third revision (hereinafter - the "Revised Roadmap"). Among other things, the Revised Roadmap postponed the firsttime application to January 1 2025. Furthermore, the Revised Roadmap included a requirement for the Company to conduct several quantitative impact studies (hereinafter - "QIS"). Subsequent to the reporting date, the Company completed the first QIS regarding the calculation of the opening balances of selected portfolios on the transition date as of January 1, 2023.
For further details, please see Note 2(FF) to the 2022 Periodic Report. Regarding the deferral of the standard's application date, see Section 2.2.2 below.
11 The award of the options to the Chairman of the Company's Board of Directors as part of the Meeting was subjec t to the approval of an amendment to the Compensation Policy, which was also presented for the Meeting 's approval.

In July 2023, the Company published an ESG report for 2022. The report was published on the Company's website and on the websites of the TASE and the Israel Securities Authority. To view the full report, as published on the Company's website, see the Company's website at:
https://www.fnx.co.il/sites/docs/genery/for_new_site/esg/ESG_BOOK_2022_HEB_ Digital_new.pdf
In July 2023, the Company executed a buyback of NIS 124 million in bonds (Series 6). The Company's Board of Directors decided to execute the transaction due to its positive effect on the Company's capital structure and liquidity, and due to the fact that the buyback price reflects a bargain purchase. For further details, please see the immediate report dated July 2, 2023 (Ref. No.: 2023-01-061600).
On July 11, 2023, S&P Maalot announced the upgrading of the Company's rating from ilAA- to ilAA with a stable outlook, and the rating of The Phoenix Insurance Company from ilAA+ to ilAAA with a stable outlook.
On August 23, 2023, Midroog announced it is reiterating the rating of The Phoenix Insurance at Aa1.il, and upgrading the outlook from stable to positive. Accordingly, the rating outlook of the subordinated bonds that were issued by The Phoenix Capital Raising (2009) Ltd. were upgraded from stable to positive.
On May 23, 2023 Moody's - the international rating agency - announced the assignment of an A2 international credit rating with a stable outlook to The Phoenix Insurance.

2.1.1. Provisions regarding the implementation of the Economic Solvency Regime The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Economic Solvency Regime"), which was published on October 14, 2020. The Economic Solvency Regime is a regulatory directive that regulates capital requirements and risk management processes among insurance companies. The Economic Solvency Regime sets a standard model for calculating eligible capital and the regulatory solvency capital requirement, with the aim of bringing insurance companies to hold buffers to absorb losses arising from the materialization of unexpected risks to which they are exposed. The solvency ratio is the ratio between an insurance company's economic shareholders' equity recognized for solvency purposes and the required capital.
The Phoenix Insurance opted for the alternative provided by the Economic Solvency Regime regarding the transitional provisions, whereby the economic capital may be increased by gradually deducting from the insurance reserves until 2032 (hereinafter - the "Deduction during the Transitional Period"). The Deduction During the Transitional Period as of December 31, 2022, amounts to NIS 3,385 million after its linear amortization as at this date (compared with NIS 4,710 million as of December 31, 2021). This amount matches the expected increase rate in The Phoenix Insurance's capital surplus during the Transitional Period, and reflects, at the very least, the expected expiry of the solvency capital requirements (SCR) and the risk margin of the existing portfolio as of the calculation date. For more information, see Section 2A(2) to The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.
The Economic Solvency Ratio Report as of December 31, 2022 was published at the same time as the Financial Statements as of the first quarter, on May 31, 2023 and was prepared and presented in accordance with the provisions of Chapter 1, Part 4, Section 5 of the Consolidated Circular, according to Circular 2020-1-17 (hereinafter the "Disclosure Provisions"). In accordance with the Consolidated Circular, the economic solvency ratio report in respect of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.
Furthermore, in view of the listing of additional Tier 1 capital on the main list, and in accordance with The Phoenix Insurance's undertakings under the deed of trust, as from 2023 the Company will publish to the public an estimated quarterly solvency ratio as of March 31 and September 30, as part of the periodic report published following the calculation date. The calculation of the estimated quarterly solvency ratio is not audited or reviewed by the independent auditor, and the controls conducted by The Phoenix Insurance for the purpose of publishing the estimated ratio are less in scope compared to those executed for the purpose of publishing the

solvency ratio report, which is published in accordance with the Commissioner's directives.
Set forth below are details regarding the economic solvency ratio as published in the latest economic solvency ratio report published by The Phoenix Insurance. The meaning of the terms in this section is the same as in Appendix B to Chapter 2 in Part 2 of Section 5 of the Consolidated Circular - "Economic Solvency Regime".
| As of December 31 | ||
|---|---|---|
| 2022 | 2021 | |
| Audited* | ||
| NIS thousand | ||
| Shareholders equity in respect of SCR | 14,711,664 | 14,212,110 |
| Solvency capital requirement (SCR) | 6,968,263 | 7,666,458 |
| Surplus | 7,773,401 | 6,545,652 |
| Economic solvency ratio (in %) | 211% | 185% |
| Effect of material capital-related measures taken in the period between the calculation date and the publication date of the solvency ratio report: |
||
| Raising (redemption) of equity instruments** | (410) | 346,133 |
| Shareholders equity in respect of SCR | 14,711,254 | 14,558,243 |
| Surplus | 7,742,991 | 6,891,784 |
| Economic solvency ratio (in %) | 211% | 190% |
For details regarding the economic solvency ratio without applying the transitional provisions for the Transitional Period, and without adjusting the stock scenario, and regarding the target economic solvency ratio and restrictions applicable to the Company in connection with dividend distribution, see below.
For explanations about key changes in the capital surplus and in the economic solvency ratio as of December 31, 2022 compared with December 31, 2021, see Section 1(a) to The Phoenix Insurance's economic solvency ratio report as of December 31, 2022.
Below is a link to the Economic Solvency Ratio Report on The Phoenix Insurance's website.
https://www.fnx.co.il/investors-relations-hebrew/kosherpiraon/

| As of December 31 | |||
|---|---|---|---|
| 2022 | 2021 | ||
| Audited | |||
| NIS thousand | |||
| Minimum capital requirement (MCR) | 1,843,583 | 1,916,615 | |
| Shareholders equity for MCR | 11,596,249 | 11,024,131 |
According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Dividend Distribution Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.
The Phoenix Insurance's policy is to have a solid capital base to ensure its solvency and ability to meet its liabilities to policyholders, to preserve The Phoenix Insurance's ability to continue its business activity such that it is able to provide returns to its shareholders. The Phoenix Insurance is subject to capital requirements set by the Commissioner.
The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which The Phoenix Insurance seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%.
The minimum economic solvency ratio target, taking into account the transitional provisions, was set at 135%, and the minimum solvency ratio target without taking into account the provisions during the Transitional Period is set to reach 135% at the end of the Transitional Period according to the Company's capital plan. On August 23, 2023, the Board of Directors of The Phoenix Insurance increased the minimum economic solvency ratio target by 4 percentage points without taking into account the provisions during the Transitional Period - from a rate of 111% to a rate of 115%, beginning on June 30, 2023.
Therefore, based on the audited results as of December 31, 2022, and on the estimated solvency ratio as of March 31, 2023, which is not audited or reviewed, The Phoenix Insurance meets the minimum capital targets set by the Board of Directors. It is hereby clarified that the aforesaid does not guarantee that The Phoenix Insurance will meet the set capital targets at all times.

The following are data as published in the latest economic solvency ratio report published by The Phoenix Insurance, about the economic solvency ratio calculated without taking into account the transitional provisions and the solvency ratio target set by The Phoenix Insurance's Board of Directors, as required in the letter referred to above. As of December 31, 2022 and December 31, 2021, this ratio is higher than the target set by the Board of Directors.
| As of December 31 | ||
|---|---|---|
| 2022 | 2021 | |
| Audited | ||
| NIS thousand | ||
| Shareholders equity in respect of SCR | 12,301,691 | 11,112,151 |
| Solvency capital requirement (SCR) | 8,254,667 | 9,818,889 |
| Surplus | 4,047,024 | 1,293,262 |
| Economic solvency ratio (in %) | 149% | 113% |
| Effect of material capital-related measures taken in the period between the calculation date and the publication date of the solvency ratio report: |
||
| Raising of capital instruments* | - | 354,205 |
| Shareholders equity in respect of SCR | 12,301,691 | 11,466,356 |
| Surplus | 4,047,024 | 1,647,467 |
| Economic solvency ratio (in %) | 149% | 117% |
| Capital surplus after capital-related actions in relation to the Board of Directors' target: |
||
| Minimum solvency ratio target without applying the Transitional Provisions |
111% | 108% |
| Excess capital over target | 3,139,011 | 861,956 |
* Subsequent to December 31, 2022, The Phoenix Insurance redeemed NIS 411 million in Series F bonds (immediate report dated January 15, 2023, Ref. No.: 2023-01-006268); the said redemption does not affect the solvency ratio without applying the transitional provisions to the transitional period, and without adjusting the stock scenario as of December 31, 2022, in view of the unrecognized Tier 2 capital balances due to the quantitative limit on the recognition of Tier 2 capital.
In accordance with the undertakings of The Phoenix Capital Raising (2009) Ltd. under the provisions of the deed of trust for Series L Subordinated Bonds which are part of Additional Tier 1 capital, and which it published on April 24, 2023, the Company made an estimate of its economic solvency ratio as of March 31, 2023 (hereinafter - the "Estimate"); the Estimate is not audited or reviewed by the independent auditor. The calculation (of the Estimate) was carried out in accordance with the guidelines of the Solvency II-based Economic Solvency Regime, and in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the

"Provisions of the Economic Solvency Regime"), which was published on October 14, 2020. The Company carries out the Estimate and publishes this quarterly disclosure in addition to the publication of a mandatory solvency ratio reports as required under the Provisions of the Economic Solvency Regime. It should be noted that the scope of the controls executed by the Company for the purpose of publishing the Estimate is reduced compared to those executed for the purpose of publishing the economic solvency ratio report, which is published in accordance with the Commissioner's guidance.
In accordance with the Estimate, the Company's economic solvency ratio as of March 31, 2023, is 208% (with the implementation of the transitional provisions to the transitional period and adjustment of a stock scenario, and after the dividend distribution as outlined in Section 2.1.6 below.
The said Estimate of the solvency ratio as of March 31, 2023, does not include the changes and effects that took place since March 31, 2023, and through the publication date of this report, including the effect of the business activity of The Phoenix Insurance, changes in the mix and amounts of insurance investments and liabilities, exogenous effects, inter alia changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.
The assessment is based, among other things, on forecasts and estimates of future events, the materialization of which is uncertain and is not under the Company's control, and which should be considered as "forward-looking information" as the term is defined in Section 32A to the Securities Law, 1968.
Changes in the linked shekel risk-free yield curve affect the Company's economic solvency ratio, especially in the mid- to long-terms, affect The Phoenix Insurance's economic solvency ratio. During 2023, there was a substantial increase in the riskfree linked interest rate curve, has had a positive effect on The Phoenix Insurance's solvency ratio.
| Range/years | December 31, 2022 | June 30, 2023 | August 17, 2023 | |
|---|---|---|---|---|
| Short term | 1-3 | Between 0.68% and 0.86% |
Between 1.86% and 1.20% |
Between 1.91% and 1.31% |
| Mid-term | 4-10 | Between 0.88% and 0.86% |
Between 1.12% and 1.03% |
Between 1.27% and 1.31% |
| Mid-long term | 11-15 | Between 0.88% and 0.97% |
Between 1.03% and 1.06% |
Between 1.30% and 1.29% |
| Long term | 16-25 | Between 1.00% and 1.10% |
Between 1.07% and 1.19% |
Between 1.29% and 1.33% |
The following table summarizes the positive (negative) risk-free linked interest ("spot") rates:4
The Phoenix Insurance estimated the sensitivity of the economic solvency ratio at a 50 bps decrease in the risk-free interest, after applying the transitional provisions, and including adjusting the stock scenario; the estimation was carried out based on the data and results of the calculation of the economic solvency ratio as of December 31, 2022. The estimation resulted in a 18% decrease in the economic solvency ratio (after applying the transitional provisions and adjusting the stock scenario).
It should be noted that the sensitivity is not necessarily linear; i.e., sensitivity at other rates is not necessarily a simple extrapolation of the sensitivity test presented. For the results of the sensitivity tests of the economic solvency ratio to various risk factors, see Section 8 to The Phoenix Insurance's Economic Solvency Ratio Report as of December 31, 2022.
Set forth below are material regulatory directives published during the reporting period and thereafter, and which are not included in the Report on the Corporation's Business for 2022 and the Report of the Board of Directors for the first quarter of 2023. For further details regarding material regulatory directives published during the reporting period, please see Section 4.1.1 to the 2022 Report on the Corporation's Business and Section 2.2 to the Report of the Board of Directors for the first quarter of 2023.
2.2.1. In June 2023, the Economic Plan Law (Legislative Amendments for Implementing Economic Policies for the Budget Years 2023 and 2024), 2023 (hereinafter - the "Economic Arrangements Law") was published; it included provisions on the following:
The amendment prescribes that an institutional entity will not "unreasonably refuse" to engage with a pension advisor in an agreement for the execution of a transaction for a customer, and will not terminate an engagement in such an agreement with a pension advisor under the circumstances listed in the definition of "unreasonable refusal".
The objective of the Amendment is to reduce the incidence of overlapping insurance in the surgical procedures subsegment between Supplementary Healthcare Services (hereinafter - the "SHABAN Plans") of health maintenance organizations and private health insurance policies; the aim is to reach a situation where most of private surgical procedures in Israel will be conducted by the health management organizations as
4 The risk-free linked interest rate curves were taken from Fair Spread Ltd. To calculate the solvency ratio, the Company takes into account other components in addition to the risk-free interest rate.

part of the SHABAN Plans. In effect, the Amendment implements the recommendations of the public committee for strengthening healthcare services in Israel and regulating the public and private health system (hereinafter - the "Ash Committee"), which were published in November 2022. According to the Amendment, where a policyholder has an health insurance policy that includes insurance coverage that is not dependent on the exercise of the policyholder's rights under the SHABAN Plan, and such policyholder filed a claim to cover a private surgical procedure in Israel under his/her rights by virtue of the SHABAN Plan, and this surgical procedure is covered by the policyholder's insurance policy, the insurer shall pay the health maintenance organization through which the surgical procedure was carried out a total equal to the price of the surgical procedure paid by the health maintenance organization as per the Ministry of Health's price list, or an amount equal to the price of the insurance arrangement as paid by the insurer - the lower of the two. It was also established that on the next renewal date of a first shekel individual surgical procedure policy that was taken out before the amendment came into force (hereinafter - the "Original Policy"), the insurer will be required to add the policyholders of the said policy, who also have SHABAN Plans in place, to a surgical procedures policy of the SHABAN Plan instead of the original policy. This will be the case unless the policyholders informed the insurer that he/she do not wish to be transferred to a SHABAN Plan, all in accordance with the provisions listed in the Amendment to the Law.

give a service provider access to "financial information about credit"; it was also decided that the law will not apply to the transfer of financial information to the pension clearing system. The circular sets provisions that regulate the activities of institutional entities, which are "sources of information" in accordance with the law.

Following are drafts of material regulatory provisions published during the reporting period and thereafter, which are not included in the 2022 Report on the Corporation's Business or in the Report of the Board of Directors for the first quarter of 2023. For further details regarding additional drafts of material regulatory provisions published during the reporting period, please see Section 4.1 to the 2022 Report on the Corporation's Business as well as Section 2.3 of the Report of the Board of Directors for the first quarter of 2023.



Set forth below is a summary description of trends, events and developments in the Group's macroeconomic environment, that have or are expected to have an effect on the Group.
Growth forecasts for the Israeli economy in 2023 were revised downwards; those of the Bank of Israel - from 2.8% to 2.5% and those of the International Monetary Fund's forecast - from 2.9% to 2.5%; however, S&P's downwards revision of its forecast was the sharpest - from 2.0% to 1.5%. On the other hand, the average of the economists' forecasts (according to Bloomberg) remained at 2.9%. The key revisions were global downwards revisions to growth and global trade, including by the IMF, further interest rate hikes, and concerns regarding the consequences of the judiciary reform. In connection with the judicial reform, the Bank of Israel described two scenarios: 1. A scenario in which the dispute around the changes to legislation pertaining to the judiciary is resolved in a manner that does not impact the economic activity from now on; 2. A scenario that presents an analysis of potential economic consequences if legislative and institutional changes shall involve an increase in Israel's risk premium, have an adverse effect on exports, and cause a decline in domestic investments and in private consumption. On a different subject - during the balance sheet period, the state budget was approved concurrently with the Economic Arrangements Law for 2023- 2024. In the geopolitical arena, Israel launched the "Shield and Arrow" military

operation in the Gaza Strip, during which hundreds of rockets were fired into the south and center regions of the country, which resulted in minor disruption to economic activity. S&P reiterated Israel's credit rating outlook at AA-. The unemployment rate was down to 3.6%. On the other hand, the Composite State-of-the-Economy Index of the Bank of Israel stopped deteriorating. Inflation "cooled down" in May more than expected, reaching a level of 4.6%, and the Bank of Israel increased its interest rate to 4.75%, and no longer signals that further hikes are expected. After significant underperformance in the first quarter, during the period subsequent to the balance sheet date the local share indexes recorded overperformance compared with other capital markets across the world:
The TA 125 Index increased by 2.9%, the yield on 10-year government bond was down to 3.66%, the Tel-Bond 60 Index was up by 2.5%, the NIS devalued against the USD and the EUR, reaching a rate of NIS 3.71 per USD 1, and NIS 4.05 per EUR 1.
The Bank of Israel upgraded its growth forecast for the Israeli economy for 2023 from 2.5% to 3.0%, apparently ignoring the risks of the judiciary reform and the reactions to it. The Bank of Israel claims that the upgrade stems mainly from the surprisingly positive trend in GDP data in the first quarter - 3.2% compared to an expected increase of 1.8% (according to forecasters' average). At a later date, the Central Bureau of Statistics revised the figure downwards to 2.9%, but on the other hand it published the estimated GDP figure for the second quarter, which was also surprisingly high, and increased by 3% compared with the expected 2.3%. As mentioned above, in May rating agency S&P cut Israel's growth forecast to 1.5%, mainly due to the risks arising from the judicial reform; on the other hand, Citi Bank reaffirmed Israel's growth forecast for 2023 at a relatively high level of 3.1%, arguing that the reform is not expected to have an immediate effect on GDP, since the increase in revenues remains strong and therefore the personal consumption will also remain strong. Citi's assessment of the situation was supported by the unemployment rate data, which was down in July from 3.6% to 3.5%. The Bank of Israel's semi-annual Financial Stability Report referred to the two scenarios regarding the effects of the judicial reform on the Israeli economy; those scenarios had already been presented by the Bank of Israel during the reporting period. Despite the legislation of the abolishment of the standard of reasonableness by the Knesset, Israel's debt risk premium (CDS) did not increase, and even decreased. Similarly, the two rating agencies - S&P and Fitch - affirmed Israel's credit rating and its rating outlook. Inflation rate in July was surprisingly low, for the third consecutive month, with an annual rate of 3.3%.
The TA 125 Index increased by 5.0%, the yield on 10-year government bond increased to 3.93%, the Tel-Bond 60 Index was up by 0.3%, the NIS devalued against the USD and the EUR, reaching a rate of NIS 3.77 per USD 1, and NIS 3.10 per EUR 1.
Growth rate in the USA during the first quarter was in line with expectations - 2.0%, and in Europe growth was disappointing with a contraction of 0.1% (in quarterly terms), that is to say - two consecutive quarters in which the economy contracted. The International Monetary Fund (in its April quarterly update) slashed its 2023 growth forecasts for the USA to 1.6% (and 0.8% for the Eurozone). The banking crisis in the USA - which began in March - continued, which was manifested in further withdrawal of deposits and further declines in prices of small banks' shares; at the same time,

concerns increased about the possibility of the US administration hitting the debt ceiling; this was reflected in a sharp increase in the USA's debt risk premium (CDS). Those concerns were resolved in May, and the debt risk premium declined back to previous levels. The US Federal Reserve has, indeed, increased its interest rate to 5.25%, but in view of the concerns regarding the economy it hinted heavily that this interest rate hike campaign approaches its end, also due to the sharp decline in inflation rate in May leading to annual levels of 4.0%, and expectation that inflation will cool even further, but that core inflation will remain "sticky". In Europe, inflation continued cooling until May, declining to annual levels of 6.1%; the ECB increased the interest on deposits to 3.25% and signaled that there will be further hikes. The relative "hawkishness" of the ECB, together with a correction to the sharp declines in the euro's exchange rates since 2022 (against the backdrop of concerns of an impending energy crisis) led to a sharp increase in the currency's exchange rate. Equity markets were supported by extensive optimism regarding the Artificial Intelligence (AI) revolution, which was reflected - through May - in a sharp rise in rates of a very small number of mega-tech shares, which drove stock indexes up. In June, prices of other shares increased too. The optimism in the markets was also driven by the announcement regarding the resolution of the US debt ceiling crisis, as referred to above.
The yield on 10-year US bonds increased to 3.84%, the S&P 500 Index increased by 10.3%, the EURO-STOXX 50 Index increased by 5.0%; and the EUR strengthened against the USD, reaching an exchange rate of 1.10%.
Growth in the second quarter was surprisingly good, with a 2.4% increase in the USA compared with expected growth of 1.8%, and in Europe - growth of 0.3% compared with an expectation of 0.2% (QoQ). In addition, Europe's growth rate in the first quarter was upgraded from -0.1% to 0.0%. The global inflation environment cooled faster than expected; in the USA, annual inflation reached 3.0% and in Europe - 5.3%. However, central banks were careful not to sound complacent; interest rates were increased both in the USA and in Europe; in the USA, rates increased to 5.50%, and in Europe to 3.75%; central banks continued to estimate that there may be further interest rate hikes, although in the USA market expectations are that the likelihood of such hikes is lower than 50%, and in Europe only one to two further interest rate hikes are expected. Central banks implement a new approach - a "data dependent" policy based on incoming information. Economic data from across the world indicate a continued slowdown, but expectations are that it will be a "soft landing" change; in the USA, for example, this was reflected in retail sales data and in new positions data. The central bank of Japan, which is normally a staunch supporter of loose monetary policy, made an unexpected move by introducing larger flexibility to its yield on 10-year bonds; the move was initially perceived as a type of "tightening", but at a later stage the central bank clarified that this was not the intended result of this move. Across the world there were many indications that the drop in commodity prices and in prices of physical products has stopped, which was reflected in increases in the prices of most commodities and in some of the marine freight rate indexes. In stock indexes there were increases in other sectors besides those recorded in technology stocks. The Fitch rating agency surprised the markets when it downgraded the USA's perfect credit rating.
The yield on 10-year US bonds increased to 4.27%, the S&P 500 Index decreased by 0.9%, the EURO-STOXX 50 decreased by 2.5%; and the EUR devalued slightly against the USD, reaching an exchange rate of 1.088.

The Group's business strategy and targets constitute forward-looking information, as defined in Section 32A of the Securities Law, and are based on the data and information available to the Group as of the report date, its plans as a result thereof, the market situation and the Group's position. The Group's business strategy and targets may change from time to time. In addition, the achievement of the Group's targets and strategy is uncertain and is not under the sole control of the Group. The Group's business strategy and targets may not materialize due to, among other things, changes in the Group's priorities, new needs of the Group, market developments, macro changes, other business opportunities, etc.
The multi-year strategic plan - which was approved in December 2020 - is based on four fundamental principles: yield-focused growth, technological innovation and efficiency, maximization of the portfolio's value and capital management, all of which are relevant to the group's key areas of activity: insurance, asset management, agencies and credit. Since the publication of the plan, the Company has acted consistently to implement and execute it. The Company reviews its targets from time to time in the light of its achievements and market conditions; accordingly, in March 2022, the Company's Board of Directors adopted an update to the strategic plan (hereinafter - the "Strategic Plan"), as part of which the Company's targets for the plan's period were updated as described in the chart below.


(*) For further details, please see Section 5.4.5 below.
The interim targets are based on (a) multi-year work plans for a 5-year period (from its approval date); (b) an assumption of net return on investment of 3%. Compared to the plan's objective, actual results are based on the actual returns in the financial markets in Israel and around the world, macroeconomic growth, the Company's results and other variables. For the Company's actual results taking into account a 3% return, see Sections 5.4-5.6.
The Group's operations are affected by constant regulatory changes and reforms. In addition, as the controlling shareholder of institutional entities, the Group must also deal with the minimum capital requirements that apply to the activity of the institutional entities, which impose, among other things, restrictions on dividend distribution by the institutional entities.
The Group's operations and results are significantly affected by the capital markets, including, among other things, the low-interest environment that has implications for its insurance liabilities and on the returns embodied in the Group's financial asset portfolios, and consequently - on the management fees and financial margins from investments as well.

Assets under management as of June 30, 2023
Premiums, gross, contributions towards benefits and proceeds in respect of investment contracts for 1-6/2023

Total assets under management by provident funds, excluding guaranteed return provident fund tracks, pension funds, ETFs, and customers' investment portfolios are not included in the Financial Statements. Proceeds in respect of investment contracts are not included in the premiums line item; rather, they are charged directly to liabilities in respect of insurance contracts and investment contracts.
For further details on the premiums in the various operating segments, please see Note 3 to the Financial Statements.


5.3.1. Set forth below are key data from the consolidated balance sheets (in NIS billion):

Total financial assets in respect of yield-dependent contracts and cash and cash equivalents in respect of yield-dependent contracts as of June 30, 2023, amounted to approximately NIS 101.7 billion, compared to approximately NIS 95.2 billion as of June 30, 2022, and NIS 96.1 billion as of December 31, 2022. Other assets as of June 30, 2023 amounted to NIS 53.9 billion, compared with NIS 50.9 billion as of June 30, 2022 and NIS 51.4 billion as of December 31, 2022.
Liabilities in respect of insurance contracts and yield-dependent investment contracts amounted to approximately NIS 98.3 billion as of June 30, 2023, compared to approximately NIS 93.1 billion as of June 30, 2022, and NIS 94 billion as of December 31, 2022. Other liabilities as of June 30, 2023 amounted to NIS 46.8 billion, compared with NIS 42.9 billion as of June 30, 2022 and NIS 43 billion as of December 31, 2022.


Set forth below is the composition of the Company's financial performance by segments in the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):


For the effects on the results at the segment level, please see details in Sections 5.5- 5.6 below.
| 1-6/2023 | 1-6/2022 | 1-12/2022 | |
|---|---|---|---|
| In NIS million | |||
| Payments and change in liabilities in respect of insurance contracts | |||
| and investment contracts - retention in the income statement | 9,899 | (1,890) | 1,965 |
| Net of amounts included | |||
| in the above amounts: | |||
| Investment gains (losses) in respect of yield-dependent policies(*) | 4,803 | (5,903) | (6,618) |
| Changes in interest | 103 | (1,120) | (1,645) |
| Special items in the insurance segment | (81) | (154) | (85) |
| Total investment income, changes in interest and special items | 4,825 | (7,177) | (8,348) |
| Total payments and change in liabilities in respect | |||
| of yield-dependent policies, net of investment income, | |||
| changes in interest and special items | 5,074 | 5,287 | 10,313 |
| 1-6/2023 | 1-6/2022 | 1-12/2022 | |
|---|---|---|---|
| In NIS million | |||
| Items from the income statement | |||
| Investment income | 5,289 | (5,435) | (5,555) |
| Equity profits | 43 | 30 | 62 |
| Other comprehensive income | 297 | (324) | (231) |
| Tax effect on comprehensive income | 141 | (177) | (133) |
| Total | 5,770 | (5,906) | (5,858) |
| Less: | |||
| Investment gains (losses) in respect of yield-dependent policies | 4,803 | (5,903) | (6,618) |
| Gains (losses) attributable to the credit and financial services segment | 168 | 34 | 103 |
| 4,971 | (5,869) | (6,514) | |
| Total investment income - nostro | 799 | (37) | 657 |
| Income from nostro investments, real return at 3% | 1,365 | 1,483 | 2,661 |
| Income from nostro investments, over or above real return at 3% (*) | (566) | (1,520) | (2,004) |
(*) See Section 5.4.5 below.


Operating profit after deducting effects of the capital market, Special Items and interest increased by NIS 57 million in the reporting period, compared with the corresponding period last year.
In the reporting period, the nominal return from nostro investments was an annualized 6.2%, and the real return in the reporting period was an annualized 1.2%. After transferring annual real return of 3%, and an amount in respect of variable management fees, which is calculated based on the real return, the negative effect of the capital market after the said deduction is NIS 566 million, see Section 5.4.1 regarding the review of sources of earnings.
The total positive change in investment income, in excess of a real return of 3% in the reporting period compared with the corresponding period last year totaled NIS 954 million, in view of the lower downturns in financial markets in Israel and across the world. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax). The change as a result of the effect of the risk-free interest rate curve and the decline in the illiquidity premium in the reporting period compared with the corresponding period last year caused a NIS 1,223 million decrease in profit in the reporting period, compared with the corresponding period last year. The total net negative effect of the interest and capital market effects (in excess of a real return of 3%) in the reporting period amounted to NIS 669 million before tax, as reflected in the above chart.
During the reporting period, the special items line item decreased by NIS 161 million compared with the corresponding period last year; most of the decrease stemmed from the recognition of a higher one-off earning in the corresponding period last year as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance, and a one-off earning from assuming control over The Phoenix Capital net of studies compared with the recognition of one-off capital gain, during the reporting

period, from assuming control in FNX Private Partnerships (for more information, see Section 1.3.5 above), which was partially offset from a study on costs for disability coverage (for further details, see Section 1.3.4 above).
For information about the effects on the results at the segment level, please see details in Sections 5.5-5.6 below.

Operating profit after deducting effects of the capital market, Special Items and interest decreased by NIS 54 million in the second quarter of the reporting period, compared with the corresponding quarter last year.
After transferring annual real return of 3%, and an amount in respect of variable management fees, which is calculated based on the real return, the negative effect of the capital market after the said deduction is NIS 116 million, see Section 5.4.1 regarding the review of sources of earnings.
The total positive change in investment income, in excess of a real return of 3% in the second quarter of the reporting period compared with the corresponding quarter last year totaled NIS 730 million, in view of the lower downturns in financial markets in Israel and across the world.
As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).
The change as a result of the effect of the risk-free interest rate curve and the decline in the illiquidity premium in the second quarter of the reporting period compared with the corresponding quarter last year is a reduction in profit of NIS 576 million. The total net negative effect of the interest and capital market effects (in excess of a real return of 3%) in the second quarter of the reporting period amounted to a pre-tax profit of NIS 369 million as reflected in the above chart.
During the second quarter of the reporting period, the special items line item decreased by NIS 76 million compared with the corresponding quarter last year; most of the decrease stemmed from the recognition of a higher one-off earning in the corresponding period last year as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance, and a one-off earning from assuming control, in the second quarter of the reporting period, in The Phoenix Capital compared with the recognition of one-off capital gain from assuming control over FNX Private partnerships (for more information, see Section 1.3.5 above), which was partially offset from a study on costs for disability coverage in the life insurance segment (for further details, see Section 1.3.4 above).
5.4.6. Set forth below is the composition of the differences between the interest rate effects and main special items on pre-tax insurance liabilities for the 6-month in the reporting period compared to the corresponding period last year (in NIS million):

5.4.7. Set forth below is the composition of the differences between the interest effects and main special items effects on pre-tax insurance liabilities in the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):


| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | |
|---|---|---|---|---|---|
| Return on shareholders' equity for the | |||||
| period (based on comprehensive income | 6.0% | 11.4% | 9.0% | 7.9% | 11.4% |
| for the period)(*) | |||||
| Adjusted return on shareholders' equity for | |||||
| the period (based on comprehensive | 13.0% | 12.3% | 15.0% | 15.4% | 11.9% |
| income for the period)(**) |
Set forth below is a composition of the main effects and changes on the results of the property and casualty insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million, before tax):

The NIS 141 million increase in underwriting profits in the reporting period compared with the corresponding period last year stems mainly from the compulsory motor insurance subsegment, motor property insurance subsegment, and other liability subsegments; the said profit is offset against a decrease in profitability in other property subsegments.
The NIS 339 million increase in investment income in the reporting period compared with the corresponding period last year stemmed from a lower negative effect in financial markets in Israel and globally during the reporting period, compared with the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities. The NIS 73 million decrease in interest income in the reporting period compared with the corresponding period last year stems mainly from an increase in insurance liabilities in compulsory motor insurance and from a decrease in liability insurance as a result of a change in the discount rate.


5.5.1.1. Set forth below is the pre-tax comprehensive income in the various subsegments of property and casualty insurance (P&C) for the reporting period compared with the corresponding period last year (in NIS million):


Set forth below is the pre-tax underwriting profit in the various subsegments of property and casualty insurance (P&C) for the reporting period compared with the corresponding period last year (in NIS million):

The increase in underwriting profit in the reporting period compared with the corresponding period last year arises mainly from the motor property subsegment, mainly as a result of an improvement of the damage rate, and from the liability subsegment as a result of a NIS 40 million decrease in insurance liabilities in the Sales Law guarantees subsegment; for more information, see Note 8A(4) to the financial statements. The increase in the compulsory motor subsegment stems mainly from an increase in average premium. On the other hand, some of the increase in profitability was offset against a decrease in profitability of other property insurance subsegments as a result of an increase in the cost of claims in home and business insurance.
5.5.1.2. Following is the pre-tax comprehensive income (loss) in the various subsegments of property and casualty insurance for the second quarter of 2023 compared with the corresponding quarter last year (in NIS million):



The increase in underwriting profit in the second quarter of the reporting period compared with the corresponding quarter last year arises mainly from the compulsory motor subsegment as a result of an increase in the average premium and an increase in the underwriting profit in the motor property subsegment, mainly as a result of an improvement in the damage rate from accidents, that was partially offset due to an increase in vehicle thefts.
The increase in profitability was partially offset against a decrease in profitability of other property insurance subsegments as a result of an increase in the cost of claims in home and business insurance, and in the liability subsegment - as a result of an increase in the cost of claims in third party insurance.
| Motor property (*) | ||||||
|---|---|---|---|---|---|---|
| In NIS million | ||||||
| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | ||
| Gross loss ratio | 86.0% | 86.0% | 87.8% | 69.8% | 91.0% | |
| Retention loss ratio | 86.0% | 86.1% | 87.8% | 69.9% | 91.1% | |
| Gross combined ratio | 107.0% | 110.7% | 108.2% | 96.0% | 116.6% | |
| Retention combined ratio | 107.0% | 110.7% | 108.2% | 96.0% | 116.6% |
| Property and other subsegments | |||||
|---|---|---|---|---|---|
| In NIS million | |||||
| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | |
| Gross loss ratio | 63.5% | 35.0% | 45.8% | 34.1% | 31.4% |
| Retention loss ratio | 37.0% | 21.9% | 38.1% | 20.8% | 22.5% |
| Gross combined ratio | 90.0% | 62.5% | 71.6% | 63.4% | 58.9% |
| Retention combined ratio | 68.7% | 51.9% | 69.4% | 59.6% | 53.3% |
(*) Includes UGL (excess value of illiquid assets); for more information, see Section 5.5.1 above.

Earnings on investments affects the profitability of this segment, some of whose products (such as long-term care coverage) are characterized by accrual of significant reserves over long periods. Investment earnings are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that at this stage, the Company has ceased to market long-term care insurance policies in view of the guaranteed return in long-term care insurance plans, and the complexity of the related reinsurance in this area.
The agreement and the group long-term health insurance policy for Maccabi members expire on December 31, 2023. The Company informed the policyholder - "Maccabi Healthcare Services" - and the Commissioner that it will not extend the agreement, and that it is making preparations for the expiry of the agreement in accordance with its provisions.

The decrease in underwriting profits in the reporting period compared to the corresponding period last year in the amount of NIS 61 million is mainly due to longterm care insurance policies.
The NIS 41 million increase in investment income in the reporting period compared with the corresponding period last year stemmed mainly from more positive effects in financial markets in Israel and globally, compared with adverse effects in financial markets in Israel and globally in the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities.
The NIS 736 million decrease in interest income in the reporting period compared with the corresponding period last year stems mainly from an increase in insurance liabilities as a result of the decrease in the illiquidity premium in the reporting period compared to the decrease in insurance liability as a result of the effect of the increase in the discount rate in the corresponding period last year, and the change in excess value of illiquid assets, which was recognized in the LAT reserve.
In addition, the results in the reporting period compared with the corresponding period last year were affected from a NIS 14 million decrease in earnings in the Special Items

line item. In the reporting period, the Company recognized a NIS 113 million one-off capital gain from assuming control in the FNX Private partnerships (for more information, see Section 1.3.5 above); this gain was partially offset against changes in assumptions, model revisions, and others. In the corresponding period last year, the Company recorded a one-off earning of NIS 99 million as a result of the transfer of the Company's rights in Phoeniclass Ltd. to The Phoenix Insurance; this one-off earning was recognized in the LAT reserve as part of the excess value of illiquid assets.
Following is a composition of the main effects and changes on the results of the health insurance subsegment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):

The NIS 30 million decrease in underwriting profit in the second quarter of the reporting period, compared to the corresponding quarter last year, is mainly due to a decrease in profit from long-term health insurance policies, which was partially offset against an increase in travel insurance policies.
The NIS 7 million increase in investment income in the second quarter of the reporting period compared with the corresponding quarter last year stemmed mainly from positive effects in financial markets in Israel and globally, compared with negative effects in financial markets in Israel and globally in the corresponding period last year, in relation to the mix of the portfolio against the segment's liabilities.
The NIS 321 million decrease in interest income in the second quarter of the reporting period compared with the corresponding quarter last year stems mainly from an increase in insurance liability as a result of the effect of the decrease in the illiquidity premium in the second quarter of the reporting period, compared to a decrease in insurance liability in the corresponding quarter last year, and the change in excess value of illiquid assets, which was recognized in LAT reserve (for further details, see Section 1.3.5 above).
Furthermore, the results in the reporting period compared with the corresponding period last year were impacted by the NIS 79 million increase in the special items line item mainly as a result of the recognition of a NIS 113 million one-off earning in the second quarter of the reporting period as a result of assuming control over the FNX Private partnerships (for further details, see Section 1.3.5 above); the profit was partially offset by changes in assumptions, model revisions, etc.
As of June 30, 2023, the LAT reserve balance amounts to NIS 358 million.

5.5.2.1. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of health insurance for the reporting period compared with the corresponding period last year (in NIS million):

5.5.2.2. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of health insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

5.5.2.3. Set forth below is the pre-tax underwriting income (loss) in the various subsegments of health insurance for the reporting period compared with the corresponding period last year (in NIS million):

The decrease in underwriting profits in the reporting period compared to the corresponding period last year in the amount of NIS 61 million is mainly due to an increase in incidence of claims and a change in LAT reserve for LTC policies compared with last year.

Set forth below is the pre-tax underwriting income (loss) in the various subsegments of health insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):

The decrease in underwriting profits in the second quarter of the reporting period, compared to the corresponding quarter last year, in the amount of NIS 30 million is mainly due to an increase in incidence of claims and change in LAT reserve.
5.5.3.1. Earnings on investments have a material effect on the profitability of this segment, which is characterized by accrual of significant reserves over long periods. Investment earnings are affected by financial market fluctuations, as well as changes in interest rates and the rate of change in the Israeli consumer price index, which affect the yields on liquid financial asset portfolios held against insurance and contingent claims reserves. It should be noted that a significant portion of the investment income was carried to participating policies and has no direct effect on the Company's results.
Set forth below is the composition of the main effects and changes on the results of the life insurance subsegment for the reporting period compared to the corresponding period last year (in NIS million):


The results in the reporting period were affected mainly by a NIS 414 million decrease in profit as a result of the change in the risk-free interest rate curve and illiquidity premium during the reporting period compared with the corresponding period last year. In addition, the results in the reporting period compared with the corresponding period last year were affected by a NIS 40 million decrease in underwriting profit, which stemmed mainly from the decrease in fixed management fees as a result of the negative yields.
Furthermore, in the reporting period, the results were affected - compared with the corresponding period last year - by a NIS 61 million decrease in investment income in excess of a real return of 3%, which mainly arose from lower revenues on nostro investments in the corresponding period last year. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).
The NIS 46 decrease in profit in the special items line item stems from a NIS 38 million profit in the reporting period, mainly as a result of the effects of the study regarding long-term health insurance (for more information, see Section 1.3.5 above), which was partially offset by model revisions and provisions for class actions, compared with a NIS 84 million profit in the corresponding period last year as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by the implementation of a circular regarding the revision to mortality assumptions, model revisions and provisions for class actions.

The results in the second quarter of the reporting period compared with the corresponding quarter last year were affected mainly by a NIS 162 million decrease in profit as a result of the change in the risk-free interest rate curve and illiquidity premium. In addition, the results in the second quarter of the reporting period compared with the corresponding quarter last year were affected by a NIS 28 million decrease in underwriting profit, which stemmed

mainly from the decrease in fixed management fees as a result of the negative yields, and an increase in general and administrative expenses.
Furthermore, in the second quarter of the reporting period, the results were affected - compared with the corresponding quarter last year - by a NIS 76 million decrease in investment income in excess of a real return of 3%, which mainly arose from lower revenues on nostro investments in the corresponding period last year. As of June 30, 2023, the effect of the decline in planholders' portfolios will lead to non-collection of future variable management fees in the amount of approx. NIS 571 million, before tax (as of the report publication date - NIS 529 million before tax).
The NIS 54 decrease in profit in the special items line item stems from a NIS 49 million profit in the second quarter of the reporting period, mainly as a result of the effects of the study regarding long-term health insurance (for more information, see Section 1.3.5 above), which was partially offset by model revisions and provisions for class actions, compared with a NIS 103 million profit in the corresponding quarter last year as a result of the effects of a study on retirement age and pension uptake rates, which was partially offset by the implementation of a circular regarding the revision to mortality assumptions, model revisions and provisions for class actions.
5.5.3.2. Set forth below is the results of the (pre-tax) comprehensive income (loss) in the various subsegments of life insurance for the reporting period compared with the corresponding period last year (in NIS million):

5.5.3.3. Set forth below is the (pre-tax) comprehensive income (loss) in the various subsegments of life insurance in the second quarter of the reporting period compared with the corresponding quarter last year (in NIS million):



The NIS 40 million decrease in underwriting profits in the reporting period, compared with the corresponding period last year is attributed mainly to a decrease in underwriting profit in policies issued through 1990, as a result of a decrease in the financial margin, and the effect of the expenses, and in policies issued as from 2004 - as a result of the decline in fixed management fees and the effect of the expenses.

The NIS 28 million decrease in underwriting profits in the second quarter, compared with the corresponding quarter last year is attributed mainly to a decrease in underwriting profit in policies issued through 1990, as a result of a decrease in the financial margin, and the effect of the expenses, and in policies issued as from 2004 - as a result of the decline in fixed management fees and the effect of the expenses.

| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | |
|---|---|---|---|---|---|
| In NIS million | |||||
| Investment gains (losses) credited to policyholders net of management fees |
4,118 | (5,442) | 3,447 | (4,272) | (6,325) |
| Management fees | 296 | 300 | 147 | 149 | 591 |
(*) Excluding investment gains credited (debited) to policyholders in the health insurance segment.
Set forth below are the nominal returns on participating policies in respect of policies issued from 1992 to 2003:
| Policies issued up to 2004 (Fund J) | |||||||
|---|---|---|---|---|---|---|---|
| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | |||
| Nominal returns before payment of management fees |
4.21% | (5.54%) | 3.77% | (4.68%) | (5.69%) | ||
| Nominal returns after payment of management fees Real returns before payment of management fees Real returns after payment of management fees |
3.92% | (5.84%) | 3.63% | (4.82%) | (6.29%) | ||
| 1.71% | (8.41%) | 2.38% | (6.48%) | (10.42%) | |||
| 1.42% | (8.70%) | 2.24% | (6.62%) | (10.99%) |
Fluctuations in these returns are a function of capital market returns in Israel and abroad, changes in the consumer price index, and changes in the exchange rate of the shekel against major currencies.
| Policies issued from 2004 and thereafter | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1-6/2023 | 1-6/2022 | 4-6/2023 | 4-6/2022 | 1-12/2022 | |||||
| Nominal returns before payment of management fees |
4.56% | (6.61%) | 3.72% | (5.44%) | (6.64%) | ||||
| Nominal returns after payment of management fees |
4.11% | (7.05%) | 3.50% | (5.66%) | (7.49%) | ||||
| Real returns before payment of management fees |
2.05% | (9.44%) | 2.33% | (7.23%) | (11.32%) | ||||
| Real returns after payment of management fees |
1.61% | (9.87%) | 2.11% | (7.45%) | (12.13%) |



The decrease in loss of NIS 575 million and NIS 480 million, respectively, in other capital gains in the reporting period and the second quarter compared with the corresponding period last year stems mainly from lower declines in financial markets in Israel and globally compared with the corresponding period last year.

The Group manages various types of pension funds and provident funds through The Phoenix Pension and Provident Fund. In addition, the Group manages - through Halman-Aldubi IEC Gemel Ltd. - the central provident fund for annuity of Israel Electric Corporation employees. As of the report date, the Company holds - directly and indirectly - 100% of the shares of The Phoenix Pension and Provident, and 100% of the shares of Halman-Aldubi IEC Gemel Ltd.
Set forth below is the composition of the main effects and changes on the results of the investment management - pension and provident subsegment for the reporting period compared to the corresponding period last year (in NIS million):

Set forth below is the composition of the main effects and changes on the results of the asset management - pension and provident segment for the second quarter of 2023 compared to the corresponding quarter last year (in NIS million):


The Group manages provident and advanced education funds through The Phoenix Pension and Provident, a wholly owned subsidiary of the Company, which manages benefits and severance pay funds, advanced education funds, a central benefits and severance pay fund, a yield-guaranteed provident fund, an investment provident fund, a child long-term investment provident fund for savings, a self-directed benefits provident fund, and a personally managed advanced education fund.
The pre-tax comprehensive income in the reporting period amounted to approximately NIS 53 million compared to approximately NIS 54 million during the corresponding period last year.The pre-tax comprehensive income in the second quarter of the reporting period amounted to approximately NIS 36 million compared to approximately NIS 37 million during the corresponding quarter last year.


Based on Ministry of Finance data,5 aggregate contributions towards benefits in the provident funds subsegment in the first half of 2023 totaled approximately NIS 23.1 billion, compared to a total of approximately NIS 27.0 billion in the corresponding quarter last year, reflecting a decrease of approximately 14.14%. According to the Ministry of Finance data, as of June 30, 2023, total assets under management in the provident funds subsegment amounted to approximately NIS 685 billion, compared to approximately NIS 644 billion as of June 30, 2022, an increase of approximately 6.56%.
The Group's pension subsegment is conducted through The Phoenix Pension and Provident, a wholly-owned subsidiary of the Company.
The pre-tax earnings in the reporting period amounted to NIS 6 million compared with pre-tax earnings of NIS 5 million in the corresponding period last year. The pre-tax comprehensive income in the second quarter of the reporting period amounted to approximately NIS 3 million compared to approximately NIS 1 million during the corresponding quarter last year.
5 Based on Gemel Net data.


Based on Ministry of Finance data,6 aggregate contributions towards benefits in the new comprehensive pension funds subsegment in the first half of 2023 totaled approximately NIS 32.2 billion, compared to a total of approximately NIS 27.7 billion in the corresponding quarter last year, reflecting an increase of approximately 16.1%.
According to Ministry of Finance data, as of June 30, 2023, total assets under management in the new comprehensive pension funds subsegment amounted to a total of approximately NIS 671 billion, compared to approximately NIS 574 billion on June 30, 2022, an increase of approximately 17.0%.
The activity in this area is carried out mainly through The Phoenix Investment House (formerly - Excellence Investments), and as from June 30, 2022 partly through The Phoenix Advanced Investments. For more information about the completion of the merger of KSM ETN Holdings Ltd. with The Phoenix Investment House in January 2023, see Note 8G to the financial statements.

6 Based on Pension Net data.

The NIS 36 million decrease in profits in the reporting period compared with the corresponding period last year arises mainly from a NIS 48 million improvement in the profitability of the TASE Member, which was partially offset against a NIS 84 million decrease in profits, mainly as a result of the recognition of a one-off capital gain from assuming control in The Phoenix Capital in the corresponding period last year.

The NIS 64 million decrease in profits in the second quarter of the reporting period compared with the corresponding quarter last year arises mainly from a NIS 28 million improvement in the profitability of the TASE Member, which was offset against a NIS 83 million decrease in profits, mainly as a result of the recognition of a one-off capital gain from assuming control in The Phoenix Capital in the corresponding period last year.
Set forth below is the composition of the main effects and changes on the results of the insurance agencies subsegment for the reporting period compared to the corresponding period last year (in NIS million):



In the reporting period, hiring of new employees in Israel was down, which led to a decline in commissions. In the reporting period, EBITDA increased to NIS 167 million compared with NIS 161 million in the corresponding period last year.
As to the option of introducing an international partner to The Phoenix Agencies, see Section 1.3.6(c) above.
Set forth below is the composition of the main effects and changes on the results of the credit segment subsegment for the reporting period compared to the corresponding period last year (in NIS million):



The increase in operating profit in the reporting period compared with the corresponding period last year stems mainly from an increase in activity turnovers and an increase in credit spreads in the reporting period compared with the corresponding period last year. Gama continued to consistently expand the credit card activity as well as the business credit portfolio and guarantee activity. As part of the Company's responsible growth strategy, and in view of the macroeconomic picture that is reflected in significant interest rate hikes in Israel, Gama reduced its checks factoring activity.
Gama's credit loss expenses in the reporting period amounted to NIS 7.7 million, of which NIS 3.5 million is recorded in respect of a general provision for debts in the credit portfolio, which are ordinary debts.
For more information regarding The Phoenix Investments' tender offer subsequent to the balance sheet date, see Section 1.3.9 above.
Set forth below is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to operating segments in the reporting period compared to the corresponding period last year (in NIS million, before tax):


Following is the composition of the main effects and changes on the results of "other" segment and activity that is not attributed to operating segments in the second quarter of 2023 compared to the corresponding quarter last year (in NIS million before tax):

The results in the reporting period and in the second quarter compared with the corresponding periods last year were mainly affected by a NIS 5 million decrease and a NIS 7 million decrease, respectively, in the financial margin, and from a NIS 16 million one-off capital gain as a result of buyback of bonds.
The consolidated cash flows from operating activities in the reporting period amounted to approximately NIS 2.096 million. The consolidated cash flows used in investing activities in the reporting period amounted to approximately NIS 431 million and included mainly a total of NIS 169 million used to purchase property, plant, and equipment, NIS 200 million used to acquire and capitalize costs of intangible assets, and NIS 88 million used for investment in associates.
The consolidated cash flows used for financing activities in the reporting period amounted to approximately NIS 21 million; the cash flows included, among other things, a total of NIS 772 million arising from a REPO liability, a total of NIS 678 million used to repay financial liabilities, and a total of NIS 227 million arising from issuance of financial liabilities.
The Group's cash and cash-equivalent balances increased from a total of approximately NIS 19,798 million at the beginning of the reporting period to approximately NIS 21,442 million at the end of the reporting period.
For liquidity purposes, the Company relies, among other things, on net financial assets and on distribution of dividends by some of its investees. Set forth below is a breakdown of the material investees for liquidity purposes.
It is hereby clarified that some of the investees are subject to regulatory provisions in addition to the distribution restrictions set in the Companies Law, 1999:
A. The Phoenix Insurance - the dividends from The Phoenix Insurance depend on the solvency ratio target set by the Board of Directors, which is higher than the minimum target set by the Banking Supervision Department; the dividends also depend on the policy set by the Board of Directors of The Phoenix Insurance, see Section 2.1 above.
For the purpose of making a conservative assessment of the Company's future cash flows, the Company assumes a payment of dividend by The Phoenix Insurance to the Phoenix Holdings in accordance with the work plan.
The Company considers its holding in a Restricted Tier 1 capital instrument of The Phoenix Insurance as a source of liquidity, and classifies this holding as a financial investment (for more details, see Section 1.3.3 above).
B. The Phoenix Pension and Provident - the dividend paid by The Phoenix Pension and Provident depend on the capital requirements set by the Banking Supervision Department, and on The Phoenix Pension and Provident's dividend distribution policy. The Company does not expect payment of dividend by The Phoenix Pension and Provident in the next two years. However, for purposes of the future cash flow, the Company takes into account the repayment of the loan it extended to The Phoenix Pension and Provident.(For further details, please see Section 1.3.7 below).
Furthermore, the Company controls the following entities which are not subject to special Regulatory Restrictions in addition to the Companies Law:
It should be noted that such work plans are reflected in the Company's targets as stated in Section 4 above.
Set forth below is a table providing a breakdown of the net financial debt (the table includes the following companies: the Company, The Phoenix Investments and The Phoenix Agencies (for information regarding the restructuring in The Phoenix Agencies, see Section 1.3.6 above) and does not include The Phoenix Insurance and The Phoenix Pension and Provident, which are subject to Regulatory Restrictions in addition to the distribution restrictions set out in the Companies Law, 1999):
| as of June 30, | as of June 30, | As of December | |
|---|---|---|---|
| 2023 | 2022 NIS thousand |
31, 2022 | |
| Financial assets | |||
| Cash and cash equivalents | 245 | 151 | 160 |
| Other financial investments | 1,094 | 1,087 | 1,158 |
| Total assets | 1,339 | 1,238 | 1,319 |
| Less current maturities | |||
| Financial liabilities - current (*) | 71 | 45 | 35 |
| Current financial assets net of current maturities | 1,268 | 1,193 | 1,284 |
| Non-current financial liabilities | |||
| Non-current financial liabilities | 1,473 | 1,429 | 1,496 |
| Other liabilities | - | 5 | 10 |
| Total liabilities | 1,473 | 1,434 | 1,506 |
| Net financial debt | (205) | (241) | (222) |
| LTV | 2% | 2% | 2% |
(*) The other financial investments include an investment in a Restricted Tier 1 capital instrument of The Phoenix Insurance, which has been listed on the main list since April 2023, amounting to NIS 1,024 million (fair value as of June 30, 2023 - NIS 979 million). Stock exchange value as of August 22, 2023 is NIS 959 million.
(**) The Company LTV is calculated as net financial debt as described above, in relation to the Company's market value as of March 31, 2023. For the calculation of LTV in accordance with financial covenants, please see Section 9.2 below.
(***) The Phoenix Agencies declared a NIS 675 million dividend to the shareholders, of which NIS 250 million were paid as of the report publication date.

Generally, during the reporting period there were no material changes in the exposure to market risks and the manner of management of those risks compared to what is described in the 2022 Periodic Report, except as follows:
In June 2023, the Company executed a buyback of NIS 124 million par value of bonds (Series 6). The bonds are not linked to the CPI (principal and interest), and bear unlinked annual interest, as stated above, at the rate of 1.94%, which is paid in two annual payments in 2023-2032. Following this acquisition, there has been a change in the exposure to shekel interest rates in relation to the data as of March 30, 2023.
The following table summarizes the results of the sensitivity tests to the non-linked shekel interest rate on profit before tax, as of in June 30, 2023. The results are presented in NIS million, and do not include the insurance company:
| Profit (loss) from changes in the risk factor |
Profit (loss) from changes in the risk factor |
|||||||
|---|---|---|---|---|---|---|---|---|
| Type of instrument | Absolute increase of 2% |
10% increase |
5% increase |
Fair value |
5% decrease |
Decrease of 10% |
Absolute decrease of 2% |
|
| Government bonds | (0.8) | (0.2) | (0.1) | 39.8 | 0.1 | 0.2 | 1.1 | |
| Corporate bonds | (2.1) | (0.0) | (0.0) | 31.1 | 0.0 | 0.0 | 2.2 | |
| Capital note to the insurance company |
- | - | - | - | - | - | - | |
| MAOF options | - | - | - | - | - | - | - | |
| Total assets | (3.0) | (0.2) | (0.1) | 70.8 | 0.1 | 0.2 | 3.2 | |
| Loans from banking corporations | - | - | - | - | - | - | - | |
| The Phoenix bonds | 24.3 | 4.8 | 2.4 | (683.1) | (2.5) | (5.0) | (28.0) | |
| Total liabilities | 24.3 | 4.8 | 2.4 | (683.1) | (2.5) | (5.0) | (28.0) | |
| Total | 21.4 | 4.6 | 2.3 | (612.2) | (2.4) | (4.7) | (24.8) |
(*) The value of The Phoenix's bonds under the model is 3.4% lower than their market value.
Fair value: Fair value was calculated using the discounted cash flow model, using the suitable interest rate for the cash flow period. The discount rate was calculated based on the market interest rate for the cash flow period, plus the risk premium derived from the security's rating.
Scenarios: For the interest risk, the calculation was based on absolute increase/decrease of 2% during the course of a day. This scenario was selected after a study of the yield curve database found that in the past 10 years, no absolute change exceeding 2% was observed in any single day. Scenario outcomes were calculated at the single asset level, so as to avoid distorting results by aggregating different instruments.
| s ind ies in in I el No n-l ink ed CP I-li nke d For eig net ite ice Tot al n c urr enc mo ary ms com pan sra s com pan y y Inta ible As set 1, 830 ,7 84 476 861 10, 618 1, 008 ,1 91 3, ng s - - - - , Def d ta ts 80, 623 779 10, 036 6,4 48 erre x a sse - - - - Def d a isiti ts 034 619 991 2, 1, ,54 1 1, erre cqu on cos - - - - - - , lant & ipm Pro ty, ent 147 634 2,1 00 10, 792 1, 077 ,41 5 1, per p equ - - - - , Inv est nts in i ste 23, 439 19, 929 140 995 1,4 56, 411 1, me nve es - - - - , Inv est nt p erty in t me rop res pec of y ield -de den t co ntra cts 2, 206 935 2, pen - - - - - - - , Inv est nt p erty the 86, 334 1,1 1,1 me rop - o r - - - - - - - Rei ts 3, 604 340 3, nsu ran ce a sse - - - - - - - , dit for cha f se Cre ities 644 000 111 000 755 pur se o cur - - - - - - , , Cur t ta ts 20, 815 2 6 226 ,55 4 ren x a sse - - - - bles d d ebit ba lanc Rec eiva 415 ,7 25 8, 013 48, 818 7,5 74 446 ,5 32 an es - - - Pre miu coll ect ible 026 855 1, 1, ms - - - - - - - , l inv Fina ncia est nts in r ect me esp of y ield -de den t co ntra cts 80, 603 ,5 91 80, pen - - - - - - - Fina ncia l inv for hold of bon ds, ETN est nts me ers s, sho rt E TNs osit e E TNs dep osit rtifi cat , co mp ce es , and str uct d b ond 194 000 ure s - - - - - - - , dit of f Cre in r ect act orin esp g, clea d fi ring cing 3,4 88, 853 3,4 an nan - - - - - - - Liqu id d ebt 9, 815 203 140 828 08 811 set 14, 417 5, 646 ,1 5, as s - - - , Illiq uid deb t as set 502 ,51 1 529 ,44 6 29, 000 937 ,55 2 12, 003 15, 276 930 17, s - - , Sha 293 821 14, 820 1, 909 806 2, res - - - - - , , Oth 17, 149 55, 096 51, 722 5,5 12, 779 5, er - - - - Cas h a nd h e ival s in ent cas qu t of ield -de den 18, 728 67 18, t co ntra cts ,4 res pec pen y - - - - - - - Oth ash d c ash uiva lent 460 ,5 32 63, 000 90, 583 33, 191 2, 065 ,75 2 2,7 er c an eq s - - - - - Tot al a ts 2, 056 02 2 584 607 228 365 2,5 48, 953 2,7 98, 606 3,5 73, 073 194 000 143 609 ,4 39 155 ,5 sse , , , , , Liab ilitie t of s in ins ntra cts res pec ura nce co and ield -de den t in tme nt c ont ract 1, 045 054 26, 204 ,45 3 27, 249 no n-y pen ves s - - - - - - , Liab ilitie s in t of ins ntra cts res pec ura nce co and ield -de den t in tme nt c ont ract 98, 348 ,4 93 98, 348 y pen ves s - - - - - - - Liab ilitie t of de ferr ed s in tax 35, 623 85, 469 426 280 547 res pec es - - - - - , Liab ility for loye e b fits t 24, 105 208 185 4, 47, 75, em p ene , ne - - - - - Liab ility in t of t ta 57, 186 4,7 98 9,4 91 5, 636 77, res pec cu rren xes - - - - abl nd dit bala Pay 482 ,7 63 429 93, 776 42, 378 3,5 66, 793 4,1 86, es a cre nce s - - - Liab ilitie s fo r bo nds sh , ET Ns, ort ETN ite s, c om pos nd red bo nds ETN stru ctu 193 000 193 s a - - - - - - - , Fina ncia l lia bilit ies ( *) 2, 329 6 912 655 142 000 2, 817 3, 027 610 998 80 ,57 7, ,4 14, - - , , , Tot al l iab ilit ies 2, 836 ,44 4 969 84 1 142 ,4 29 35, 623 1, 231 914 3, 083 687 193 000 136 ,5 97, 320 145 090 , , , , , |
NIS | Oth er non - |
sio pen n |
Cre dit co mp any |
ETN link age s - to iou var |
i ins Isr ael ura nce |
||||
|---|---|---|---|---|---|---|---|---|---|---|
| 326 ,45 4 |
||||||||||
| 97, 886 |
||||||||||
| 654 32 ,5 |
||||||||||
| 237 941 , |
||||||||||
| 640 ,77 4 |
||||||||||
| 206 935 , |
||||||||||
| 86, 334 |
||||||||||
| 604 340 , |
||||||||||
| 000 , |
||||||||||
| 247 377 , |
||||||||||
| 926 662 , |
||||||||||
| 026 855 , |
||||||||||
| 603 ,5 91 |
||||||||||
| 194 000 , |
||||||||||
| 88, 853 |
||||||||||
| 371 , |
||||||||||
| 287 ,44 2 |
||||||||||
| 218 ,44 7 |
||||||||||
| 636 ,74 6 |
||||||||||
| 728 67 ,4 |
||||||||||
| 13, 058 |
||||||||||
| 93, 065 |
||||||||||
| ,5 07 |
||||||||||
| ,4 93 |
||||||||||
| 372 | ||||||||||
| , 498 |
||||||||||
| 111 | ||||||||||
| 139 | ||||||||||
| 000 | ||||||||||
| , 413 38 ,1 |
||||||||||
| 258 | ||||||||||
| , , |
al e Tot xpo sur e |
( 22) 780 ,4 |
( ) 385 234 |
85, 936 |
2,5 13, 330 |
1,5 66, 692 |
489 386 |
1, 000 |
7, 01 2,1 19 |
, 10, 502 807 , |
Linkage bases of assets and liabilities in the consolidated balance sheet (in NIS thousand) as of June 30, 2023
85,936(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked
2,513,330 1,566,692 489,386
| NIS | ETN lin kag e to s - |
li ins Isr ae |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| No n-l ink ed |
CP I-l ink ed |
For eig n c en cy urr |
Oth er no n- net ite mo ary ms |
sio pen n ies in com pan |
ies in com pan l Isr ae |
rio us ind va ice s |
ura nce com pan y |
To tal |
|
| Int ible As set ang s |
- | - | - | 1, 707 983 |
442 768 |
5, 950 |
- | 762 425 |
2, 919 126 |
| Def ed tax set err as s |
- | - | - | , 60, 747 |
, 63 |
6, 233 |
- | , - |
, 67, 043 |
| Def ed uis itio ost err acq n c s |
- | - | - | 3, 535 |
700 677 |
- | - | 576 814 1, |
2, 281 026 |
| lan t & Pro ty, uip nt per p eq me |
- | - | - | 178 256 |
, 8, 109 |
8, 461 |
- | , 751 439 |
, 946 265 |
| Inv est nts in inv est me ees |
94, 367 |
17, 830 |
- | , 69, 467 |
- | 59 | - | , 1, 292 677 |
, 1, 400 474 |
| Inv est nt p erty in t me rop res pec |
, | , | |||||||
| of y ield -de den t co ntra cts pen |
- | - | - | - | - | - | - | 1, 903 600 |
1, 903 600 |
| Inv the est nt p erty me rop - o r |
- | - | - | - | - | - | - | , 1, 038 015 |
, 1, 038 015 |
| Rei ets nsu ran ce ass |
- | - | - | - | - | - | - | , 3, 167 199 |
, 3, 167 199 |
| Cre dit for cha of s ritie pur se ecu s |
695 630 |
- | 58, 370 |
- | - | - | - | , - |
, 000 754 |
| Cur t ta ts ren x a sse |
, - |
25, 757 |
- | - | - | 5, 210 |
- | 350 | , 31, 317 |
| abl and de bit bal Rec eiv es anc es |
440 204 |
- | - | - | 31, 195 |
14, 899 |
- | 585 866 |
1, 072 164 |
| Pre miu col lect ible ms |
, - |
- | - | - | - | - | - | , 933 629 |
, 933 629 |
| Hel d-f sale f d sal set ispo or- as s o gro up |
- | - | - | - | - | - | - | , - |
, - |
| ial Fin inv est nts in t anc me res pec |
|||||||||
| of y ield -de den t co ntra cts pen fo f bo Fin ial inv est nts r ho lde nds anc me rs o |
- | - | - | - | - | - | - | 78, 267 921 , |
78, 267 921 , |
| , hor dep ETN t ET Ns, osit e E TN osit s, s co mp s, |
|||||||||
| tific nd red bo nds ate stru ctu cer s a |
- | - | - | - | - | - | 217 000 |
- | 217 000 |
| dit of fac Cre in r ect tor ing esp |
, | , | |||||||
| , clea d fi ring cin an nan g |
- | - | - | - | - | 3, 208 322 |
- | - | 3, 208 322 |
| Liq uid de bt a ts sse |
10, 309 |
20, 328 |
847 | - | 742 57, |
, - |
- | 6, 312 247 |
, 6, 401 473 |
| Illiq uid de bt a ts sse |
1, 588 980 |
422 019 |
87, 000 |
- | 977 404 |
11, 508 |
- | , 14, 106 324 |
, 17, 193 235 |
| Sha res |
, - |
, - |
- | 344 823 |
, 24, 792 |
- | - | , 2, 144 175 |
, 2, 513 790 |
| Oth er |
1, 000 |
- | 22, 309 |
, 63, 881 |
25, 961 |
- | - | , 4, 358 036 |
, 4, 471 187 |
| Cas h a nd h e iva len ts i cas qu n |
, | , | |||||||
| t of ield -de den t co ntra cts res pec y pen |
- | - | - | - | - | - | - | 789 357 14, |
789 357 14, |
| Oth ash d c ash ale uiv nts er c an eq |
375 328 , |
- | 22, 000 |
- | 69, 233 |
10, 909 |
- | , 1, 981 770 , |
, 2, 459 240 , |
| To tal set as s |
3, 20 5, 81 8 |
48 5, 93 4 |
190 52 6 , |
2, 42 8, 69 2 |
2, 33 7, 94 4 |
3, 27 1, 55 1 |
21 7, 00 0 |
133 97 1, 84 4 , |
146 109 30 9 , , |
| Lia bilit ies in r of ins ect ntra cts esp ura nce co |
|||||||||
| and ield -de den t in tme nt c ont ts no n-y pen ves rac |
- | - | - | - | 989 995 , |
- | - | 24, 325 518 , |
25, 315 513 , |
| of Lia bilit ies in r ect ins ntra cts esp ura nce co |
|||||||||
| and ield -de den t in tme nt c ont ts pen ves rac y |
- | - | - | - | - | - | - | 93, 114 756 , |
93, 114 756 , |
| Lia bilit ies in r of def ed ect tax esp err es |
- | - | - | 60, 490 |
72, 634 |
- | - | 421 249 , |
554 373 , |
| bilit for loy ben efit Lia et y em p ee s, n |
20, 648 |
- | - | - | 881 | 6, 158 |
- | 55, 833 |
83, 520 |
| Lia bilit in r of ect t ta y esp cur ren xes |
- | 961 17, |
- | - | 8, 859 |
2, 085 |
- | 561 44, |
73, 466 |
| abl and dit bal Pay es cre anc es |
536 572 , |
- | - | - | 252 697 , |
26, 567 |
- | 2, 442 802 , |
3, 258 638 , |
| Lia bilit ies for bon ds, ET Ns, sh ETN ort s, |
|||||||||
| ite ETN nd red bo nds stru ctu com pos s a |
- | - | - | - | - | - | 215 058 , |
- | 215 058 , |
| ial liab ilitie s ( *) Fin anc |
3, 060 659 , |
1, 172 337 , |
177 000 , |
- | 3, 624 |
2, 926 171 , |
- | 6, 092 210 , |
13, 432 001 , |
| To tal lia bil itie s |
3, 61 7, 87 9 |
1, 190 29 8 , |
- 17 7, 00 0 |
60, 49 0 |
1, 32 8, 69 0 |
2, 96 0, 98 1 |
21 5, 05 8 |
126 49 6, 92 9 , |
136 04 7, 32 5 , |
| tal To ex pos ure |
( 2, 06 1) 41 |
( 70 36 4) 4, |
13, 52 6 |
2, 36 8, 20 2 |
00 9, 254 1, |
31 0, 0 57 |
94 2 1, |
91 7, 47 4, 5 |
10, 06 98 1, 4 |
(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked.
| NIS | ETN link s - age |
i ins Isr ael |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| No n-l ink ed |
CP I-li nke d |
For eig n c urr enc y |
Oth er non - ite net mo ary ms |
sio pen n ies in com pan |
dit Cre co mp any in I el sra |
to iou s ind var ice s |
ura nce com pan y |
Tot al |
|
| ible Inta As set ng s |
- - |
- | 1,7 18, 822 |
459 ,1 86 |
8, 362 |
- | 805 ,15 6 |
2, 991 ,5 26 |
|
| Def d ta ts erre x a sse |
- - |
- | 63, 261 |
1, 250 |
8,1 38 |
- | - | 72, 649 |
|
| Def d a isiti ts erre cqu on cos |
- - |
- | 3,5 98 |
897 824 |
- | - | 1,5 51, 961 |
2,4 53, 383 |
|
| lant Pro ty, & ipm ent per p equ |
- - |
- | 180 965 |
, 2, 276 |
8,5 34 |
- | 959 668 |
1,1 51, 443 |
|
| Inv est nts in i ste me nve es |
014 15, |
19, 409 |
- | , 124 838 |
- | - | - | , 34, 476 1,4 |
93, 737 1,5 |
| Inv est nt p erty in t me rop res pec |
, | ||||||||
| of y ield -de den t co ntra cts pen |
- - |
- | - | - | - | - | 2,1 42, 074 |
2,1 42, 074 |
|
| Inv the est nt p erty me rop - o r |
- - |
- | - | - | - | - | 1,1 47, 899 |
1,1 47, 899 |
|
| Rei ts nsu ran ce a sse |
- - |
- | - | - | - | - | 3,1 72, 249 |
3,1 72, 249 |
|
| Cre dit for cha f se ities pur se o cur |
673 90 ,7 |
- | 91, 210 |
- | - | - | - | - | 765 000 , |
| Cur t ta ts ren x a sse |
33, 610 - |
- | - | - | - | - | 124 225 , |
157 835 , |
|
| bles d d ebit ba lanc Rec eiva an es |
138 963 , |
- | 5, 805 |
- | 51, 000 |
12, 896 |
- | 521 629 , |
730 293 , |
| Hel d-fo le a t r-sa sse |
- - |
- | 18, 387 |
- | - | - | - | 18, 387 |
|
| coll ible Pre miu ect ms |
- - |
- | - | - | - | - | 757 329 , |
757 329 , |
|
| Fina ncia l inv in r est nts ect me esp |
|||||||||
| of y ield -de den t co ntra cts pen |
- - |
- | - | - | - | - | 77, 394 271 , |
77, 394 271 , |
|
| l inv for hold of bon ds, Fina ncia est nts ETN me ers s, |
|||||||||
| sho dep rtifi rt E TNs osit e E TNs osit cat , co mp ce es , |
|||||||||
| and d b ond str uct ure s |
- - |
- | - | - | - | 201 000 , |
- | 201 000 , |
|
| Cre dit in r of f orin ect act esp g, |
|||||||||
| clea ring d fi cing an nan |
- - |
- | - | - | 3,4 43, 337 |
- | - | 3,4 43, 337 |
|
| id d ebt Liqu set as s |
7, 888 |
6,4 18 |
552 | - | 118 687 , |
- | - | 5,5 26, 350 |
5, 659 895 , |
| Illiq uid deb t as set s |
391 000 , |
428 ,5 06 |
40, 000 |
- | 894 368 , |
10, 711 |
- | 14, 696 915 , |
16, 461 ,5 00 |
| Sha res |
- - |
- | 513 300 , |
19, 364 |
- | - | 1, 869 608 , |
2,4 02, 272 |
|
| Oth er |
400 | - | 35, 439 |
27, 152 |
49, 650 |
- | - | 890 ,1 82 4, |
002 823 5, , |
| h a nd h e ival Cas ent s in t cas qu res pec |
|||||||||
| of y ield -de den t co ntra cts pen |
- - |
- | - | - | - | - | 16, 358 ,5 09 |
16, 358 ,5 09 |
|
| Oth ash d c ash uiva lent er c an eq s |
07 455 ,5 |
- | 000 14, |
- | 197 ,17 7 |
20, 269 |
- | 2,7 52, 813 |
3,4 39, 766 |
| - | - | ||||||||
| Tot al a ts sse |
1, 68 2,5 62 |
48 7, 943 |
187 006 , |
2, 650 323 , |
2, 690 ,7 82 |
3,5 12, 247 |
201 000 , |
136 ,1 05, 314 |
147 ,51 7,1 77 |
| Liab ilitie s in t of ins ntra cts res pec ura nce co |
|||||||||
| and ield -de den t in tme nt c ont ract no n-y pen ves s |
- - |
- | - | 016 001 1, |
- | - | 24, 442 95 ,4 |
25, 458 96 ,4 |
|
| t of Liab ilitie s in ins ntra cts res pec ura nce co |
, | ||||||||
| and ield -de den t in tme nt c ont ract y pen ves s |
- - |
- | - | - | - | - | 94, 042 093 |
94, 042 093 |
|
| Liab ilitie s in t of de ferr ed tax res pec es |
- - |
- | 54, 652 |
75, 085 |
- | - | , 460 ,1 60 |
, 589 897 |
|
| Liab ility for loye e b fits t em p ene , ne |
19, 149 |
- | - | - | - | 5,4 78 |
- | 42, 040 |
, 66, 667 |
| Liab ility in t of t ta res pec cu rren xes |
32, 333 - |
- | - | 23, 024 |
9, 251 |
- | 185 | 64, 793 |
|
| abl nd dit bala Pay es a cre nce s |
392 948 |
- | 739 | - | 443 ,4 02 |
45, 095 |
- | 2,5 73, 387 |
3,4 55, 571 |
| Liab ilitie s fo r bo nds , ET Ns, sh ETN ite ort s, c om pos |
, | ||||||||
| ETN nd red bo nds stru ctu s a |
- - |
- | - | - | - | 200 698 |
- | 200 698 |
|
| l lia bilit ( *) Fina ncia ies |
2, 043 986 , |
1,1 98, 421 |
108 000 , |
- | 4,7 33 |
2, 986 ,5 69 |
, - |
6,7 63, 855 |
, 13, 105 ,5 64 |
| Tot al l iab ilit ies |
2,4 56, 083 |
1, 230 ,75 4 |
108 ,7 39 |
54, 652 |
1,5 62, 245 |
3, 046 393 , |
200 698 , |
128 324 215 , , |
136 983 ,77 9 , |
78,267(*) Against CPI-linked financial liabilities, the Company holds The Phoenix Insurance's Bonds (Series L), which is CPI-linked
2,595,671
1,128,537 465,854 7,781,099
302
10,533,398
(742,811)
(773,521) Total exposure

Amendment No. 3 to the Securities Regulations (Periodic and Immediate Reports), 2009 (hereinafter - "ISOX"), which deals with internal controls over financial reporting and the disclosure thereof (hereinafter - the "Regulations"), was published in December 2009. The amendment enacts a number of changes aimed at improving the quality of financial reporting and disclosure by reporting corporations.
As from the publication date of the ISOX amendment, and as set out in the Company's previous Reports of the Board of Directors, the Company has acted and is acting on an ongoing basis to implement the required procedure in The Phoenix group in accordance with the provisions of the ISOX amendment. In accordance with the provisions of the ISOX amendment, the Company opted to implement to the internal controls of all of its consolidated institutional entities the provisions of the circulars of the Commissioner of the Capital Market, Insurance and Savings applicable thereto the Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Control over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for Internal Control over Financial Reporting - Amendment"; Circular 2010-9-7 "Internal Control over Financial Reporting - Statements, Reports and Disclosures" (hereinafter - "Management's Responsibility Circulars").
The reports and statements required in accordance with the ISOX amendment are attached below to the periodic Financial Statements, please see Part 5 - Report on the Effectiveness of Internal Controls over Financial Reporting and Disclosure. The processes relating to the activities of institutional entities are also addressed in the Insurance Commissioner's Circulars, please see Section 8.1.2 below.
Alongside the process described in Section 8.1.1 above, The Phoenix group's institutional entities apply the provisions of Management's Responsibility Circulars pertaining to controls and procedures regarding disclosure and internal controls over financial reporting of an institutional entity, and implement the procedures required in connection therewith, as described below; this is done in accordance with the stages and dates set out in the above-mentioned circulars and in collaboration with external consultants engaged for that purpose. As part of this process, the Group's institutional entities adopted the internal control model of COSO - the Committee of Sponsoring Organization of the Treadway Commission - which is a generally accepted framework for assessment of internal controls.

Managements of the institutional entities, together with their CEOs and CFOs, assessed the effectiveness of the controls and procedures concerning the said institutional entities' disclosure in their Financial Statements as of the end of the period covered in this report. Based on this assessment, the CEOs and CFOs of the institutional entities in The Phoenix group concluded that, as of the end of this period, the controls and procedures as to the institutional entities' disclosure are sufficiently effective for recording, processing, summarizing, and reporting the information that the institutional entities are required to disclose in their quarterly report in accordance with the provisions of the law and the reporting provisions set by the Commissioner of the Capital Market, Insurance, and Savings and on the date set out in these provisions.
During the quarter ending June 30, 2023, no changes took place in the internal control over financial reporting of the Group's institutional entities that had a material effect, or is expected to have a material effect, on the institutional entities' internal control over financial reporting. Furthermore, the Group's institutional entities are improving and streamlining processes and/or internal controls and/or customer service.
The reports and statements relating to the relevant processes are attached to the financial statements of The Phoenix Group's institutional entities, in accordance with the provisions of Management's Responsibility Circulars.

For further details regarding events subsequent to the balance sheet date, please see Note 9 to the Financial Statements.
| Series/issuance date | Bonds Series 4 | Bonds Series 5 | Bonds Series 6 | |
|---|---|---|---|---|
| Rating agency | Midroog / Maalot | Midroog / Maalot | Midroog / Maalot | |
| Rating as of the report date | Aa2.il ilAA /- | Aa2.il ilAA /- | Aa2.il ilAA /- | |
| Par value on issuance date | NIS 487,564,542 | NIS 822,616,000 | NIS 472,612,000 (*) | |
| Interest type | Unlinked | CPI-linked | Unlinked | |
| Nominal interest | The Bank of Israel's variable quarterly interest rate plus a 1.28% spread |
0.44% | 1.94% | |
| Effective interest rate on issuance date |
1.7% | 0.55% | 4.6% (*) | |
| Listed on the TASE | Yes | Yes | Yes | |
| Principal payment dates | 2 equal annual installments of 12% on July 31 of each of the years 2020 and 2021 and 4 equal annual installments of 19% on July 31 of each of the years 2025 through 2028. |
3 equal annual installments of 4% on July 1 of each of the years 2022 through 2024, one installment of 28% on May 1, 2028, and 2 equal annual installments of 30% on May 1 of each of the years 2029 through 2030. |
9 annual installments: 1 installment of 4% on December 31, 2024, 3 equal installments of 12% on December 31 of each of the years 2025 through 2027, 3 equal installments of 10% on December 31 of each of the years 2028 through 2030, and 2 installments of 15% in each of the years 2031 through 2032. |
|
| Interest payment dates | Quarterly interest on January 31, April 30, July 31, and October 31 |
Semi-annual interest on May 1 and November 1 |
Semi-annual interest on June 30 and December 31 |
|
| Nominal p.v. as of June 30, 2023 |
NIS 398 million | NIS 756 million | NIS 349 million | |
| CPI-linked nominal p.v. as of June 30, 2023 |
NIS 398 million | NIS 834 million | NIS 349 million | |
| Carrying amount of bonds' outstanding balances as of June 30, 2023 |
NIS 397 million | Approx. NIS 324 million | ||
| Carrying amount of interest payable as of June 30, 2023 |
Approx. NIS 3.9 million | Approx. NIS 0.6 million | - | |
| Market value as of June 30, 2023 (*) |
Approx. NIS 413 million | Approx. NIS 749 million | Approx. NIS 296 million | |
| Series' materiality | The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 |
The series is material as this term is defined in Regulation 10(b)13(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 |
(*) Series 6 Bonds - in January 2023, an expansion of NIS 172 million par value was carried out; a buyback of NIS 124 million par value of the original number of Series 6 Bonds was carried out in June 2023.
(**) The market value includes interest accrued as of July 2, 2023.

As part of the deed of trust of the Company's Series 4 bonds, the Company undertook not to place a general floating charge on its assets as long as the Series 4 bonds have not been repaid in full, unless it obtains the bondholders' consent in advance and placed on that date a charge of the same rank in favor of the Series 4 bondholders. Furthermore, with respect to Series 4 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 4); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 2.9 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. For further details, please see the Shelf Offering Report dated May 7, 2019.
As part of the deed of trust of the Company's Series 5 bonds, the Company undertook not to place a general floating charge on its assets as long as the Series 5 bonds have not been repaid in full, unless it obtains the bondholders' consent in advance and placed on that date a charge of the same rank in favor of the Series 5 bondholders.
Furthermore, with respect to Series 5 bonds, the Company assumed restrictions on dividend distribution; the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.2 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 50% for two consecutive quarters. In addition, a mechanism for adjusting the rate of change in interest rate due to noncompliance with financial covenants was set: In the event that the Company's shareholders' equity falls below NIS 3.5 billion, the annual interest rate will increase by the rate set in Section 5.9 of the Deed of Trust. For further details, please see the shelf offering report dated February 20, 2020.
As part of the deed of trust of the Company's Series 6 Bonds, the Company undertook not to place a general floating charge on its assets as long as Series 6 bonds are not repaid in full, unless it has obtained the bondholders' consent in advance and placed on that date a lien of the same rank in favor of Series 6 bondholders. Furthermore, with respect to Series 6 bonds, the Company assumed restrictions on distribution of dividends and expansion of the Bonds (Series 6); the Company also undertook to comply with financial covenants whereby its shareholders' equity will not fall below NIS 3.6 billion for two consecutive quarters, and that the Company's net financial debt to total assets ratio will not exceed 48% for two consecutive quarters. For further details, please see the Shelf Offering Report dated January 5, 2022.
As of balance sheet date, the Company complies with the financial covenants described above. The net financial debt ratio as of June 30, 2023 was approximately 4.17% (including Restricted Tier 1 capital instrument issued by The Phoenix Insurance through The Phoenix Capital Raising), and the Company's shareholders' equity as per its separate financial statements as of June 30, 2023, was approximately NIS 10,055 million, which is higher than the above required shareholders' equity.
For further details – please see Note 5 to the Company's financial statements as of June 30, 2023.
The members of the Board of Directors thank the Company's management, employees and agents for their contribution to the Company.
Benjamin Gabbay Chairman of the Board of Directors
Eyal Ben Simon Chief Executive Officer
August 23, 2023

Consolidated Interim Financial Statements

| Page | |
|---|---|
| Review Report of the Independent Auditors………………………………………………………2 | |
| Condensed Consolidated Interim Statements of Financial Position……………………3-4 | |
| Condensed Consolidated Interim Income Statements…………………………………………5 | |
| Condensed Consolidated interim Statements of Comprehensive Income………………6 | |
| Condensed Consolidated Interim Statements of Changes in Equity…………………7-11 | |
| Condensed Consolidated Interim Statements of Cash Flow…………………………12-14 | |
| Notes to the Condensed Consolidated Interim Financial Statements…………….15-112 | |
| Appendix to the Condensed Consolidated Interim Financial Statements……113-116 |

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102 Tel. +972-3-6232525 Fax +972-3-5622555 ey.com
We have reviewed the accompanying financial information of The Phoenix Holdings Ltd. And subsidiaries (the "Company"), the condensed consolidated statement of financial position as of June 30, 2023, the related condensed consolidated statements of profit or loss, comprehensive income, changes in equity and cash flows for the six and three-months periods then ended. The Company's Board of Directors and management are responsible for the preparation and presentation of financial information for this interim periods in accordance with the Israel Securities Regulations (Periodic and Immediate Reports), 1970, which pertain to insurers' holding companies, as described in Note 2(a). Our responsibility is to express a conclusion regarding the financial information for this interim periods based on our review.
We did not review the condensed interim financial information of certain subsidiary, whose assets included in consolidation constitute approximately 2.3% of the total consolidated assets as of June 30, 2023 and whose revenues included in consolidation constitutes approximately 1.5% and 1.1% of total consolidated revenuesfor the six and three-month periodsthen ended, respectively. Furthermore, we did not review condensed financial information for the interim periods of companies presented on the basis of the equity method. the investment in which, at equity, amounted to approximately NIS 688,475 thousand as of June 30, 2023, and the Company's share in the earning (loss) amounted to approximately NIS 31,224 thousand and (183) thousand for the six and three-month periods then ended, respectively. The condensed interim financial information of those companies was reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial information in respect of these companies, is based on the review reports of the other independent auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially lessin scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that may be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the above-mentioned financial information does not comply, in all material respects, with the Israel Securities Regulations (Periodic and Immediate Reports), 1970, which pertain to insurers' holding companies, as described in Note 2(a) to the financial information.
Without qualifying the above conclusion, we draw attention to Note 7 to the financial statements regarding exposure to contingent liabilities.
Tel Aviv, Kost Forer Gabbay & Kasierer August 23, 2023 Certified Public Accountants
Condensed Cons olidat ed Int erim Statem ents of Financial Position

| As of | ||||
|---|---|---|---|---|
| June 30, | June 30, | December 31, | ||
| 2023 | 2022 | 2022 | ||
| Unaudited | Audited | |||
| Note | NIS thousand | |||
| Assets | ||||
| Intangible assets | 4 | 3,326,454 | 2,919,126 | 2,991,526 |
| Deferred tax assets | 97,886 | 67,043 | 72,649 | |
| Deferred acquisition costs | 2,654,532 | 2,281,026 | 2,453,383 | |
| Property, plant & equipment | 1,237,941 | 946,265 | 1,151,443 | |
| Investments in associates | 1,640,774 | 1,474,400 | 1,593,737 | |
| Investment property in respect | ||||
| of yield-dependent contracts | 2,206,935 | 1,903,600 | 2,142,074 | |
| Investment property - other | 1,186,334 | 1,038,015 | 1,147,899 | |
| Reinsurance assets | 3,604,340 | 3,167,199 | 3,172,249 | |
| Credit for purchase of securities | 755,000 | 754,000 | 765,000 | |
| Current tax assets | 247,377 | 31,317 | 157,835 | |
| Receivables and debit balances | 926,662 | 1,072,164 | 730,293 | |
| Held-for-sale asset | - | - | 18,387 | |
| Premiums collectible | 1,026,855 | 933,629 | 757,329 | |
| Financial investments in respect | ||||
| of yield-dependent contracts | 5A | 80,603,591 | 78,267,921 | 77,394,271 |
| Financial investments for holders of | ||||
| deposit certificates and structured bonds | 194,000 | 217,000 | 201,000 | |
| Credit assets in respect of | ||||
| factoring, clearing and financing | 5C | 3,488,853 | 3,208,322 | 3,443,337 |
| Other financial investments: | ||||
| Liquid debt assets | 5,811,371 | 6,401,473 | 5,659,895 | |
| Illiquid debt assets | 17,287,442 | 17,193,235 | 16,461,500 | |
| Shares | 2,218,447 | 2,513,790 | 2,402,272 | |
| Other | 5,636,746 | 4,471,187 | 5,002,823 | |
| Total other financial investments | 5B | 30,954,006 | 30,579,685 | 29,526,490 |
| Cash and cash equivalents in respect | ||||
| of yield-dependent contracts | 18,728,467 | 14,789,357 | 16,358,509 | |
| Other cash and cash equivalents | 2,713,058 | 2,459,240 | 3,439,766 | |
| Total assets | 155,593,065 | 146,109,309 | 147,517,177 | |
| Total assets for yield-dependent contracts | 101,743,507 | 95,216,686 | 96,055,588 | |

| As of | |||||
|---|---|---|---|---|---|
| June 30, 2023 |
June 30, 2022 |
December 31, 2022 |
|||
| Unaudited | Audited | ||||
| Note | NIS thousand | ||||
| Equity | |||||
| Share capital | 313,168 | 310,514 | 311,640 | ||
| Premium and capital reserves | |||||
| in respect of shares | 858,022 | 845,296 | 851,918 | ||
| Treasury shares | 8F | (167,733) | (155,628) | (155,628) | |
| Capital reserves | 1,210,070 | 934,615 | 1,123,705 | ||
| Retained earnings | 7,841,012 | 7,773,062 | 8,013,123 | ||
| Total equity attributable to | |||||
| the Company's shareholders | 10,054,539 | 9,707,859 | 10,144,758 | ||
| Non-controlling interests | 448,268 | 354,125 | 388,640 | ||
| Total equity | 10,502,807 | 10,061,984 | 10,533,398 | ||
| Liabilities | |||||
| Liabilities in respect of insurance contracts | |||||
| and non-yield-dependent investment contracts | 27,249,507 | 25,315,513 | 25,458,496 | ||
| Liabilities in respect of insurance contracts | |||||
| and yield-dependent investment contracts | 98,348,493 | 93,114,756 | 94,042,093 | ||
| Liabilities in respect of deferred taxes | 547,372 | 554,373 | 589,897 | ||
| Liability for employee benefits, net | 75,498 | 83,520 | 66,667 | ||
| Liability in respect of current taxes | 77,111 | 73,466 | 64,793 | ||
| Payables and credit balances | 4,186,139 | 3,258,638 | 3,455,571 | ||
| Liabilities in respect of structured products | 193,000 | 215,058 | 200,698 | ||
| Financial liabilities | 5D | 14,413,138 | 13,432,001 | 13,105,564 | |
| Total liabilities | 145,090,258 | 136,047,325 | 136,983,779 | ||
| Total capital and liabilities | 155,593,065 | 146,109,309 | 147,517,177 |
| Benjamin Gabbay | Eyal Ben Simon | Eli Schwartz | |
|---|---|---|---|
| Chairman of the Board | CEO | EVP, CFO |
Date of approval of the financial statements - August 23, 2023
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.
Condensed Cons olidat ed Int erim Statem ents of Incom e

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | |
| Unaudited | Audited | ||||
| NIS thousand | |||||
| Premiums earned, gross Premiums earned |
5,939,588 | 6,032,809 | 2,987,989 | 3,018,421 | 12,137,231 |
| by reinsurers | 797,567 | 791,985 | 405,735 | 400,792 | 1,570,094 |
| Premiums earned - retention | 5,142,021 | 5,240,824 | 2,582,254 | 2,617,629 | 10,567,137 |
| Investment income (losses), | |||||
| net and finance income Income from |
5,289,458 | (5,435,372) | 4,371,716 | (4,753,868) | (5,554,831) |
| management fees Income from fees |
817,870 | 762,044 | 409,328 | 389,199 | 1,547,728 |
| and commissions Income from other |
406,078 | 430,265 | 192,710 | 197,051 | 835,912 |
| financial services | 160,000 | 101,000 | 90,000 | 57,000 | 223,000 |
| Income from factoring and clearing |
90,568 | 63,827 | 44,356 | 35,215 | 142,754 |
| Other income (Note 4B) | 142,083 | 136,787 | 137,539 | 132,104 | 144,780 |
| Total income | 12,048,078 | 1,299,375 | 7,827,903 | (1,325,670) | 7,906,480 |
| Payments and change in liabilities in respect of |
|||||
| insurance contracts and | |||||
| investment contracts, gross | 10,639,493 | (1,282,558) | 7,089,554 | (2,217,378) | 2,988,830 |
| Reinsurers' share in | |||||
| payments and in changes in | |||||
| liabilities in respect of | |||||
| insurance contracts | 740,826 | 607,294 | 369,803 | 308,137 | 1,023,801 |
| Payments and change in | |||||
| liabilities in respect of insurance contracts and |
|||||
| investment contracts - | |||||
| retention | 9,898,667 | (1,889,852) | 6,719,751 | (2,525,515) | 1,965,029 |
| Fees and commissions, | |||||
| marketing expenses and | |||||
| other purchase expenses | 1,009,544 | 922,167 | 501,784 | 458,682 | 1,933,805 |
| General and | |||||
| administrative expenses | 1,003,194 | 877,458 | 511,566 | 444,592 | 1,805,284 |
| Other expenses | 59,846 | 31,509 | 39,191 | 14,926 | 91,096 |
| Finance expenses | 191,536 | 150,105 | 95,176 | 90,464 | 318,534 |
| Total expenses | 12,162,787 | 91,387 | 7,867,468 | (1,516,851) | 6,113,748 |
| Share in profits of equity accounted investees |
43,073 | 30,274 | 37,037 | 26,355 | 61,548 |
| Profit (loss) before | |||||
| taxes on income | (71,636) | 1,238,262 | (2,528) | 217,536 | 1,854,280 |
| Taxes on income | |||||
| (tax benefit) | (125,984) | 336,902 | (90,054) | 6,367 | 504,336 |
| Profit for the period | 54,348 | 901,360 | 87,526 | 211,169 | 1,349,944 |
| Attributed to: | |||||
| Company's shareholders | 1,594 | 859,963 | 58,642 | 184,866 | 1,257,124 |
| Non-controlling interests | 52,754 | 41,397 | 28,884 | 26,303 | 92,820 |
| Profit for the period | 54,348 | 901,360 | 87,526 | 211,169 | 1,349,944 |
| Earnings per share | |||||
| attributable to the | |||||
| Company's shareholders (in NIS): |
|||||
| Basic earnings per share | |||||
| Earnings per ordinary share | |||||
| of NIS 1 par value (in NIS) | 0.01 | 3.42 | 0.24 | 0.74 | 5.00 |
| Diluted earnings | |||||
| per share Earnings per ordinary share |
|||||
| of NIS 1 par value (in NIS) | 0.01 | 3.34 | 0.23 | 0.71 | 4.91 |
| Condensed Consolidated interim Statements of Comprehensive Income |

| For the six months | For the three months | For the year ended | |||||
|---|---|---|---|---|---|---|---|
| ended June 30 | ended June 30 | December 31 | |||||
| 2023 | 2022 | 2023 | 2022 | 2022 | |||
| Unaudited | Unaudited | Audited | |||||
| NIS thousand | |||||||
| Profit for the period | 54,348 | 901,360 | 87,526 | 211,169 | 1,349,944 | ||
| Other comprehensive | |||||||
| income (loss): | |||||||
| Amounts that will be or that have been |
|||||||
| reclassified to profit | |||||||
| or loss when specific | |||||||
| conditions are met | |||||||
| Net change in fair value of | |||||||
| financial assets classified as | |||||||
| available for sale, carried to | |||||||
| capital reserves | 203,942 | (634,247) | 191,480 | (233,659) | (685,971) | ||
| Net change in fair value of | |||||||
| financial assets classified as | |||||||
| available for sale, carried to the income statement |
(88,771) | (300,044) | (41,580) | (102,476) | (318,278) | ||
| Gain on impairment of | |||||||
| financial assets classified as | |||||||
| available for sale, carried to | |||||||
| the income statement | 296,895 | 414,604 | 76,981 | 311,690 | 612,492 | ||
| The Group's share in other | |||||||
| comprehensive income of | |||||||
| equity-accounted investees | 25,734 | 18,823 | 9,904 | 16,416 | 27,511 | ||
| Tax effect | (140,886) | 177,241 | (78,052) | 8,073 | 133,322 | ||
| Total components of net other comprehensive income |
|||||||
| (loss) subsequently | |||||||
| reclassified to profit or loss | 296,914 | (323,623) | 158,733 | 44 | (230,924) | ||
| Amounts that shall not | |||||||
| be subsequently | |||||||
| reclassified to profit or | |||||||
| loss | |||||||
| Revaluation of property, | |||||||
| plant and equipment | - | - | - | - | 124,168 | ||
| Actuarial gain (loss) in respect of defined |
|||||||
| benefit plans | - | 1,110 | - | - | 3,684 | ||
| Company's share in other | |||||||
| comprehensive income | |||||||
| (loss), net of equity | |||||||
| accounted companies | - | - | - | - | - | ||
| Tax effect | - | (255) | - | - | (29,602) | ||
| Total net income | |||||||
| components that will not be | |||||||
| subsequently reclassified to | |||||||
| profit or loss Total other |
- | 855 | - | - | 98,250 | ||
| comprehensive | |||||||
| income (loss), net | 296,914 | (322,768) | 158,733 | 44 | (132,674) | ||
| Total comprehensive | |||||||
| income for the period | 351,262 | 578,592 | 246,259 | 211,213 | 1,217,270 | ||
| Attributed to: | |||||||
| Company's shareholders | 298,508 | 536,933 | 217,375 | 184,910 | 1,123,907 | ||
| Non-controlling interests | 52,754 | 41,659 | 28,884 | 26,303 | 93,363 | ||
| Comprehensive | 351,262 | 578,592 | 246,259 | 211,213 | 1,217,270 | ||
| income for the period |

| Condensed Cons olidat ed Int erim Statem ents of Changes in Equity | Attributed to Company's shareholders | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity | |
| Balance on January 1, | |||||||||||||
| 2023 (audited) Effect of first-time |
311,640 | 851,918 | (155,628) | 8,013,123 | (56,503) | 11,000 | 62,920 | 224,054 | (14,435) | 896,669 | 10,144,758 | 388,640 | 10,533,398 |
| application of IFRS 9 (*) Balance as of January 1, 2023 after first-time |
- | - | - | 1,522 | - | - | - | - | - | (1,522) | - | - | - |
| application of IFRS 9 Net profit |
311,640 - |
851,918 - |
(155,628) - |
8,014,645 1,594 |
(56,503) - |
11,000 - |
62,920 - |
224,054 - |
(14,435) - |
895,147 - |
10,144,758 1,594 |
388,640 52,754 |
10,533,398 54,348 |
| Total other comprehensive income |
- | - | - | - | - | - | - | - | 25,734 | 271,180 | 296,914 | - | 296,914 |
| Total comprehensive | |||||||||||||
| income | - | - | - | 1,594 | - | - | - | - | 25,734 | 271,180 | 298,508 | 52,754 | 351,262 |
| Share-based payment Dividend to non |
- | (216) | - | - | - | 9,489 | - | - | - | 9,273 | - | 9,273 | |
| controlling interests | - | - | - | - | - | - | - | - | - | - | - | (176,639) | (176,639) |
| Acquisition of | |||||||||||||
| treasury shares | - | - | (12,105) | - | - | - | - | - | - | - | (12,105) | - | (12,105) |
| Exercise of employee options |
1,528 | 6,320 | - | - | - | - | (7,848) | - | - | - | - | - | - |
| Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the |
|||||||||||||
| depreciation amount | - | - | - | 1,945 | - | - | - | (1,945) | - | - | - | - | - |
| Dividend (Note 8H) | - | - | - | (177,172) | - | - | - | - | - | - | (177,172) | - | (177,172) |
| Acquisition of minority interests (see Note 1H) |
- | - | - | - | (10,848) | - | - | - | - | - | (10,848) | (43,089) | (53,937) |
| Commencement of | |||||||||||||
| consolidation (Note 4B) | - | - | - | - | - | - | - | - | - | - | - | 27,309 | 27,309 |
| Allocation of shares of a | |||||||||||||
| consolidated company to minority interests |
- | - | - | - | 1,730 | - | - | - | - | - | 1,730 | 2,781 | 4,511 |
| Transaction with | |||||||||||||
| minority interest | |||||||||||||
| (see Note 1F and 8J) | - | - | - | - | (199,605) | - | - | - | - | - | (199,605) | 196,512 | (3,093) |
| Balance as of June 30, 2023 (unaudited) |
313,168 | 858,022 | (167,733) | 7,841,012 | (265,226) | 11,000 | 64,561 | 222,109 | 11,299 | 1,166,327 | 10,054,539 | 448,268 | 10,502,807 |
(*) See Note 2B regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity | |
| Balance on January 1, 2022 (audited) Net profit |
310,323 - |
849,309 - |
(99,769) - |
7,331,992 859,963 |
(45,655) - |
11,000 - |
51,652 - |
131,354 - |
(41,946) - |
1,155,104 - |
9,653,364 859,963 |
269,725 41,397 |
9,923,089 901,360 |
| Other comprehensive income (loss) |
- | - | - | 593 | - | - | - | - | 18,823 | (342,446) | (323,030) | 262 | (322,768) |
| Total comprehensive income (loss) Share-based payment |
- - |
- (4,993) |
- - |
860,556 - |
- - |
- - |
- 10,035 |
- - |
18,823 - |
(342,446) - |
536,933 5,042 |
41,659 - |
578,592 5,042 |
| Dividend paid to non controlling interests |
- | - | - | - | - | - | - | - | - | - | - | (8,716) | (8,716) |
| Acquisition of treasury shares Dividend Commencement |
- - |
- - |
(55,859) - |
- (421,000) |
- - |
- - |
- - |
- - |
- - |
- - |
(55,859) (421,000) |
- - |
(55,859) (421,000) |
| of consolidation | - | - | - | - | - | - | - | - | - | - | - | 50,624 | 50,624 |
| Exercise of employee options Transfer from revaluation reserve in respect of revaluation of property, plant and equipment, at |
191 | 980 | - | - | - | - | (1,171) | - | - | - | - | - | - |
| the depreciation amount Acquisition of non |
- | - | - | 1,514 | - | - | - | (1,514) | - | - | - | - | - |
| controlling interests Allocation of shares of a consolidated company to |
(12,000) | - | - | (12,000) | - | (12,000) | |||||||
| minority interests | - | - | - | - | 1,379 | - | - | - | - | - | 1,379 | 833 | 2,212 |
| Balance as of June 30, 2022 (unaudited) |
310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 | 354,125 | 10,061,984 |
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available-for sale assets |
Total | Non controlling interests |
Total equity | |
| Balance as of April 1, 2023 (unaudited) Net profit Total other |
311,817 - |
851,225 - |
(161,926) - |
7,781,449 (*) 58,642 |
(135,725) - |
11,000 - |
67,407 - |
223,030 - |
1,395 - |
1,017,498 (*) - |
9,967,170 58,642 |
449,122 28,884 |
10,416,292 87,526 |
| comprehensive income Total |
- | - | - | - | - | - | - | - | 9,904 | 148,829 | 158,733 | - | 158,733 |
| comprehensive income Share-based |
- | - | - | 58,642 | - | - | - | - | 9,904 | 148,829 | 217,375 | 28,884 | 246,259 |
| payment Dividend to non controlling |
- | 1,428 | - | - | - | - | 3,874 | - | - | - | 5,302 | - | 5,302 |
| interests (see Note 1F) |
- | - | - | - | - | - | - | - | - | - | - | (148,818) | (148,818) |
| Acquisition of treasury shares |
- | - | (5,807) | - | - | - | - | - | - | - | (5,807) | - | (5,807) |
| Exercise of employee options Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the |
1,351 | 5,369 | - | - | - | - | (6,720) | - | - | - | - | - | - |
| depreciation amount Acquisition of |
- | - | - | 921 | - | - | - | (921) | - | - | - | - | - |
| minority interests (see Note 1H) Commencement |
- | - | - | - | (9,985) | - | - | - | - | - | (9,985) | (30,479) | (40,464) |
| of consolidation (Note 4B) Allocation of shares of a consolidated |
- | - | - | - | - | - | - | - | - | - | - | 27,309 | 27,309 |
| company to minority interests Transaction with |
- | - | - | - | 896 | - | - | - | - | - | 896 | 1,838 | 2,734 |
| minority interest (see Note 1F) Balance as of |
- | - | - | - | (120,412) | - | - | - | - | - | (120,412) | 120,412 | - |
| June 30, 2023 (unaudited) |
313,168 | 858,022 | (167,733) | 7,841,012 | (265,226) | 11,000 | 64,561 | 222,109 | 11,299 | 1,166,327 | 10,054,539 | 448,268 | 10,502,807 |
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder - bonus |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity | |
| Balance as of April 1, 2022 (unaudited) Net profit |
310,366 - |
851,131 - |
(155,628) - |
7,587,379 184,866 |
(45,408) - |
11,000 - |
56,835 - |
130,657 - |
(39,539) - |
829,030 - |
9,535,823 184,866 |
278,224 26,303 |
9,814,047 211,169 |
| Other comprehensive income (loss) |
- | - | - | - | - | - | - | - | 16,416 | (16,372) | 44 | - | 44 |
| Total comprehensive income (loss) |
- | - | - | 184,866 | - | - | - | - | 16,416 | (16,372) | 184,910 | 26,303 | 211,213 |
| Share-based payment |
- | (6,568) | - | - | - | - | 4,562 | - | - | - | (2,006) | - | (2,006) |
| Dividend to non controlling interests |
- | - | - | - | - | - | - | - | - | - | - | (1,780) | (1,780) |
| Commencement of consolidation Exercise of |
- | - | - | - | - | - | - | - | - | - | - | 50,624 | 50,624 |
| employee options Transaction with |
148 | 733 | - | - | - | - | (881) | - | - | - | - | - | - |
| minority interest Transfer from revaluation reserve in respect of revaluation of property, plant and |
- | - | - | - | - | - | - | - | - | - | 85 | 85 | |
| equipment, at the depreciation |
|||||||||||||
| amount Acquisition of non |
- | - | - | 817 | - | - | - | (817) | - | - | - | - | - |
| controlling interests Allocation of shares of a consolidated |
- | - | - | - | (12,000) | - | - | - | - | - | (12,000) | - | (12,000) |
| company to minority interests Balance as of June |
- | - | - | - | 1,132 | - | - | - | - | - | 1,132 | 669 | 1,801 |
| 30, 2022 (unaudited) |
310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 | 354,125 | 10,061,984 |
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

| Attributed to Company's shareholders | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transactions with controlling shareholders |
Capital reserve from share based payment NIS thousand |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale assets |
Total | Non controlling interests |
Total equity | |
| Balance on January 1, 2022 (audited) Net profit Total other |
310,323 - |
849,309 - |
(99,769) - |
7,331,992 1,257,124 |
(45,655) - |
11,000 - |
51,652 - |
131,354 - |
(41,946) - |
1,155,104 - |
9,653,364 1,257,124 |
269,725 92,820 |
9,923,089 1,349,944 |
| comprehensive income (loss) Total |
- | - | - | 2,097 | - | - | - | 95,610 | 27,511 | (258,435) | (133,217) | 543 | (132,674) |
| comprehensive income (loss) Share-based |
- | - | - | 1,259,221 | - | - | - | 95,610 | 27,511 | (258,435) | 1,123,907 | 93,363 | 1,217,270 |
| payment Exercise of |
- | (2,362) | - | - | - | - | 17,556 | - | - | - | 15,194 | - | 15,194 |
| employee options Acquisition of |
1,317 | 4,971 | - | - | - | - | (6,288) | - | - | - | - | - | - |
| treasury shares Dividend paid to |
- | - | (55,859) | - | - | - | - | - | - | - | (55,859) | - | (55,859) |
| non-controlling interests |
- | - | - | - | - | - | - | - | - | - | - | (74,665) | (74,665) |
| Commencement of consolidation |
- | - | - | - | - | - | - | - | - | - | - | 53,886 | 53,886 |
| Dividend Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the depreciation |
- | - | - | (581,000) | - | - | - | - | - | - | (581,000) | - | (581,000) |
| amount Allocation of shares of a consolidated company to |
- | - | - | 2,910 | - | - | - | (2,910) | - | - | - | - | - |
| minority interests | - | - | - | - | 3,587 | 3,587 | 49,713 | 53,300 | |||||
| Transaction with minority interest Balance on |
- | - | - | - | (14,435) | - | - | - | - | - | (14,435) | (3,382) | (17,817) |
| December 31, 2022 (audited) |
311,640 | 851,918 | (155,628) | 8,013,123 | (56,503) | 11,000 | 62,920 | 224,054 | (14,435) | 896,669 | 10,144,758 | 388,640 | 10,533,398 |
The accompanying notes are an integral part of the condensed Consolidated Interim Financial Statements.

| Consolidated Int erim Statements of Cash Flow | For the six months | For the three months | For the year ended | |||
|---|---|---|---|---|---|---|
| ended June 30 2023 |
2022 | ended June 30 2023 |
2022 | December 31 2022 |
||
| Unaudited | Audited | |||||
| Appendix | NIS thousand | |||||
| Cash flows from | ||||||
| operating activities Profit for the period |
54,348 | 901,360 | 87,526 | 211,169 | 1,349,944 | |
| Adjustments required to | ||||||
| present cash flows from | ||||||
| operating activities | (a) | 1,694,335 | (62,472) | 2,527,725 | 47,255 | 1,379,463 |
| Net cash from | ||||||
| operating activities | 1,748,683 | 838,888 | 2,615,251 | 258,424 | 2,729,407 | |
| Cash flows from investing activities |
||||||
| Purchase of property, | ||||||
| plant and equipment | (168,618) | (64,222) | (85,146) | (34,538) | (190,135) | |
| Proceeds from disposal of | ||||||
| property, plant and equipment | 8 | 171 | 6 | 10 | 342 | |
| Investment in associates | (88,032) | (57,525) | (64,212) | (56,295) | (160,281) | |
| Dividend from associates | 11,749 | 19,657 | 10,448 | 7,802 | 41,580 | |
| Change in loans | ||||||
| granted to associates Acquisition of consolidated |
530 | 705 | 1,056 | 355 | (3,688) | |
| companies consolidated | ||||||
| for the first time | (b) | (48,000) | (6,407) | - | (6,949) | (9,775) |
| Proceeds from the sale of | ||||||
| pension funds, provident | ||||||
| funds, and fees and | ||||||
| commissions portfolios | 45 | 25,049 | - | 25,014 | 30,372 | |
| Acquisition of minority interest in a consolidated company |
(39,925) | (12,000) | (27,395) | (12,000) | (17,817) | |
| Proceeds from disposal of | ||||||
| investment in associate | 101,209 | - | 81,457 | - | 108,158 | |
| Acquisition and capitalization | ||||||
| of intangible assets costs | (200,128) | (146,623) | (117,376) | (76,936) | (334,726) | |
| Net cash used for | ||||||
| investing activities Cash flows from |
(431,162) | (241,195) | (201,162) | (153,537) | (535,970) | |
| financing activities | ||||||
| Issuance of shares to non | ||||||
| controlling interests in a | ||||||
| consolidated company | - | - | - | - | 49,713 | |
| Acquisition of Company shares | (12,105) | (55,859) | (5,807) | - | (55,859) | |
| Short-term credit | ||||||
| from banks, net Repayment of financial liabilities |
(93,000) (661,079) |
369,000 (452,150) |
(129,000) (181,719) |
302,000 (37,782) |
420,000 (651,637) |
|
| Dividend to shareholders | (177,172) | (421,000) | (177,172) | (421,000) | (581,000) | |
| Repayment of lease | ||||||
| liability principal | (21,842) | (26,028) | (11,071) | (17,652) | (50,082) | |
| Issuance/receipt | ||||||
| of financial liabilities | 557,038 | 1,305,911 | 408,670 | 697,568 | 1,910,320 | |
| Change in liability for REPO, net Dividend paid to non-controlling |
771,559 | - | (273,461) | - | 708,302 | |
| interests | (37,670) | (8,716) | (9,849) | (1,780) | (74,665) | |
| Repayment of contingent liability | ||||||
| in respect of a put option to | ||||||
| non-controlling interests | - | - | - | - | (10,000) | |
| Net cash provided by | ||||||
| (used in) financing activities | 325,729 | 711,158 | (379,409) | 521,354 | 1,665,092 | |
| Increase in cash and cash equivalents |
1,643,250 | 1,308,851 | 2,034,680 | 626,241 | 3,858,529 | |
| Balance of cash and | ||||||
| cash equivalents at | ||||||
| beginning of period | (c) | 19,798,275 | 15,939,746 | 19,406,845 | 16,622,356 | 15,939,746 |
| Balance of cash and cash | ||||||
| equivalents at end of period | (c) | 21,441,525 | 17,248,597 | 21,441,525 | 17,248,597 | 19,798,275 |

| For the six months ended June 30 |
ended June 30 | For the three months | For the year ended December 31 |
|||
|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | ||
| Unaudited | Audited | |||||
| Adjustments required to present | NIS thousand | |||||
| cash flows from operating activities: Items not involving cash flows Investment losses (income), net on financial investments in |
||||||
| respect of insurance contracts and yield-dependent investment contract |
(4,317,567) | 6,135,612 | (3,480,401) | 4,957,622 | 7,404,308 | |
| Change in fair value of investment property in respect of yield-dependent contracts |
8,571 | - | - | - | (199,182) | |
| Losses (income), net on other financial investments |
||||||
| Liquid debt assets | 67,891 | 11,775 | (46,459) | (3,435) | 137,976 | |
| Illiquid debt assets | (886,428) | (747,487) | (448,521) | (441,559) | (1,449,128) | |
| Shares | 48,849 | (199,548) | 21 | 48,444 | (155,913) | |
| Other | 362,726 | 622,718 | 91,722 | 544,721 | 691,349 | |
| Depreciation and amortization Loss from disposal of |
218,262 | 194,191 | 106,835 | 104,098 | 408,658 | |
| property, plant and equipment | - | (2) | - | - | - | |
| Profit from sale of provident funds Change in fair value of investment property |
- 4,676 |
(14,185) 6,286 |
- - |
(14,185) - |
(14,185) (96,200) |
|
| Gain on notional disposal as a result of gaining control of an investee |
(129,096) | (108,942) | (129,096) | (108,942) | (109,586) | |
| Change in financial liabilities | 726,529 | 3,374,687 | (201,922) | 3,017,433 | 1,899,625 | |
| Expenses on income tax (tax benefit) | (125,984) | 336,902 | (90,054) | 6,367 | 504,336 | |
| Company's share in the | ||||||
| profits of associates, net | (43,073) | (30,274) | (37,037) | (26,355) | (61,548) | |
| Payroll expenses in respect | ||||||
| of share-based payment | 9,489 | 10,035 | 3,874 | 4,562 | 17,556 | |
| Changes in other balance | ||||||
| sheet line items, net: | ||||||
| Change in liabilities in respect of | ||||||
| non-yield-dependent insurance contracts Change in liabilities in respect |
1,791,011 | 202,527 | 1,140,304 | 342,705 | 345,510 | |
| of yield-dependent contracts | 4,306,400 | (2,513,828) | 3,741,443 | (3,489,199) | (1,586,491) | |
| Change in liabilities for bonds, ETFs | (7,698) | 10,058 | 7,543 | 23,058 | (4,302) | |
| Change in financial investments for | ||||||
| holders of ETFs, certificates of deposit | 7,000 | (11,000) | (9,000) | (24,000) | 5,000 | |
| Change in credit assets in respect of | ||||||
| factoring, clearing and financing | (45,516) | (657,930) | (50,074) | (497,151) | (892,945) | |
| Change in deferred acquisition costs | (201,149) | (270,378) | (60,474) | (124,758) | (442,735) | |
| Change in reinsurance assets | (432,091) | (360,653) | (225,141) | (204,172) | (365,703) | |
| Change in liabilities for employee benefits, net |
8,831 | 11,850 | 2,006 | 698 | (2,469) | |
| Change in accounts receivable | ||||||
| and collectible premiums | (449,948) | (623,726) | 90,418 | (401,776) | (123,460) | |
| Change in payables and credit balances | 558,719 | 307,484 | 637,889 | 234,851 | 506,544 | |
| Change in credit for purchase of securities | 10,000 | (257,000) | (46,000) | (201,000) | (268,000) | |
| Revaluation of loans granted to associates | 453 | 2,403 | - | 3,479 | (1,100) | |
| Financial investments and investment | ||||||
| property in respect of insurance contracts | ||||||
| and yield-dependent investment contracts: | ||||||
| Acquisition of real estate properties Proceeds on sale of real estate properties |
(73,432) - |
(60,582) 219,844 |
(65,455) - |
(34,422) 123,045 |
(99,874) 219,844 |
|
| Sales (acquisitions), net | ||||||
| of financial investments | 1,108,247 | (3,304,874) | 1,107,704 | (1,239,699) | (3,699,920) | |
| Financial investments and other investment | ||||||
| property: | ||||||
| Sales (acquisitions), net | ||||||
| of financial investments | (592,115) | (2,064,056) | 576,970 | (2,337,427) | (540,903) | |
| Acquisition of real estate properties | (42,130) | (38,522) | (37,470) | (18,005) | (58,419) | |
| Proceeds on sale of real estate properties | - | 119,055 | - | 66,255 | 119,054 | |
| Cash paid and received | ||||||
| during the period for: | ||||||
| Taxes paid Taxes received |
(262,132) 65,040 |
(401,238) 36,326 |
(51,899) (1) |
(265,070) 1,072 |
(765,600) 57,366 |
|
| Total cash flows provided by | ||||||
| (used for) operating activities | 1,694,335 | (62,472) | 2,527,725 | 47,255 | 1,379,463 | |

| For the six months | For the three months | For the year ended | ||||
|---|---|---|---|---|---|---|
| ended June 30 | ended June 30 | December 31 | ||||
| 2023 | 2022 | 2023 | 2022 | 2022 | ||
| Unaudited | NIS thousand | Audited | ||||
| Acquisition of consolidated companies | ||||||
| (b) | consolidated for the first time | |||||
| Assets and liabilities of the consolidated | ||||||
| companies as of acquisition date: | ||||||
| Working capital (excluding | ||||||
| cash and cash equivalents) | (3,000) | 22,346 | - | 21,879 | 27,944 | |
| Property, plant and equipment, net | - | (783) | - | (145) | (877) | |
| Goodwill arising from acquisition | (149,793) | (82,272) | (113,793) | (35,741) | (79,216) | |
| Intangible assets | (115,277) | (64,925) | (103,277) | (64,925) | (111,217) | |
| Deferred taxes | 38,310 | 6,190 | 35,310 | 4,173 | 23,020 | |
| Minority interests | 27,309 | 50,624 | 27,309 | 50,624 | 53,886 | |
| Investments in investees Disposal of investment in an associate |
- 129,096 |
(74,732) 114,983 |
- 129,096 |
(74,732) 114,983 |
(72,109) 115,627 |
|
| Financial liabilities | - | 733 | - | 733 | 8,614 | |
| Liability for payment in respect | ||||||
| of acquisition of an investee | - | 21,050 | - | (23,950) | 24,134 | |
| Liabilities for employee benefits | - | 379 | - | 152 | 419 | |
| Payables for acquisition of a subsidiary | 25,355 | - | 25,355 | - | - | |
| (48,000) | (6,407) | - | (6,949) | (9,775) | ||
| (c) | Cash and cash equivalents | |||||
| Balance of cash and cash | ||||||
| equivalents at beginning of period: | ||||||
| Cash and cash equivalents | 3,439,766 | 2,154,153 | 2,267,523 | 3,380,462 | 2,154,153 | |
| Cash and cash equivalents in | 16,358,509 | 13,785,593 | 17,139,322 | 13,241,894 | 13,785,593 | |
| respect of yield-dependent contracts | 19,798,275 | 15,939,746 | 19,406,845 | 16,622,356 | 15,939,746 | |
| Balance of cash and cash | ||||||
| equivalents at end of period: | ||||||
| Cash and cash equivalents | 2,713,058 | 2,459,240 | 2,713,058 | 2,459,240 | 3,439,766 | |
| Cash and cash equivalents in respect | ||||||
| of yield-dependent contracts | 18,728,467 | 14,789,357 | 18,728,467 | 14,789,357 | 16,358,509 | |
| 21,441,525 | 17,248,597 | 21,441,525 | 17,248,597 | 19,798,275 | ||
| (d) | Significant non-cash activities | |||||
| Recognition of right-of-use | ||||||
| asset against a lease liability | (17,147) | (40,334) | (9,317) | (35,654) | (52,319) | |
| Dividend declared for | ||||||
| non-controlling interests | (138,969) | - | (138,969) | - | - | |
| Sale of a consolidated company consolidated for the first time |
(25,355) | - | (25,355) | - | - | |
| Acquisition of minority interest | ||||||
| in a consolidated company | (11,231) | - | (11,231) | - | - | |
| Breakdown of amounts | ||||||
| (e) | included in operating activities | |||||
| Interest paid | 135,581 | 75,514 | 63,261 | 27,690 | 178,990 | |
| Interest received | 609,626 | 438,572 | 446,202 | 318,828 | 957,447 | |
| Dividend received | 34,672 | 29,591 | 14,084 | 21,961 | 47,571 |

Notes to the Condensed Consolidated Int erim Financial Stat ements
| The Company | - | The Phoenix Holdings Ltd. |
|---|---|---|
| The Group | - | The Phoenix Holdings Ltd. and its consolidated companies. |
| The Phoenix Insurance |
- | The Phoenix Insurance Company Ltd., a wholly-owned subsidiary. |
| The Phoenix Investments |
- | The Phoenix Investments and Finances Ltd., a wholly-owned subsidiary. |
| The Phoenix Investment House |
- | The Phoenix Investment House Ltd. (formerly Excellence Investments Ltd.), a subsidiary of The Phoenix Investments, is a wholly-owned subsidiary of the Company. |
| The Phoenix Advanced Investments |
- | The Phoenix Advanced Investments Ltd., a wholly-owned subsidiary of The Phoenix Investments. |
| Gama | Gama Management and Clearing Ltd., a subsidiary in which The Phoenix Investments is a controlling shareholder. |
|
| The Phoenix Agencies |
- | The Phoenix Insurance Agencies 1989 Ltd. is held by the Company at 80%. For further details, please see Note 1F. |
| The Phoenix Pension and Provident Fund |
- | The Phoenix Pension and Provident Funds Ltd., a wholly-owned subsidiary of the Company. |
| The Phoenix Capital Raising |
- | The Phoenix Capital Raising (2009) Ltd., a wholly-owned subsidiary of The Phoenix Insurance. |
| Belenus Lux S.a.r.l | - | The controlling shareholder, held indirectly by Centerbridge Partners LP and Gallatin Point Capital LLC (hereinafter - the "Funds"). Centerbridge Partners LP is controlled by CCP III Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by Matthew Botein, Lewis (Lee) Sachs. |
| Phoeniclass | - | Phoeniclass Ltd., an investee of The Phoenix Insurance and The Phoenix Investments. |
| The Commissioner | The Commissioner of the Capital Market, Insurance and Savings. |

C. Control of The Phoenix Holdings
The controlling shareholder of the Company is Belenus Lux S.à.r.l. (hereinafter - "Belenus"), which is held indirectly, through a number of companies, by Centerbridge Partners LP and Gallatin Point Capital LLC. Centerbridge Partners LP is controlled by CCP III Cayman GP Ltd. and Gallatin Point Capital LLC is controlled by Matthew Botein, Lewis (Lee) Sachs.
In December 2022, the Company reported that a consortium of investors from the United Arab Emirates alongside other international investors are assessing the option of acquiring the control core in the Company from Belenus, and the parties' signing a memorandum of understanding. In July 2023, the Company reported that the parties reached a mutual understanding regarding the cancellation of the memorandum of understanding and concurrently, on the execution of a transaction for the sale of Belenus shares to the consortium, with Belenus retaining a stake of at least 30% of its shares, fully diluted. On August 14, a transaction for the sale of 2% of the Company's shares to a company controlled by an investor from the United Arab Emirates was completed, and as of the report's publication date Belenus holds 31.15% of the Company's shares. For further details, please see reports dated December 13, 2022, July 23, 2023 and August 15, 2023 (Ref. Nos.: 2022-01-150541, 2023-01-068953 and 2023-01-075799, respectively).
D. Effects of inflation and increase in interest rates
Further to global macroeconomic developments, which started in 2022 and continued through the report publication date, inflation rates in Israel and across the world have exceeded inflation targets of central banks. Further to steps taken to curb price increases, central banks across the world, including the Bank of Israel, continued to increase interest rates. Changes in inflation rates, interest rates and the illiquidity premium (which is calculated based on the average up-to-date and historical spreads of the bonds included in the Tel-Bond 60 Index) affect the Company's financial results, and mainly those of The Phoenix Insurance. For information about the effect of the change in interest rates in the reporting periods on the Company's financial results, see Note 8A. For information about the financial results' sensitivity to changes in interest and inflation rates, see Note 41 Section 3.2 to the Consolidated Annual Financial Statements.
E. The legal reform
In recent months, there has been uncertainty regarding the government's plans to promote changes in the judicial system, and the growing public controversy surrounding this move. During January 2023, the government began promoting a plan to make fundamental changes in the legal system in Israel, which led to controversy and widespread public protests. In July 2023, protesters intensified their protest against the legislation of the Basic Law: The Judiciary (Amendment No. 3) - Abolishing the Standard of Reasonableness, which was passed by the Knesset on July 24, 2023. Against the backdrop of promoting the changes in the judiciary, in April 2023, Moody's the international rating agency - published Israel's credit rating, leaving the rating unchanged at A1, and changing the credit rating outlook from "positive" to "stable" following its assessments regarding developments that will arise from the implementation of the changes. In May 2023, S&P - the international rating agency published Israel's credit rating. S&P reiterated Israel's AArating with a stable outlook, based on the assumption that agreement will be reached regarding the reform in the legal system.
In July 2023, immediately prior to the revocation of the standard of reasonableness, Moody's and S&P published special reports in response to the legislation of the law for the abolishment of the standard of reasonableness, which emphasized the risks and the concerns regarding potential adverse effects on the Israeli economy, which might arise from further unilateral legislation. However, no changes were made to the rating of the State of Israel and/or its rating outlook. In addition, credit rating agency Fitch reiterated Israel's credit rating at A+ and the rating outlook at "stable", but also issued a warning regarding further future developments.
At this stage the Company is unable to assess future developments, or the effect of those events on the Israeli economy in general and the Company's activity in particular.

F. In December 2022, the competent organs of The Phoenix Agencies and Agam Leaderim Holdings (2001) Ltd. (hereinafter - "Agam Holdings"), a company in which The Phoenix Agencies has a 60% stake, approved a merger offer between the two aforesaid companies, in accordance with a merger agreement under which Agam Holdings will be wound up and merged with and into The Phoenix Agencies in consideration for allotment of ordinary shares of The Phoenix Agencies that will be issued to the other shareholders of Agam Holdings, such that after the execution of the merger the Company will hold 80% of the shares of The Phoenix Agencies, and the other shareholders will hold the remaining shares. Furthermore, the Company and the other shareholders signed an agreement whereby, subject to the provisions of any law, immediately after the completion of the merger, The Phoenix Agencies shall distribute a dividend at an amount equal to the distributable profits for tax purposes, in accordance with The Phoenix Agencies' financial statements as of March 31, 2023; the profit is estimated at NIS 670 million.
The merger was completed in June 2023 after the fulfillment of all conditions precedent; accordingly, The Phoenix Agencies declared a NIS 675 million cash dividend, of which NIS 250 million were paid as of the publication date of the financial statements. In addition, it was decided that if The Phoenix Agencies will require shareholder loans in order to execute the said Dividend Distribution, the Company and the other shareholders shall advance shareholder loans at a total maximum amount of up to NIS 500 million, based on their proportionate share in The Phoenix Agencies' issued share capital. As a result of the merger, the equity attributed to the Company's shareholders decreased by NIS 120 million. For further details, please see Note 8E(3) to the Annual Financial Statements.
G. Global rating for The Phoenix Insurance On May 23, 2023 Moody's - the international rating agency - announced the assignment of an A2 international credit rating with a stable outlook to The Phoenix Insurance.
During the reporting period, The Phoenix Investments purchased 4.2 million Gama shares for a total consideration of NIS 42 million. Subsequent to the reporting period, The Phoenix Investments purchased further 6.6 million Gama shares for a total consideration of NIS 73 million. As of June 30, 2023 and the report's publication date, The Phoenix Investments holds 67.15% and 76.87% of Gama's shares, respectively.
Subsequent to these acquisitions, in August 2023, The Phoenix Investments published a full tender offer (whose validity is conditional upon the acquisition of all of the offerees' shares) to acquire all of Gama's shares.
If the full tender offer will come to fruition, the consideration which The Phoenix Investments is expected to pay will amount to NIS 220 million. It should be clarified that it is uncertain whether the tender offer will, indeed, be completed successfully. For further details, please see the immediate report dated August 10, 2023 (Ref. No. 2023-01-074644).

The consolidated interim financial statements of the Company have been drawn up in accordance with the provisions of the Securities Regulations (Periodic and Immediate Reports), 1970. In accordance with these provisions, those financial statements data that relate to a consolidated subsidiary, which falls within the scope of the definition of insurer, as defined in the Securities Regulations (Preparation of Annual Financial Statements), 2010, are drawn up in accordance with the requirements set by the Commissioner in accordance with the Financial Services Supervision Law (Insurance), 1981.
In accordance with requirements set by the Commissioner, the first-time application date of IFRS 17 regarding Insurance Contracts and IFRS 9 regarding Financial Instruments was postponed to January 1, 2025 (instead of the first-time application date that was set in the standard itself - January 1, 2023). Consequently, during the periods through the date of first-time application in Israel, those data in the financial statements that relate to The Phoenix Insurance, as stated above, continue to be drawn up in accordance with IFRS 4 regarding Insurance Contracts, and IAS 39 (of 2017) regarding Financial Instruments.
In addition, data included in The Phoenix Insurance's consolidated financial statements, which do not relate to IFRS 17 and IFRS 9 as stated above, and the remaining data in the consolidated financial statements, are drawn up in accordance with IAS 34 - "Interim Financial Reporting". In addition, the financial statements were prepared in accordance with the disclosure provisions in Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970, insofar as these regulations apply to a corporation consolidating an insurance company.
In preparing the condensed financial statements in accordance with the above, the Company is required to exercise discretion in assessments, estimates and assumptions that affect the implementation of the policy and the amounts of assets and liabilities, income and expenses. It is clarified that the actual results may differ from those estimates. Management's discretion in applying the group's accounting policies and the key assumptions used in assessments involving uncertainty is consistent with that which is applied in the preparation of the Consolidated Annual Financial Statements. For further information regarding changes in critical estimates and assumptions used to calculate the insurance reserves, please see Note 8.A.
The accounting policies applied in the preparation of the Consolidated Interim Financial Statements are consistent with those implemented in the preparation of the Consolidated Annual Financial Statements, with the exception of what is stated below:
As described in Note 2.B.1 below regarding the first-time application of IFRS 9 - Financial Instruments (hereinafter - the "Standard") in respect of the financial instruments that do not belong to a consolidated subsidiary, which falls within the scope of the definition of insurer, the Company opted to apply the provisions of the Standard retrospectively, without restating comparative figures.
For information regarding the accounting policy that was applied through December 31, 2022 in respect of all financial instruments, and for information regarding the accounting policy that is applied in respect of the financial instruments that belong to a consolidated subsidiary, which falls within the scope of the definition of insurer - see Note 2K - to the Company's Consolidated Annual Financial Statements.
The accounting policy applied as from January 1, 2023 regarding financial instruments that do not belong to a consolidated subsidiary, which falls within the scope of the definition of insurer, is as follows:

Financial assets under the scope of the standard are measured on initial recognition at fair value plus transaction costs that are directly attributable to the purchase of the financial asset, except for financial assets that are measured at fair value through profit or loss, for which transaction costs are carried to profit or loss.
The Company classifies and measures the debt instruments in its financial statements based on the following criteria:
The Company's financial model is to hold the financial assets in order to collect contractual cash flows; furthermore, the contractual terms and conditions of the financial asset provide entitlement, at specified dates, to cash flows that are only principal and interest payments in respect of the outstanding principal amount.
Subsequent to initial recognition, instruments included in this group shall be presented according to their terms at cost, plus direct transaction costs, using the amortized cost method.
Furthermore, an entity may designate a financial instrument irrevocably on initial recognition as measured at fair value through profit or loss, if such designation eliminates or significantly reduces a measurement or recognition inconsistency. For example, where the relating financial liabilities are also measured at fair value through profit or loss.
The Company's business model is both to hold the financial assets in order to collect contractual cash flows and to sell the financial assets; furthermore, the contractual terms and conditions of the financial asset provide entitlement, at specified dates, to cash flows that are only principal and interest payments in respect of the outstanding principal amount. Subsequent to initial recognition, instruments in this group are measured at fair value. Gains or losses arising from fair value adjustments, except for interest and exchange rate differentials are recognized in other comprehensive income.
A financial asset that constitutes a debt instrument does not comply with the criteria for measurement at amortized cost or at fair value through other comprehensive income, including a financial asset that constitutes a debt instrument, which, under certain conditions, is designated to be subsequently measured at fair value through profit or loss. Subsequent to initial recognition, the financial asset is measured at fair value; gains or losses arising from fair value adjustments are charged to profit or loss.

IFRS 9 - Financial Instruments (cont.)
Financial assets that constitute investments in equity instruments do not comply with the said criteria and are therefore measured at fair value through profit or loss. In connection with equity instruments that are not held for trading the Company may, on initial recognition, irrevocably opt to present in other comprehensive income subsequent changes in fair value, which would have otherwise been measured at fair value through profit or loss. These changes will not be recognized in profit or loss in the future, even when the investment is derecognized.
At each reporting date, the Company tests the provision for loss in respect of financial debt instruments that are not measured at fair value through profit or loss should be estimated. The Company differentiates between two situations of recognition of a provision for loss:
B) Debt instruments with significant deterioration in credit quality since initial recognition and their credit risk is not low, the provision for loss recognized will take into account the expected credit losses - over the balance of the useful life of the instrument. The Company applies the expedient, according to which it assumes that the credit risk of a debt instrument has not increased significantly since its initial recognition, if it is determined, at the reporting date, that the instrument has low credit risk, for example
if the instrument has an external "investment grade" rating. The impairment in respect of debt instruments measured at amortized cost shall be recognized in profit or loss against a provision, whereas the impairment in respect of debt instruments measured at fair value through other comprehensive income shall be recognized against capital reserve, and will not reduce the carrying amount of the financial asset in the statement of financial position.
The Company has financial assets with short credit periods, to which it may apply the expedient set forth in the model, i.e., the Company measures the impairment provision at an amount equal to expected credit losses throughout the entire life of the instrument. The Company opted to apply the expedient available in respect of these financial assets.

The Company derecognizes a financial asset if and only if:
Transactions for the sale of financial assets are accounted for as a derecognition when the conditions specified above are fulfilled.
If the Company transfers its rights to receive cash flows from an asset and neither transfers nor retains substantially all the risks and rewards of the asset or transfers control thereof, a new asset is recognized in accordance with the Company's continuing involvement therein. Continuing involvement by way of providing a guarantee for the transferred asset is measured at the lower of the original balance of the asset in the financial statements and the maximum amount of consideration that the Company may be required to repay (the guarantee amount).
When the Company continues to recognize an asset to the extent of its continuing involvement, the entity also recognizes an associated liability. The associated liability is measured in such a way that the net carrying amount of the transferred asset and the associated liability is:
At initial recognition, the Company measures the financial liabilities that fall within the scope of the standard at fair value net of transaction costs that are directly attributable to the issue of the financial liability, except for financial liability measured at fair value through profit or loss, for which transaction costs are recognized in profit or loss.
Upon initial recognition, the Company designated a financial liability as a liability measured at fair value through profit or loss. Changes in the fair value of the financial liability that are attributable to changes in the Company's credit risk are presented in other comprehensive income.

IFRS 9 - Financial Instruments (cont.)
Subsequent to initial recognition, the Company measures all financial liabilities at amortized cost, except for:
The Company derecognizes a financial liability if and only if it is extinguished - that is to say, when the obligation established in a contract is repaid or canceled or expires.
A financial liability is extinguished when the debtor repays the liability by a cash payment, other financial assets, goods or services, or is legally released from the liability.
If the terms of an existing financial liability change, the Company assesses whether the terms of the liability are materially different than the existing terms.
When a material change has been made to the terms of an existing financial liability, the change is accounted for as a derecognition of the original liability and a recognition of a new liability. The difference between the balance of the two liabilities in the financial statements is carried to profit or loss.
In the event that the change is immaterial, the Company is required to update the liability amount, that is to say, to discount the new cash flows at the original effective interest rate, and the differences will be recognized in profit or loss.
When determining whether a change has occurred in the substantive terms and conditions of an existing liability, the Company takes qualitative and quantitative considerations into account.
Financial assets and financial liabilities are offset and the net amount is presented in the statement of financial position if there is a legally enforceable right to set off the recognized amounts and there is an intent to dispose of the asset and liability on a net basis or realize the asset and dispose of the liability simultaneously. The right to offset must be legally enforceable not only in the ordinary course of business of the parties to the contract, but also in the event of bankruptcy or insolvency of one of the parties. In order for the offset right to be readily available, it must not be contingent on a future event, or have periods of time in which it is inapplicable, nor events that may cause it to expire.

IFRS 9 - Financial Instruments (cont.)
Convertible bonds, that include an equity conversion component and a liability component are split into two components. Such a split is calculated by first determining the value of the liability component based on the fair value of a similar liability without a conversion option; the value of the equity conversion component is determined as residual value. Direct transaction costs were allocated between the equity component and the liability component based on the allocation of the consideration between the equity component and the liability component.
When a package of securities is issued, the consideration received (before issuance expenses) is allocated to the securities issued as part of the package in accordance with the following allocation order: financial derivatives and other financial instruments presented periodically at fair value. Thereafter, the fair value is determined for financial liabilities measured at amortized cost, and the consideration allocated to equity instruments is determined as residual value. Issuance costs are allocated to each component in accordance with the ratio of the amounts that was determined for each component of the package.
When the Group grants a put option to non-controlling interests, the option is classified as a financial liability and the non-controlling interests' share in the profits of the consolidated company is not conferred upon them. At each reporting date, the financial liability is measured at the present value of the estimated consideration to be transferred when the put option or is exercised based on the fair value of the consideration determined. Changes in the liabilities are recognized in profit or loss.
Equity instruments that were issued in order to replace debt are measured at the fair value of the equity instruments that were issued, if it may be reliably estimated. If the fair value of the issued equity instrument cannot be reliably measured, the equity instruments are measured in accordance with the fair value of the settled financial liability on its settlement date. The difference between the financial statement balance of the extinguished financial liability and the fair value of the issued equity instruments is recognized in profit or loss.
In accordance with the provisions of the standard, derivatives embedded into financial assets shall not be separated from a host contract. These hybrid contracts shall be measured as a whole at amortized cost or at fair value, in accordance with the criteria of the business model and the contractual cash flows.
When a host contract does not falls within the scope of the definition of financial asset, an embedded derivative is separated from the host contract and is accounted for as a derivative, if the economic characteristics and risks of an embedded derivative are not closely related to the economic characteristics and risks of the host contract, the embedded instrument meets the definition of a derivative, and the hybrid contract is not measured at fair value with changes in fair value recognized in profit or loss.
The need to bifurcate an embedded derivative is only reassessed if there is a change in the terms and conditions of the contract that significantly modifies the cash flows from the contract.

In July 2014, the IASB published the full and final version of IFRS 9 - Financial Instruments, which replaces IAS 39 - Financial Instruments: Recognition and Measurement. IFRS 9 (hereinafter - the "New Standard") focuses mainly on the classification and measurement of financial assets and is applicable to all financial assets that fall within the scope of IAS 39.
The New Standard is applied for the first time in these financial statements to the financial instruments that are not owned by a consolidated subsidiary, which falls within the scope of the definition of insurer.
The New Standard is applied retrospectively without restating the comparative figures, as allowed under the provisions of the New Standard. The Company recognizes any difference between the previous carrying amount and the carrying amount on the first-time application date in the opening balance of retained earnings.
The New Standard's effect on the Company's financial statements, other than a consolidated subsidiary, which falls within the scope of the definition of insurer, is immaterial.
In February 2021, the IASB issued an amendment to IAS 8: "Accounting Policies, Changes in Accounting Estimates and Errors" (hereinafter - the "Amendment). The purpose of the amendment is to introduce a new definition of the term "accounting estimates".
Accounting estimates are defined as "financial amounts in the financial statements subject to measurement uncertainty". The Amendment clarifies what changes in accounting estimates are and how they differ from changes in accounting policies and corrections of errors.
The Amendment was applied prospectively to annual periods beginning on January 1, 2023 and shall apply to changes in accounting policies and accounting estimates that occur at the beginning of that period or thereafter.
The above Amendment did not have a material effect on the Consolidated Interim Financial Statements of the Company.
In May 2021, the IASB issued an amendment to IAS 12, Taxes on Income (hereinafter - "IAS 12" or the "Standard"), which narrows the scope of the "initial recognition exemption" (hereinafter - the "Exemption") for deferred taxes set forth in Sections 15 and 24 to IAS 12 (hereinafter - the "Amendment").
Under the guidelines for recognition of deferred tax assets and liabilities, IAS 12 exempts recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from initial recognition of assets and liabilities in certain transactions. The Amendment narrows the scope of the exemption and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from a transaction that is not a business combination and for which equal temporary differences are generated in debit and credit, even if they meet the other terms and conditions of the IRE.

The Amendment was applied as from annual periods beginning on January 1, 2023. The above Amendment did not have a material effect on the Consolidated Interim Financial Statements of the Company.
In February 2021, the IASB issued an amendment to IAS 1: Presentation of Financial Statements (hereinafter - the "Amendment"). In accordance with the Amendment, companies are required to disclose their material accounting policies; this will replace the requirement to disclose companies' significant accounting policies. One of the main reasons for this amendment stems from the fact that the term "significant" is not defined in IFRS, whereas the term "material" is defined in various standards, and specifically in IAS 1. The Amendment was applied as from annual periods beginning on January 1, 2023.
The above Amendment did not have a material effect on the condensed consolidated interim financial statements of the Company; however, it is expected to affect the accounting policy in the Company's Consolidated Annual Financial Statements.
Further to what is stated in Note 2FF to the Company's Annual Financial Statements - disclosure of the new IFRSs in the period prior to their application - IFRS 17 - "Insurance Contracts" (hereinafter - "IFRS 17") and IFRS 9 - "Financial Instruments" (hereinafter - "IFRS 9"), on June 1, 2023, the Commissioner of the Capital Market, Insurance and Savings Authority published a third revision of the "Roadmap for the Adoption of International Accounting Standard (IFRS) 17 - Insurance Contracts" (hereinafter - the "Third Revision"), which includes a number of amendments compared with the "Roadmap - Second Revision", that was published on December 14, 2022.
As part of the Third Revision the first-time application date of IFRS 17 and IFRS 9 in Israel was postponed to the quarterly and annual periods beginning on January 1, 2025; (accordingly, the transition date shall be January 1, 2024).
In accordance with the Third Revision, in 2024, as part of the financial statements for the third quarter, the companies will be required to include, as part of a dedicated note in the financial statements, only a pro forma statement of financial position as of January 1, 2024 (opening balances data as of the transition date, without comparative figures), drawn up in accordance with the provisions of IFRS 17 and IFRS 9. In their 2024 Annual Financial Statements, companies will be required to include key proforma statements (statement of financial position as of January 1, 2024 and selected line items from the statement of comprehensive income for 2024 at the very least, and without comparative figures), that will be prepared in accordance with the provisions of IFRS 17 and IFRS 9 according to the disclosure format attached to the Third Revision. Furthermore, as part of the Third Revision, the milestones for the implementation of the standards in 2023 and 2024 were amended in line with the postponement of the first-time application date of IFRS 17 and IFRS 9, and in order to ensure the preparedness of Israeli insurance companies for a fair and reliable application of the standards. The key amendments pertain to the reporting requirements to the Capital Market, Insurance and Savings Authority before the first-time application date, the time table for adapting the IT systems, the completion of the formulation of the accounting policy, the preparations for the calculation of the risk adjustment for a non-financial risk, the involvement of the independent auditors, and the disclosure of high-quality supplementary information for the dedicated note as from the financial statements for the first quarter of 2024.

The Company continues to assess the effects of the adoption of the said standards on its financial statements, and is preparing for their implementation according to said schedule.
As part of the standard's adoption process, the Company is implementing and integrating IT systems that are necessary for the implementation of the standard's provisions. In addition, the Company is testing and mapping the required controls and the flow of information to the financial statements.
Furthermore, in accordance with the Third Revision, by August 31, 2023 the Company will report to the Capital Markets Authority the results of the first Quantitative Impact Study (hereinafter - "QIS") for assessing the effect of the first-time application of IFRS 17. As part of the first QIS, the Company conducted quantitative tests in order to check the methodology employed to calculate the opening balances, based on the opening balances as of January 1, 2023 of certain insurance contracts set in the Third Revision.
Reclassifications were made in the Condensed Consolidated Interim Financial Statements and in the notes to the financial statements. The reclassifications did not have an effect on the equity, profit and loss and comprehensive income.
| CPI | Representative | ||||
|---|---|---|---|---|---|
| Known CPI % |
In lieu CPI % |
exchange rate of US dollar % |
|||
| For the six months ended on: | |||||
| June 30, 2023 | 2.5 | 2.2 | 5.1 | ||
| June 30, 2022 | 3.1 | 3.2 | 12.5 | ||
| For the three months ended on: | |||||
| June 30, 2023 | 1.4 | 1.0 | 2.4 | ||
| June 30, 2022 | 1.9 | 1.7 | 10.2 | ||
| For the year ended December 31, 2022 | 5.3 | 5.3 | 13.2 |

The Company operates in the following operating segments:
The life insurance and savings segment includes the life insurance subsegments and related coverages. The segment includes various categories of insurance policies as well insurance coverages in respect of various risks such as: death, disability, permanent health insurance, and more.
The health insurance segment includes the Group's health insurance activity. The segment includes long-term care, medical expenses, surgery and transplants, dental, travel and foreign workers insurance and more.
The property and casualty insurance segment includes the liability and property subsegments. In accordance with the Commissioner's directives, the property and casualty insurance segment in Israel is broken down into compulsory motor insurance, motor property, other property and other liability subsegments:
The compulsory motor subsegment focuses on coverage, the purchase of which by the vehicle owner or driver is mandatory, in respect of bodily injury caused as a result of the use of a motor vehicle (to the driver, passengers, or pedestrians).
The motor property subsegment focuses on coverage against property damage to the policyholder's vehicle and third-party property damage caused by the insured vehicle.
The liability subsegments provide coverage in respect of the policyholder's liability for any third-party damage he/she may cause. These subsegments include: third-party liability, employers' liability, professional liability, product liability and other subsegments.
▪ Property and other subsegments Property subsegments other than motor and liability as well as other insurance subsegments.
The pension and provident segment includes the management of pension funds and provident funds through The Phoenix Pension and Provident, which is a wholly-owned subsidiary of the Company.
In accordance with the Commissioner's directives, segment activity is described separately for the pension activity and the provident activity.

The financial services segment includes the results of The Phoenix Investment House (formerly Excellence). The segment includes investment management activity, including mutual funds, ETFs, brokerage services, underwriting services, market making in various securities and other services.
In addition, the results of this segment include those of The Phoenix Investments including The Phoenix group's alternative investment funds.
The insurance agencies segment includes the activity of the pension arrangement agencies and other insurance agencies in the group.
The credit segment includes Gama. Gama is a credit aggregator providing financing against postdated checks (factoring), clearing, and management of credit vouchers services, financing against real estate properties, loans and credit, equipment financing and supplier financing.
This activity includes part of the group's HQ function that is not attributed to the operating segments, activities which are ancillary/overlapping with the group's activity and holding assets and liabilities against the Company's share capital in accordance with the Capital Regulations. Financial liabilities that serve the Company's equity requirements and finance expenses in respect thereof are not allocated to the operating segments.
It should be noted that the Company allocates the assets which are not measured at fair value in accordance with the provisions of the law and Company's procedures, and specifically the allocation in accordance with the consolidated circular on testing the appropriateness of the LAT reserve and the Commissioner's Position - Best Practice for Calculation of Reserves in Property and Casualty Insurance (for more information, see Note 41, Sections 5.1 and 5.2 to the Annual Financial Statements). This allocation may have an effect on investment income allocated to the different segments.

| For the 6-month period ended June 30, 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Premiums earned, gross | 2,352,787 | 1,638,610 | 1,948,191 | - | - | - | - | - | - | 5,939,588 |
| Premiums earned by reinsurers | 138,246 | 116,624 | 542,697 | - | - | - | - | - | - | 797,567 |
| Premiums earned - retention |
2,214,541 | 1,521,986 | 1,405,494 | - | - | - | - | - | - | 5,142,021 |
| Investment income (losses), net and finance income | 4,750,212 | 464,406 | 89,425 | 55,835 | 16,521 | 11,525 | 74,461 | (160,123) | (12,804) | 5,289,458 |
| Income from management fees | 294,599 | - | - | 361,442 | 177,543 | 1,030 | - | 2,162 | (18,906) | 817,870 |
| Income from fees and commissions (e) | 17,474 | 21,243 | 117,841 | - | - | 385,599 | - | - | (136,079) | 406,078 |
| Income from financial services | - | - | - | - | 160,000 | - | - | - | - | 160,000 |
| Income from factoring and clearing | - | - | - | - | - | - | 90,568 | - | - | 90,568 |
| Other income (see Note 4B) | 255 | 113,454 | - | 16,826 | 3,241 | 8,874 | - | 8 | (575) | 142,083 |
| Total income | 7,277,081 | 2,121,089 | 1,612,760 | 434,103 | 357,305 | 407,028 | 165,029 | (157,953) | (168,364) | 12,048,078 |
| Payments and change in liabilities in respect of | ||||||||||
| insurance contracts and investment contracts, gross | 7,148,603 | 1,981,131 | 1,459,815 | 49,944 | - | - | - | - | - | 10,639,493 |
| Reinsurers' share in payments and in changes in | ||||||||||
| liabilities in respect of insurance contracts | 134,217 | 219,337 | 387,272 | - | - | - | - | - | - | 740,826 |
| Payments and change in liabilities in respect of | ||||||||||
| insurance contracts and investment contracts - retention |
7,014,386 | 1,761,794 | 1,072,543 | 49,944 | - | - | - | - | - | 9,898,667 |
| Fees and commissions and other purchase expenses | 301,480 | 253,314 | 356,182 | 181,637 | 29,468 | - | 2,822 | 63 | (115,422) | 1,009,544 |
| General and administrative expenses | 203,855 | 88,611 | 73,461 | 118,879 | 205,054 | 237,754 | 51,533 | 46,276 | (22,229) | 1,003,194 |
| Other expenses (income) | (662) | - | - | 17,107 | 13,613 | 13,078 | 4,059 | 12,877 | (226) | 59,846 |
| Finance expenses | 13,854 | - | 8,400 | 7,183 | 3,944 | 2,231 | 51,761 | 115,638 | (11,475) | 191,536 |
| Total expenses | 7,532,913 | 2,103,719 | 1,510,586 | 374,750 | 252,079 | 253,063 | 110,175 | 174,854 | (149,352) | 12,162,787 |
| Company's share in the net results of investees | 10,413 | 26,984 | 747 | 362 | 5,396 | 1,289 | - | (2,118) | - | 43,073 |
| Profit (loss) before taxes on income | (245,419) | 44,354 | 102,921 | 59,715 | 110,622 | 155,254 | 54,854 | (334,925) | (19,012) | (71,636) |
| Other comprehensive income before taxes on income |
162,053 | 28,512 | 69,665 | - | - | - | - | 177,570 | - | 437,800 |
| Total comprehensive income (loss) before taxes on income |
(83,366) | 72,866 | 172,586 | 59,715 | 110,622 | 155,254 | 54,854 | (157,355) | (19,012) | 366,164 |
| June | 30, 2023 | |||||||||
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and yield-dependent investment contracts | 92,392,142 | 5,956,351 | - | - | - | - | - | - | - | 98,348,493 |
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and non-yield-dependent investment contracts | 12,806,395 | 5,560,457 | 7,837,601 | 1,045,054 | - | - | - | - | - | 27,249,507 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the 6-month period ended June 30, 2022 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | ||
| Unaudited | |||||||||||
| NIS thousand | |||||||||||
| Premiums earned, gross | 2,916,520 | 1,479,230 | 1,637,059 | - | - | - | - | - | - | 6,032,809 | |
| Premiums earned by reinsurers | 164,347 | 106,451 | 521,187 | - | - | - | - | - | - | 791,985 | |
| Premiums earned - retention |
2,752,173 | 1,372,779 | 1,115,872 | - | - | - | - | - | - | 5,240,824 | |
| Investment income (losses), net and finance income | (4,652,642) | (665,610) | 79,815 | 50,829 | 4,417 | 4,498 | 29,851 | (270,761) | (15,769) | (5,435,372) | |
| Income from management fees | 298,435 | - | - | 328,313 | 155,826 | 1,589 | - | 2,055 | (24,174) | 762,044 | |
| Income from fees and commissions (e) | 38,545 | 26,960 | 121,265 | - | - | 353,652 | - | - | (110,157) | 430,265 | |
| Income from financial services | - | - | - | - | 101,000 | - | - | - | - | 101,000 | |
| Income from factoring and clearing | - | - | - | - | - | - | 63,827 | - | - | 63,827 | |
| Other income | - | - | - | 14,853 | 91,367 | 31,302 | - | 2 | (737) | 136,787 | |
| Total income | (1,563,489) | 734,129 | 1,316,952 | 393,995 | 352,610 | 391,041 | 93,678 | (268,704) | (150,837) | 1,299,375 | |
| Payments and change in liabilities in respect of | |||||||||||
| insurance contracts and investment contracts, gross | (2,346,987) | (258,730) | 1,269,744 | 53,415 | - | - | - | - | - | (1,282,558) | |
| Reinsurers' share in payments and in changes | 121,965 | 139,514 | 345,815 | - | - | - | - | - | - | 607,294 | |
| in liabilities in respect of insurance contracts | |||||||||||
| Payments and change in liabilities in respect of insurance | |||||||||||
| contracts and investment contracts - retention Fees and commissions and other purchase expenses |
(2,468,952) 277,629 |
(398,244) 227,294 |
923,929 319,029 |
53,415 150,384 |
- 36,500 |
- 8,854 |
- 2,410 |
- - |
- (99,933) |
(1,889,852) 922,167 |
|
| General and administrative expenses | 187,477 | 75,733 | 60,836 | 113,535 | 165,388 | 204,951 | 44,538 | 52,617 | (27,617) | 877,458 | |
| Other expenses (income) | (353) | - | - | 10,286 | 6,453 | 11,290 | 4,059 | - | (226) | 31,509 | |
| Finance expenses (income) | 1,044 | - | 19,777 | 7,627 | (2,758) | 1,344 | 19,205 | 118,306 | (14,440) | 150,105 | |
| Total expenses | (2,003,155) | (95,217) | 1,323,571 | 335,247 | 205,583 | 226,439 | 70,212 | 170,923 | (142,216) | 91,387 | |
| Company's share in the net results of investees | 16,899 | 12,456 | (2,969) | - | 1,397 | 2,491 | - | - | - | 30,274 | |
| Profit (loss) before taxes on income | 456,565 | 841,802 | (9,588) | 58,748 | 148,424 | 167,093 | 23,466 | (439,627) | (8,621) | 1,238,262 | |
| Other comprehensive income | |||||||||||
| (loss) before taxes on income | 20,934 | 1,249 | (224,814) | - | (1,035) | - | 850 | (296,938) | - | (499,754) | |
| Total comprehensive income | |||||||||||
| (loss) before taxes on income | 477,499 | 843,051 | (234,402) | 58,748 | 147,389 | 167,093 | 24,316 | (736,565) | (8,621) | 738,508 | |
| June 30, 2022 | |||||||||||
| Unaudited | |||||||||||
| NIS thousand | |||||||||||
| Liabilities, gross in respect of insurance contracts | |||||||||||
| and yield-dependent investment contracts | 87,356,951 | 5,757,805 | - | - | - | - | - | - | - | 93,114,756 | |
| Liabilities, gross in respect of insurance contracts | |||||||||||
| and non-yield-dependent investment contracts | 12,340,232 | 4,661,998 | 7,323,289 | 989,994 | - | - | - | - | - | 25,315,513 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.
(e) Arises from fees and commissions income received from agencies owned by the group, mainly from activities in the life insurance and savings.

| For the 3-month period ended June 30, 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | ||
| Unaudited | |||||||||||
| NIS thousand | |||||||||||
| Premiums earned, gross | 1,145,188 | 830,869 | 1,011,932 | - | - | - | - | - | - | 2,987,989 | |
| Premiums earned by reinsurers | 69,676 | 58,727 | 277,332 | - | - | - | - | - | - | 405,735 | |
| Premiums earned - retention |
1,075,512 | 772,142 | 734,600 | - | - | - | - | - | - | 2,582,254 | |
| Investment income, net and finance income | 3,842,791 | 366,709 | 65,665 | 34,084 | 5,524 | 5,938 | 39,117 | 19,698 | (7,810) | 4,371,716 | |
| Income from management fees | 146,727 | - | - | 183,154 | 89,512 | 595 | - | 1,167 | (11,827) | 409,328 | |
| Income from fees and commissions (e) | 2,634 | 10,821 | 58,507 | - | - | 194,314 | - | - | (73,566) | 192,710 | |
| Income from financial services | - | - | - | - | 90,000 | - | - | - | - | 90,000 | |
| Income from factoring and clearing | - | - | - | - | - | - | 44,356 | - | - | 44,356 | |
| Other income (see Note 4B) | - | 113,454 | - | 16,356 | 2,118 | 5,772 | - | 8 | (169) | 137,539 | |
| Total income | 5,067,664 | 1,263,126 | 858,772 | 233,594 | 187,154 | 206,619 | 83,473 | 20,873 | (93,372) | 7,827,903 | |
| Payments and change in liabilities in respect of | |||||||||||
| insurance contracts and investment contracts, gross | 5,002,336 | 1,321,485 | 739,092 | 26,641 | - | - | - | - | - | 7,089,554 | |
| Reinsurers' share in payments and in changes in liabilities in respect of insurance contracts |
87,656 | 136,440 | 145,707 | - | - | - | - | - | - | 369,803 | |
| Payments and change in liabilities in respect of insurance | |||||||||||
| contracts and investment contracts - retention |
4,914,680 | 1,185,045 | 593,385 | 26,641 | - | - | - | - | - | 6,719,751 | |
| Fees and commissions and other purchase expenses | 143,036 | 130,510 | 183,705 | 92,694 | 12,597 | - | 1,232 | 63 | (62,053) | 501,784 | |
| General and administrative expenses | 105,413 | 43,599 | 37,551 | 61,685 | 107,287 | 116,524 | 25,591 | 27,240 | (13,324) | 511,566 | |
| Other expenses | 404 | - | - | 9,300 | 8,037 | 6,657 | 2,029 | 12,877 | (113) | 39,191 | |
| Finance expenses | 8,785 | - | 3,851 | 4,227 | 1,593 | 1,468 | 27,803 | 54,594 | (7,145) | 95,176 | |
| Total expenses | 5,172,318 | 1,359,154 | 818,492 | 194,547 | 129,514 | 124,649 | 56,655 | 94,774 | (82,635) | 7,867,468 | |
| Company's share in the net results of investees | 7,325 | 2,358 | 25,009 | 362 | 2,120 | 388 | - | (525) | - | 37,037 | |
| Profit (loss) before taxes on income | (97,329) | (93,670) | 65,289 | 39,409 | 59,760 | 82,358 | 26,818 | (74,426) | (10,737) | (2,528) | |
| Other comprehensive income before taxes on income | 91,348 | 16,269 | 31,543 | - | - | - | - | 97,625 | - | 236,785 | |
| Total comprehensive income | |||||||||||
| (loss) before taxes on income | (5,981) | (77,401) | 96,832 | 39,409 | 59,760 | 82,358 | 26,818 | 23,199 | (10,737) | 234,257 | |
| June 30, 2023 | |||||||||||
| Unaudited | |||||||||||
| NIS thousand | |||||||||||
| Liabilities, gross in respect of insurance contracts | |||||||||||
| and yield-dependent investment contracts | 92,392,142 | 5,956,351 | - | - | - | - | - | - | - | 98,348,493 | |
| Liabilities, gross in respect of insurance contracts | |||||||||||
| and non-yield-dependent investment contracts | 12,806,395 | 5,560,457 | 7,837,601 | 1,045,054 | - | - | - | - | - | 27,249,507 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the 3-month period ended June 30, 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life | Pension | |||||||||
| insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Premiums earned, gross | 1,418,185 | 755,168 | 845,068 | - | - | - | - | - | - | 3,018,421 |
| Premiums earned by reinsurers | 83,068 | 54,799 | 262,925 | - | - | - | - | - | - | 400,792 |
| Premiums earned - retention |
1,335,117 | 700,369 | 582,143 | - | - | - | - | - | - | 2,617,629 |
| Investment income (losses), net and finance income | (3,884,676) | (572,269) | (21,967) | 27,419 | 3,431 | 2,010 | 16,317 | (314,114) | (10,019) | (4,753,868) |
| Income from management fees | 148,360 | - | - | 168,199 | 81,024 | 1,589 | - | 1,215 | (11,188) | 389,199 |
| Income from fees and commissions (e) | 20,646 | 12,041 | 59,286 | - | - | 180,115 | - | - | (75,037)(e) | 197,051 |
| Income from financial services | - | - | - | - | 57,000 | - | - | - | - | 57,000 |
| Income from factoring and clearing | - | - | - | - | - | - | 35,215 | - | - | 35,215 |
| Other income | - | - | - | 14,538 | 90,012 | 27,916 | - | - | (362) | 132,104 |
| Total income | (2,380,553) | 140,141 | 619,462 | 210,156 | 231,467 | 211,630 | 51,532 | (312,899) | (96,606) | (1,325,670) |
| Payments and change in liabilities in respect of | ||||||||||
| insurance contracts and investment contracts, gross | (2,737,755) | (87,124) | 576,971 | 30,530 | - | - | - | - | - | (2,217,378) |
| Reinsurers' share in payments and in changes | ||||||||||
| in liabilities in respect of insurance contracts | 66,076 | 85,437 | 156,624 | - | - | - | - | - | - | 308,137 |
| Payments and change in liabilities in respect of insurance | ||||||||||
| contracts and investment contracts - retention |
(2,803,831) | (172,561) | 420,347 | 30,530 | - | - | - | - | - | (2,525,515) |
| Fees and commissions and other purchase expenses | 134,920 | 117,697 | 172,874 | 80,489 | 17,571 | 4,168 | 1,123 | - | (70,160) | 458,682 |
| General and administrative expenses | 94,287 | 36,688 | 30,321 | 51,599 | 85,497 | 106,270 | 22,884 | 29,978 | (12,932) | 444,592 |
| Other expenses (income) | (1,503) | - | - | 4,944 | 3,453 | 6,116 | 2,029 | - | (113) | 14,926 |
| Finance expenses (income) | 425 | - | 16,175 | 4,532 | (557) | 752 | 13,392 | 65,099 | (9,354) | 90,464 |
| Total expenses | (2,575,702) | (18,176) | 639,717 | 172,094 | 105,964 | 117,306 | 39,428 | 95,077 | (92,559) | (1,516,851) |
| Company's share in the net results of investees | 9,766 | 17,262 | (2,221) | - | 641 | 907 | - | - | - | 26,355 |
| Profit (loss) before taxes on income | 204,915 | 175,579 | (22,476) | 38,062 | 126,144 | 95,231 | 12,104 | (407,976) | (4,047) | 217,536 |
| Other comprehensive income (loss) before taxes on | ||||||||||
| income | 108,755 | 12,141 | (69,459) | - | (1,269) | (260) | - | (57,937) | - | (8,029) |
| Total comprehensive income | ||||||||||
| (loss) before taxes on income | 313,670 | 187,720 | (91,935) | 38,062 | 124,875 | 94,971 | 12,104 | (465,913) | (4,047) | 209,507 |
| June 30, 2022 | ||||||||||
| Unaudited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and yield-dependent investment contracts | 87,356,951 | 5,757,805 | - | - | - | - | - | - | - | 93,114,756 |
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and non-yield-dependent investment contracts | 12,340,232 | 4,661,998 | 7,323,289 | 989,994 | - | - | - | - | - | 25,315,513 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| For the year ended December 31, 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance and savings (a) |
Health (b) | Property and casualty insurance (c) |
Pension and provident funds (d) |
Financial services |
Insurance agencies |
Credit | Not attributed to operating segments |
Adjustments and offsets |
Total | |
| Audited | ||||||||||
| NIS thousand | ||||||||||
| Premiums earned, gross | 5,611,196 | 3,054,811 | 3,471,224 | - | - | - | - | - | - | 12,137,231 |
| Premiums earned by reinsurers | 282,181 | 222,363 | 1,065,550 | - | - | - | - | - | - | 1,570,094 |
| Premiums earned - retention |
5,329,015 | 2,832,448 | 2,405,674 | - | - | - | - | - | - | 10,567,137 |
| Investment income (losses), net and finance income | (4,716,483) | (693,537) | 105,630 | 90,823 | 14,526 | 10,632 | 87,879 | (432,161) | (22,140) | (5,554,831) |
| Income from management fees | 587,708 | - | - | 670,387 | 337,279 | 469 | - | 3,868 | (51,983) | 1,547,728 |
| Income from fees and commissions (e) | 68,306 | 48,549 | 247,245 | - | - | 723,577 | - | - | (251,765) | 835,912 |
| Income from financial services | - | - | - | - | 223,000 | - | - | - | - | 223,000 |
| Income from factoring and clearing | - 4,204 |
- - |
- - |
- 15,864 |
- 90,919 |
- 35,228 |
142,754 - |
- 2 |
- (1,437) |
142,754 144,780 |
| Other income | 1,272,750 | 2,187,460 | 2,758,549 | 777,074 | 665,724 | 769,906 | 230,633 | (428,291) | (327,325) | 7,906,480 |
| Total income | ||||||||||
| Increase in insurance liabilities and payments in respect of insurance contracts |
(73,812) | 730,355 | 2,234,066 | 98,221 | - | - | - | - | - | 2,988,830 |
| Reinsurers' share in payments and in changes | ||||||||||
| in liabilities in respect of insurance contracts | 180,954 | 272,140 | 570,707 | - | - | - | - | - | - | 1,023,801 |
| Payments and change in liabilities in respect of insurance | ||||||||||
| contracts and investment contracts - retention |
(254,766) | 458,215 | 1,663,359 | 98,221 | - | - | - | - | - | 1,965,029 |
| Fees and commissions and other purchase expenses | 573,176 | 481,619 | 701,452 | 315,325 | 71,433 | 8,854 | 5,696 | - | (223,750) | 1,933,805 |
| General and administrative expenses | 379,479 | 152,882 | 122,715 | 229,351 | 345,900 | 423,455 | 92,667 | 117,618 | (58,783) | 1,805,284 |
| Other expenses | 1,187 | - | - | 31,879 | 17,583 | 32,782 | 8,118 | - | (453) | 91,096 |
| Finance expenses (income) | 8,483 | - | 24,161 | 13,315 | (2,054) | 7,472 | 52,907 | 233,734 | (19,484) | 318,534 |
| Total expenses | 707,559 | 1,092,716 | 2,511,687 | 688,091 | 432,862 | 472,563 | 159,388 | 351,352 | (302,470) | 6,113,748 |
| Company's share in the net results of investees | 26,648 | 26,017 | 4,213 | - | 2,494 | 2,735 | (57) | (502) | - | 61,548 |
| Profit (loss) before taxes on income | 591,839 | 1,120,761 | 251,075 | 88,983 | 235,356 | 300,078 | 71,188 | (780,145) | (24,855) | 1,854,280 |
| Other comprehensive income | ||||||||||
| (loss) before taxes on income | 18,923 | (860) | (222,399) | - | (333) | 70 | 1,593 | (33,388) | - | (236,394) |
| Comprehensive income | ||||||||||
| (loss) before taxes on income | 610,762 | 1,119,901 | 28,676 | 88,983 | 235,023 | 300,148 | 72,781 | (813,533) | (24,855) | 1,617,886 |
| As of December 31, 2022 | ||||||||||
| Audited | ||||||||||
| NIS thousand | ||||||||||
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and yield-dependent investment contracts | 88,307,936 | 5,734,157 | - | - | - | - | - | - | - | 94,042,093 |
| Liabilities, gross in respect of insurance contracts | ||||||||||
| and non-yield-dependent investment contracts | 12,517,305 | 4,784,707 | 7,140,483 | 1,016,001 | - | - | - | - | - | 25,458,496 |
(a) For additional data regarding the life insurance and savings subsegments, please see Section B below.
(b) For additional data regarding the health insurance subsegments, please see Section C below.
(c) For additional data regarding the property and casualty insurance subsegments, please see Section d below.
(d) For more information regarding the pension and provident subsegments, please see Section E below.

| Policies including a saving component (including appendices) by policy issuance date |
Policies without a savings component sold as |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| From 2004 | a single policy | |||||||||
| Until | Until | Yield | ||||||||
| 1990 (1) | 2003 | dependent | Individual | Group | Total | |||||
| Unaudited | ||||||||||
| Gross premiums Proceeds in respect of investment contracts credited |
26,975 | 587,453 | NIS thousand 1,334,485 |
340,843 | 63,031 | 2,352,787 | ||||
| directly to insurance reserves Financial margin |
- | - | 2,506,919 | - | - | 2,506,919 | ||||
| including management fees (2) Payments and |
(32,941) | 101,643 (3) | 192,365 | - | - | 261,067 | ||||
| change in liabilities in respect of insurance contracts, gross Payments and change in liabilities |
549,754 | 2,083,421 (4) | 3,097,176 (4) | 168,950 | 44,881 | 5,944,182 | ||||
| for investment contracts Total payments and change in liabilities |
- | - | 1,204,421 (4) | - | - | 1,204,421 | ||||
| from life insurance and long-term savings Total comprehensive income (loss) from life insurance and |
7,148,603 | |||||||||
| savings business | (59,337) (5) | (70,227) (5) | (16,639) | 42,495 (5) | 20,342 | (83,366) |
(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.
| Policies including a saving component (including appendices) by policy issuance date From 2004 |
Policies without a savings component sold as a single policy |
|||||
|---|---|---|---|---|---|---|
| Until 1990 (1) |
Until 2003 |
Yield dependent Unaudited |
Individual | Group | Total | |
| NIS thousand | ||||||
| Gross premiums Proceeds in respect of investment contracts credited |
29,109 | 584,954 | 1,938,463 | 302,978 | 61,016 | 2,916,520 |
| directly to insurance reserves Financial margin |
- | - | 4,522,230 | - | - | 4,522,230 |
| including management fees (2) Payments and change in liabilities in respect of insurance |
(44,355) | 100,044 (3) | 197,942 | - | - | 253,631 |
| contracts, gross Payments and change in liabilities for investment |
127,077 | (1,540,181) (4) | 19,648 (4) | 170,031 | 54,638 | (1,168,787) |
| contracts Total payments and change in liabilities from life insurance and long-term |
- | - | (1,178,200) (4) | - | - | (1,178,200) |
| savings Total comprehensive income (loss) from life insurance and |
(2,346,987) | |||||
| savings business | 386,404 (5) | 81,776 (5) | (9,550) | 13,365 | 5,504 | 477,499 |
| Policies including a saving component (including appendices) by policy issuance date |
Policies without a savings component sold as |
|||||
|---|---|---|---|---|---|---|
| From 2004 | a single policy | |||||
| Until 1990 (1) |
Until 2003 |
Yield dependent |
Individual | Group | Total | |
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 13,237 | 288,280 | 637,098 | 174,576 | 31,997 | 1,145,188 |
| Proceeds in respect of investment contracts credited directly to |
||||||
| insurance reserves | - | - | 1,309,549 | - | - | 1,309,549 |
| Financial margin including |
||||||
| management fees (2) | 58,971 | 51,132 (3) | 95,221 | - | - | 205,324 |
| Payments and change in liabilities in respect of insurance |
||||||
| contracts, gross | 324,077 | 1,598,478 (4) | 2,049,775 (4) | 79,049 | 22,458 | 4,073,837 |
| Payments and change in liabilities for |
||||||
| investment contracts | - | - | 928,499 (4) | - | - | 928,499 |
| Total payments and change in liabilities from life insurance |
||||||
| and long-term savings | 5,002,336 | |||||
| Total comprehensive | ||||||
| income (loss) from life | ||||||
| insurance and savings business |
4,797 (5) | (50,048) (5) | (21,190) | 46,520 (5) | 13,940 | (5,981) |
| Policies including a saving component (including appendices) by policy issuance date |
Policies without a savings component sold as |
|||||
|---|---|---|---|---|---|---|
| From 2004 | a single policy | |||||
| Until 1990 (1) |
Until 2003 |
Yield dependent |
Individual | Group | Total | |
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 14,772 | 295,277 | 924,974 | 151,921 | 31,241 | 1,418,185 |
| Proceeds in respect of investment contracts credited directly to |
||||||
| insurance reserves | - | - | 1,829,247 | - | - | 1,829,247 |
| Financial margin including management |
||||||
| fees (2) | 31,183 | 49,005 (3) | 99,134 | - | - | 179,322 |
| Payments and change in liabilities in respect of insurance contracts, |
||||||
| gross | 88,918 | (1,420,614) (4) | (569,786) (4) | 82,192 | 27,983 | (1,791,307) |
| Payments and change in liabilities for |
||||||
| investment contracts Total payments and |
- | - | (946,448) (4) | - | - | (946,448) |
| change in liabilities from life insurance and long-term savings Total comprehensive |
(2,737,755) | |||||
| income from the life insurance and savings businesses |
248,349 (5) | 44,286 (5) | 317 | 15,492 | 5,226 | 313,670 |
(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.
(2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.
(3) As of June 30, 2022, management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 507 million.
| Policies including a saving component (including appendices) by policy issuance date |
Policies without a savings component sold as a single policy |
|||||
|---|---|---|---|---|---|---|
| Until 1990 (1) |
Until 2003 |
From 2004 Yield dependent |
Individual | Group | Total | |
| Audited | ||||||
| Gross premiums Proceeds in respect of investment contracts |
58,871 | 1,182,140 | NIS thousand 3,630,606 |
617,400 | 122,179 | 5,611,196 |
| credited directly to insurance reserves Financial margin |
- | - | 7,335,455 | - | - | 7,335,455 |
| including management fees (2) Payments and change in liabilities in respect |
57,890 | 206,820 (3) | 380,001 | - | - | 644,711 |
| of insurance contracts, gross Payments and change |
465,040 | (915,658) (4) | 1,178,225 (4) | 337,718 | 104,553 | 1,169,878 |
| in liabilities for investment contracts Total payments and change in liabilities |
- | - | (1,243,690) (4) | - | - | (1,243,690) |
| from life insurance and long-term savings Total comprehensive income from the life |
(73,812) | |||||
| insurance and savings businesses |
585,610 (5) | (11,979) (5) | 9,058 | 13,341 | 14,732 | 610,762 |
(1) Products issued until 1990 (including increases in respect thereof) were mainly guaranteed return policies that were backed mainly by designated bonds.
(2) The financial margin does not include additional income of the Company collected as a percentage of the premium and is calculated before deducting investment management expenses. The financial margin in guaranteed return policies is based on actual investment income, for the reporting year, less the product of the annual guaranteed rate of return, multiplied by the average reserve per year in the various insurance reserves. In this matter, investment income also includes the change in the fair value of available-for-sale financial assets that is charged to the statement of comprehensive income. In yield-dependent contracts, the financial margin is the total fixed and variable management fees calculated on the basis of the yield and average balance of insurance reserves.
(3) As of December 31, 2022, the estimated management fees which were not collected due to negative yield in respect of participating policies amounted to approximately NIS 643 million.

| For the 6-month period ended June 30, 2023 | |||||
|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||
| Long | Short | ||||
| Individual (5) | Group (6) | term | term | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums Payments and change in |
139,891 | 613,328 | 826,336(1) | 56,905(1) | 1,636,460 |
| liabilities in respect of insurance contracts, gross Total comprehensive income |
337,211 | 1,089,391 | 534,174 | 20,355 | 1,981,131 |
| (loss) from health insurance business |
5,293(3) | (9,959)(3) | 66,407 | 11,125 | 72,866 |
(1) Of this, individual premiums in the amount of NIS 570.651 thousand and collective premiums in the amount of NIS 312,590 thousand.
| For the 6-month period ended June 30, 2022 | |||||||
|---|---|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||||
| Long | Short | ||||||
| Individual | Group | term | term | Total | |||
| Unaudited NIS thousand |
|||||||
| Gross premiums Payments and change in |
132,214 | 541,539 | 777,055(1) | 54,804(1) | 1,505,612 | ||
| liabilities in respect of insurance contracts, gross Total comprehensive income |
(614,889) | (187,072) | 511,768 | 31,463 | (258,730) | ||
| (loss) from health insurance business |
762,668(3) | 39,064(3) | 41,952 | (633) | 843,051 |
(1) Of this, individual premiums in the amount of NIS 515.483 thousand and collective premiums in the amount of NIS 316,376 thousand.
| For the 3-month period ended June 30, 2023 | |||||||
|---|---|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||||
| Individual Group (6) |
Long term |
Short term |
Total | ||||
| Unaudited NIS thousand |
|||||||
| Gross premiums Payments and change in |
70,017 | 309,372 | 423,456(1) | 29,741(1) | 832,586 | ||
| liabilities in respect of insurance contracts, gross Total comprehensive income |
350,671 | 695,294 | 266,053 | 9,467 | 1,321,485 | ||
| (loss) from health insurance business |
(136,178)(4) | (6,202)(4) | 56,895 | 8,084 | (77,401) |
(1) Of this, individual premiums in the amount of NIS 289.523 thousand and collective premiums in the amount of NIS 163,674 thousand.

| For the 3-month period ended June 30, 2022 | |||||
|---|---|---|---|---|---|
| Long-term care | Other (2) | ||||
| Long | Short | ||||
| Individual | Group | term | term | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums Payments and change in |
66,587 | 273,418 | 382,285(1) | 35,932(1) | 758,222 |
| liabilities in respect of insurance contracts, gross |
(67,282) | (316,064) | 276,438 | 19,784 | (87,124) |
| Total comprehensive income from health insurance business |
139,572(4) | 28,888(4) | 17,737 | 1,523 | 187,720 |
(1) Of this, individual premiums in the amount of NIS 269.033 thousand and collective premiums in the amount of NIS 149,184 thousand.
| Long-term care | For the year ended December 31, 2022 Other (2) |
||||
|---|---|---|---|---|---|
| Individual | Group | Long-term Audited NIS thousand |
Short term |
Total | |
| Gross premiums Payments and change in |
268,396 | 1,107,617 | 1,545,413(1) | 139,110(1) | 3,060,536 |
| liabilities in respect of insurance contracts, gross Total comprehensive |
(660,586) | 304,476 | 1,014,645 | 71,820 | 730,355 |
| income (loss) from health insurance business |
966,680 | 46,978 | 90,821 | 15,422 | 1,119,901 |

| For the 6-month period ended June 30, 2023 | ||||||
|---|---|---|---|---|---|---|
| Compulsory | Property | |||||
| motor | Motor | and other | Other liability | |||
| insurance | property | subsegments (*) | subsegments (**) | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 388,714 | 997,604 | 554,322 | 417,882 | 2,358,522 | |
| Reinsurance premiums | 26,800 | - | 387,603 | 192,410 | 606,813 | |
| Premiums - retention | 361,914 | 997,604 | 166,719 | 225,472 | 1,751,709 | |
| Change in unearned premium | ||||||
| balance, retention | 63,772 | 219,119 | 22,175 | 41,149 | 346,215 | |
| Premiums earned - retention | 298,142 | 778,485 | 144,544 | 184,323 | 1,405,494 | |
| Investment income, net | ||||||
| and finance income | 37,636 | 16,490 | 3,659 | 31,640 | 89,425 | |
| Income from fees and commissions | 15,689 | 9 | 78,547 | 23,596 | 117,841 | |
| Total income | 351,467 | 794,984 | 226,750 | 239,559 | 1,612,760 | |
| Payments and change in liabilities in | ||||||
| respect of insurance contracts, gross | 286,838 | 669,482 | 298,322 | 205,173 | 1,459,815 | |
| Reinsurers' share in payments | ||||||
| and in changes in liabilities in | ||||||
| respect of insurance contracts | 33,674 | (57) | 244,856 | 108,799 | 387,272 | |
| Payments and change in liabilities | ||||||
| for insurance contracts - retention | 253,164 | 669,539 | 53,466 | 96,374 | 1,072,543 | |
| Fees and commissions, | ||||||
| marketing expenses and | ||||||
| other purchase expenses | 37,828 | 137,093 | 109,003 | 72,258 | 356,182 | |
| General and administrative expenses | 15,568 | 26,183 | 15,310 | 16,400 | 73,461 | |
| Finance expenses | 4,334 | - | 422 | 3,644 | 8,400 | |
| Total expenses | 310,894 | 832,815 | 178,201 | 188,676 | 1,510,586 | |
| Company's share in the | ||||||
| net results of investees | 307 | 152 | 30 | 258 | 747 | |
| Profit (loss) before taxes on income | 40,880 | (37,679) | 48,579 | 51,141 | 102,921 | |
| Other comprehensive income | ||||||
| before taxes on income | 28,633 | 14,178 | 2,783 | 24,071 | 69,665 | |
| Total comprehensive | ||||||
| income (loss) for the period | ||||||
| before taxes on income | 69,513 | (23,501) | 51,362 | 75,212 | 172,586 | |
| Liabilities in respect of | ||||||
| insurance contracts, gross, | ||||||
| as of June 30, 2023 (unaudited) | 3,140,226 | 1,262,198 | 894,524 | 2,540,653 | 7,837,601 | |
| Liabilities in respect of | ||||||
| insurance contracts - retention - | ||||||
| as at June 30, 2023 (unaudited) | 2,083,847 | 1,262,186 | 229,278 | 1,712,529 | 5,287,840 |
(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability insurance subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 79% of total premiums in these subsegments.

| For the 6-month period ended June 30, 2022 | ||||||
|---|---|---|---|---|---|---|
| Compulsory | Property | |||||
| motor | Motor | and other | Other liability | |||
| insurance | property | subsegments (*) | subsegments (**) | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 373,367 | 747,043 | 483,558 | 352,802 | 1,956,770 | |
| Reinsurance premiums | 71,665 | 6 | 338,697 | 167,719 | 578,087 | |
| Premiums - retention | 301,702 | 747,037 | 144,861 | 185,083 | 1,378,683 | |
| Change in unearned premium | ||||||
| balance, retention | 79,415 | 133,658 | 21,374 | 28,364 | 262,811 | |
| Premiums earned - retention | 222,287 | 613,379 | 123,487 | 156,719 | 1,115,872 | |
| Investment income, net and | ||||||
| finance income | 34,101 | 10,281 | 3,511 | 31,922 | 79,815 | |
| Income from fees and commissions | 32,325 | 153 | 69,628 | 19,159 | 121,265 | |
| Total income | 288,713 | 623,813 | 196,626 | 207,800 | 1,316,952 | |
| Payments and change in | ||||||
| liabilities in respect of | ||||||
| insurance contracts, gross | 329,391 | 528,245 | 140,223 | 271,885 | 1,269,744 | |
| Reinsurers' share in payments | ||||||
| and in changes in liabilities in | ||||||
| respect of insurance contracts | 84,975 | 305 | 113,205 | 147,330 | 345,815 | |
| Payments and change in liabilities | ||||||
| for insurance contracts - retention | 244,416 | 527,940 | 27,018 | 124,555 | 923,929 | |
| Fees and commissions, | ||||||
| marketing expenses and | ||||||
| other purchase expenses | 37,693 | 128,637 | 93,562 | 59,137 | 319,029 | |
| General and | ||||||
| administrative expenses | 13,573 | 22,828 | 13,130 | 11,305 | 60,836 | |
| Finance expenses | 9,699 | - | 999 | 9,079 | 19,777 | |
| Total expenses | 305,381 | 679,405 | 134,709 | 204,076 | 1,323,571 | |
| Company's share in the | ||||||
| net results of investees | (1,207) | (508) | (124) | (1,130) | (2,969) | |
| Profit (loss) before taxes on income | (17,875) | (56,100) | 61,793 | 2,594 | (9,588) | |
| Other comprehensive | ||||||
| loss before taxes on income | (91,373) | (38,500) | (9,407) | (85,534) | (224,814) | |
| Total comprehensive income | ||||||
| (loss) for the period before | ||||||
| taxes on income | (109,248) | (94,600) | 52,386 | (82,940) | (234,402) | |
| Liabilities in respect of | ||||||
| insurance contracts, gross, as | ||||||
| of June 30, 2022 (unaudited) | 3,134,450 | 1,008,282 | 739,820 | 2,440,737 | 7,323,289 | |
| Liabilities in respect of | ||||||
| insurance contracts - retention | ||||||
| - as of June 30, 2022 | ||||||
| (unaudited) | 1,951,790 | 1,007,889 | 201,962 | 1,797,629 | 4,959,270 |
(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 83% of total premiums in these subsegments.
(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

| For the 3-month period ended June 30, 2023 | ||||||
|---|---|---|---|---|---|---|
| Compulsory | Property | |||||
| motor | Motor | and other | Other liability | |||
| insurance | property | subsegments (*) | subsegments (**) | Total | ||
| Unaudited | ||||||
| NIS thousand | ||||||
| Gross premiums | 187,934 | 469,401 | 270,637 | 199,008 | 1,126,980 | |
| Reinsurance premiums | 13,248 | - | 199,255 | 99,548 | 312,051 | |
| Premiums - retention | 174,686 | 469,401 | 71,382 | 99,460 | 814,929 | |
| Change in unearned premium | ||||||
| balance, retention | 18,508 | 61,371 | (3,429) | 3,879 | 80,329 | |
| Premiums earned - retention | 156,178 | 408,030 | 74,811 | 95,581 | 734,600 | |
| Investment income, | ||||||
| net and finance income | 27,425 | 12,578 | 2,725 | 22,937 | 65,665 | |
| Income from fees and commissions | 7,373 | 13 | 39,331 | 11,790 | 58,507 | |
| Total income | 190,976 | 420,621 | 116,867 | 130,308 | 858,772 | |
| Payments and change in | ||||||
| liabilities in respect of | ||||||
| insurance contracts, gross | 136,460 | 358,206 | 111,304 | 133,122 | 739,092 | |
| Reinsurers' share in payments | ||||||
| and in changes in liabilities in | ||||||
| respect of insurance contracts | 7,782 | (56) | 82,783 | 55,198 | 145,707 | |
| Payments and change in liabilities | ||||||
| for insurance contracts - retention | 128,678 | 358,262 | 28,521 | 77,924 | 593,385 | |
| Fees and commissions, | ||||||
| marketing expenses and | ||||||
| other purchase expenses | 20,290 | 71,650 | 55,106 | 36,659 | 183,705 | |
| General and | ||||||
| administrative expenses | 8,945 | 11,709 | 7,652 | 9,245 | 37,551 | |
| Finance expenses | 1,994 | - | 208 | 1,649 | 3,851 | |
| Total expenses | 159,907 | 441,621 | 91,487 | 125,477 | 818,492 | |
| Company's share in the | ||||||
| net results of investees | 10,246 | 5,093 | 940 | 8,730 | 25,009 | |
| Profit (loss) before taxes on income | 41,315 | (15,907) | 26,320 | 13,561 | 65,289 | |
| Other comprehensive income | ||||||
| before taxes on income | 13,016 | 6,415 | 1,354 | 10,758 | 31,543 | |
| Total comprehensive income | ||||||
| (loss) for the period before | ||||||
| taxes on income | 54,331 | (9,492) | 27,674 | 24,319 | 96,832 | |
| Liabilities in respect of | ||||||
| insurance contracts, gross, as | ||||||
| of June 30, 2023 (unaudited) | 3,140,226 | 1,262,198 | 894,524 | 2,540,653 | 7,837,601 | |
| Liabilities in respect of | ||||||
| insurance contracts - retention | ||||||
| - as at June 30, 2023 | ||||||
| (unaudited) | 2,083,847 | 1,262,186 | 229,278 | 1,712,529 | 5,287,840 |
(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 82% of total premiums in these subsegments.
(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 77% of total premiums in these subsegments.

| For the 3-month period ended June 30, 2022 | |||||
|---|---|---|---|---|---|
| Compulsory | Property | ||||
| motor | Motor | and other | Other liability | ||
| insurance | property | subsegments (*) | subsegments (**) | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Gross premiums | 167,419 | 340,430 | 252,594 | 180,043 | 940,486 |
| Reinsurance premiums | 32,775 | (12) | 188,348 | 92,609 | 313,720 |
| Premiums - retention | 134,644 | 340,442 | 64,246 | 87,434 | 626,766 |
| Change in unearned premium | |||||
| balance, retention | 14,413 | 21,513 | 1,191 | 7,506 | 44,623 |
| Premiums earned - retention | 120,231 | 318,929 | 63,055 | 79,928 | 582,143 |
| Losses on investments, net and | |||||
| finance income | (7,373) | (6,793) | (529) | (7,272) | (21,967) |
| Income from fees and commissions | 15,541 | 69 | 34,880 | 8,796 | 59,286 |
| Total income | 128,399 | 312,205 | 97,406 | 81,452 | 619,462 |
| Payments and change in | |||||
| liabilities in respect of | |||||
| insurance contracts, gross | 157,808 | 222,854 | 69,137 | 127,172 | 576,971 |
| Reinsurers' share in payments | |||||
| and in changes in liabilities in | |||||
| respect of insurance contracts | 31,643 | 74 | 56,039 | 68,868 | 156,624 |
| Payments and change in liabilities | |||||
| for insurance contracts - retention | 126,165 | 222,780 | 13,098 | 58,304 | 420,347 |
| Fees and commissions, | |||||
| marketing expenses and | |||||
| other purchase expenses | 19,039 | 72,027 | 52,738 | 29,070 | 172,874 |
| General and | |||||
| administrative expenses | 6,328 | 11,447 | 6,604 | 5,942 | 30,321 |
| Finance expenses | 7,936 | - | 827 | 7,412 | 16,175 |
| Total expenses | 159,468 | 306,254 | 73,267 | 100,728 | 639,717 |
| Company's share in the | |||||
| net results of investees | (904) | (378) | (95) | (844) | (2,221) |
| Profit (loss) before taxes on income | (31,973) | 5,573 | 24,044 | (20,120) | (22,476) |
| Other comprehensive | |||||
| loss before taxes on income | (28,536) | (11,484) | (3,286) | (26,153) | (69,459) |
| Total comprehensive income | |||||
| (loss) for the period | |||||
| before taxes on income | (60,509) | (5,911) | 20,758 | (46,273) | (91,935) |
| Liabilities in respect of | |||||
| insurance contracts, gross, as | |||||
| of June 30, 2022 (unaudited) | 3,134,450 | 1,008,282 | 739,820 | 2,440,737 | 7,323,289 |
| Liabilities in respect of | |||||
| insurance contracts - retention | |||||
| - as of June 30, 2022 | |||||
| (unaudited) | 1,951,790 | 1,007,889 | 201,962 | 1,797,629 | 4,959,270 |
(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 85% of total premiums in these subsegments.
(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 80% of total premiums in these subsegments.

| For the year ended December 31, 2022 | |||||
|---|---|---|---|---|---|
| Compulsory | Property and | ||||
| motor | Motor | other | Other liability | ||
| insurance | property | subsegments (*) | subsegments (**) | Total | |
| Audited | |||||
| NIS thousand | |||||
| Gross premiums | 721,382 | 1,445,963 | 892,080 | 657,496 | 3,716,921 |
| Reinsurance premiums | 138,769 | 8 | 611,459 | 311,648 | 1,061,884 |
| Premiums - retention | 582,613 | 1,445,955 | 280,621 | 345,848 | 2,655,037 |
| Change in unearned premium | |||||
| balance, retention | 85,034 | 132,141 | 18,905 | 13,283 | 249,363 |
| Premiums earned - retention | 497,579 | 1,313,814 | 261,716 | 332,565 | 2,405,674 |
| Investment income, | |||||
| net and finance income | 45,588 | 12,991 | 5,192 | 41,859 | 105,630 |
| Income from fees and commissions | 55,428 | 209 | 149,590 | 42,018 | 247,245 |
| Total income | 598,595 | 1,327,014 | 416,498 | 416,442 | 2,758,549 |
| Payments and change in | |||||
| liabilities in respect of | |||||
| insurance contracts, gross | 443,736 | 1,196,545 | 263,456 | 330,329 | 2,234,066 |
| Reinsurers' share in payments | |||||
| and in changes in liabilities in | |||||
| respect of insurance contracts | 118,598 | 342 | 204,498 | 247,269 | 570,707 |
| Payments and change in liabilities | |||||
| for insurance contracts - retention | 325,138 | 1,196,203 | 58,958 | 83,060 | 1,663,359 |
| Fees and commissions, | |||||
| marketing expenses and | |||||
| other purchase expenses | 80,481 | 288,221 | 203,887 | 128,863 | 701,452 |
| General and administrative | |||||
| expenses | 26,755 | 47,818 | 26,314 | 21,828 | 122,715 |
| Finance expenses | 11,890 | - | 1,354 | 10,917 | 24,161 |
| Total expenses | 444,264 | 1,532,242 | 290,513 | 244,668 | 2,511,687 |
| Company's share in the | |||||
| net results of investees | 1,743 | 672 | 198 | 1,600 | 4,213 |
| Profit (loss) before taxes on income | 156,074 | (204,556) | 126,183 | 173,374 | 251,075 |
| Other comprehensive loss | |||||
| before taxes on income | (91,992) | (35,462) | (10,477) | (84,468) | (222,399) |
| Total comprehensive income | |||||
| (loss) for the period | |||||
| before taxes on income | 64,082 | (240,018) | 115,706 | 88,906 | 28,676 |
| Liabilities in respect of | |||||
| insurance contracts, gross, as | |||||
| of December 31, 2022 (audited) | 3,025,588 | 1,061,880 | 670,253 | 2,382,762 | 7,140,483 |
| Liabilities in respect of | |||||
| insurance contracts - retention | |||||
| - as of December 31, 2022 | |||||
| (audited) | 1,902,667 | 1,061,809 | 196,571 | 1,663,974 | 4,825,021 |
(*) Property and other subsegments mainly include data from the comprehensive home insurance, comprehensive business insurance and property loss insurance subsegments, whose activity constitutes 80% of total premiums in these subsegments.
(**) Other liability subsegments mainly include data from the following segments: third-party insurance, professional liability insurance and employers' liability insurance, the activity of which constitutes 82% of total premiums in these subsegments.

| For the 6-month period ended June 30, 2023 | |||
|---|---|---|---|
| Provident funds | Pension | Total | |
| Unaudited | |||
| NIS thousand | |||
| Investment income, net and finance income | 51,865 | 3,970 | 55,835 |
| Income from management fees | 214,073 | 147,369 | 361,442 |
| Other income (see Note 4B) | 15,616 | 1,210 | 16,826 |
| Total income | 281,554 | 152,549 | 434,103 |
| Change in liabilities for investment contracts | 49,944 | - | 49,944 |
| Fees and commissions, marketing | |||
| expenses and other purchase expenses | 94,414 | 87,223 | 181,637 |
| General and administrative expenses | 69,698 | 49,181 | 118,879 |
| Other expenses | 9,823 | 7,284 | 17,107 |
| Finance expenses | 4,647 | 2,536 | 7,183 |
| Total expenses | 228,526 | 146,224 | 374,750 |
| Company's share in the | |||
| net results of an investee | 362 | - | 362 |
| Total comprehensive income for | |||
| the period before taxes on income | 53,390 | 6,325 | 59,715 |
| For the 6-month period ended June 30, 2022 | ||
|---|---|---|
| Provident funds | Pension | Total |
| 54,848 | (4,019) | 50,829 |
| 208,152 | 120,161 | 328,313 |
| 14,192 | 661 | 14,853 |
| 277,192 | 116,803 | 393,995 |
| 53,415 | - | 53,415 |
| 81,795 | 68,589 | 150,384 |
| 72,608 | 40,927 | 113,535 |
| 9,370 | 916 | 10,286 |
| 5,728 | 1,899 | 7,627 |
| 222,916 | 112,331 | 335,247 |
| 54,276 | 4,472 | 58,748 |
| Unaudited NIS thousand |
| For the 3-month period ended June 30, 2023 | |||
|---|---|---|---|
| Provident funds | Pension | Total | |
| Unaudited | |||
| NIS thousand | |||
| Investment income, net and finance income | 30,719 | 3,365 | 34,084 |
| Income from management fees | 107,946 | 75,208 | 183,154 |
| Other income (see Note 4B) | 15,616 | 740 | 16,356 |
| Total income | 154,281 | 79,313 | 233,594 |
| Change in liabilities for investment contracts | 26,641 | - | 26,641 |
| Fees and commissions, marketing | |||
| expenses and other purchase expenses | 48,482 | 44,212 | 92,694 |
| General and administrative expenses | 35,442 | 26,243 | 61,685 |
| Other expenses | 5,240 | 4,060 | 9,300 |
| Finance expenses | 2,578 | 1,649 | 4,227 |
| Total expenses | 118,383 | 76,164 | 194,547 |
| Company's share in the | |||
| net results of an investee | 362 | - | 362 |
| Total comprehensive income for | |||
| the period before taxes on income | 36,260 | 3,149 | 39,409 |
| For the 3-month period ended June 30, 2022 | |||
|---|---|---|---|
| Provident funds | Pension | Total | |
| Unaudited | |||
| NIS thousand | |||
| Investment income (losses), net and finance income | 31,885 | (4,466) | 27,419 |
| Income from management fees | 103,955 | 64,244 | 168,199 |
| Other income | 14,186 | 352 | 14,538 |
| Total income | 150,026 | 60,130 | 210,156 |
| Change in liabilities for investment contracts | 30,530 | - | 30,530 |
| Fees and commissions, marketing | |||
| expenses and other purchase expenses | 42,936 | 37,553 | 80,489 |
| General and administrative expenses | 31,310 | 20,289 | 51,599 |
| Other expenses | 4,486 | 458 | 4,944 |
| Finance expenses | 3,408 | 1,124 | 4,532 |
| Total expenses | 112,670 | 59,424 | 172,094 |
| Total comprehensive income for | |||
| the period before taxes on income | 37,356 | 706 | 38,062 |

| For the year ended December 31, 2022 | ||||
|---|---|---|---|---|
| Provident funds | Pension | Total | ||
| Audited | ||||
| NIS thousand | ||||
| Investment income (losses), | ||||
| net and finance income | 95,052 | (4,229) | 90,823 | |
| Income from management fees | 415,822 | 254,565 | 670,387 | |
| Other income | 14,215 | 1,649 | 15,864 | |
| Total income | 525,089 | 251,985 | 777,074 | |
| Change in liabilities for investment contracts | 98,221 | - | 98,221 | |
| Fees and commissions, marketing | ||||
| expenses and other purchase expenses | 175,411 | 139,914 | 315,325 | |
| General and administrative expenses | 143,534 | 85,817 | 229,351 | |
| Other expenses | 20,344 | 11,535 | 31,879 | |
| Finance expenses | 9,862 | 3,453 | 13,315 | |
| Total expenses | 447,372 | 240,719 | 688,091 | |
| Total comprehensive income for | ||||
| the period before taxes on income | 77,717 | 11,266 | 88,983 |

In November 2022, The Phoenix Investment House signed an agreement with Mr. Shmuel Frenkel, Flaming Star Ltd. (a wholly-owned company of Mr. Frenkel) and Mr. Lior Aviani (hereinafter, jointly - the "Sellers"), for the acquisition of the entire issued share capital of Epsilon Investment House Ltd. (hereinafter - "Epsilon"), which holds, among other things, Epsilon Mutual Funds Management (1991) Ltd. (hereinafter - "Epsilon Funds") and Epsilon Investment Portfolio Management Ltd. (hereinafter - "Epsilon Portfolios") in consideration for NIS 44.5 million plus an amount equal to Epsilon's liquid capital amount (as this term was defined in the agreement), and net of dividends that will be distributed after the calculation date of the liquid capital and through the completion date (hereinafter - the "Transaction").
The Transaction was completed on February 13, 2023, after obtaining a permit to hold means of control in Epsilon Funds from the Israel Securities Authority, and after obtaining the approval of the Competition Commissioner. The consolidation commencement date is January 1, 2023.
As part of the completion of the Transaction, The Phoenix Investment House paid the Sellers a total of NIS 89 million.
For the purpose of the acquisition, the Company advanced a NIS 60 million loan to The Phoenix Investment House by way of expansion of the lender's Bonds (Series 4); for information regarding the terms of the bonds - see Note 27E to the Consolidated Annual Financial Statements.
Under agreements between the parties, The Phoenix Investment House intends to take steps to sell the funds owned by Epsilon Funds to KSM Mutual Funds; the activity of Epsilon Portfolio will continue to be conducted independently under the management of the Sellers, and management agreements for a period of 5 years from the completion date were signed with them for that purpose.
The Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, an acquisition cost allocation work has not yet been received from an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the acquisition as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the final measurement date, the adjustments were made by way of a restating the comparative results previously reported according to the provisional measurement.
The fair value of Epsilon's identified assets and identified liabilities as of the consolidation commencement date (January 1, 2023) is as follows:
| NIS thousand |
|
|---|---|
| Intangible assets | 12,000 |
| Working capital, net (excluding cash and cash equivalents) | 3,000 |
| Cash and cash equivalents | 41,000 |
| Liabilities in respect of deferred taxes | (3,000) |
| Total identifiable assets net of identifiable liabilities | 53,000 |
| Goodwill arising from the acquisition | 36,000 |
| Total acquisition cost | 89,000 |
As stated above, the date on which control was assumed is January 1, 2023; therefore, Epsilon's financial results are included in the financial services segment as from January 1, 2023.

As from 2011, The Phoenix Insurance and The Phoenix Pension and Provident (hereinafter - the "Companies") operate - together with Saifa Management Services (2013) Ltd. (hereinafter - "Saifa") - the "FNX Private" venture (hereinafter - "FNX Private"), which is engaged in the development, adaptation, marketing and direct marketing (rather than through external insurance agents) of The Phoenix's self-directed policies and provident funds (IRA). These are customized services and products with unique characteristics, which are mainly suitable to wealthy customers (hereinafter - the "Venture"). The Companies share in the Venture is 50%.
In the first quarter of 2023, the Companies and Saifa, entered into an agreement for the incorporation of the Venture as two separate legal entities (hereinafter - "FNX Private Partnerships"), such that the Companies will continue holding 50% of the joint Venture.
In the second quarter of 2023, the Group completed a transaction for the acquisition of further 10% in the joint Venture's partnerships in consideration for NIS 25 million, such that subsequent to the acquisition the Group holds (directly and indirectly) 60% of the venture. Subsequent to the completion of the transaction, and as a result of assuming control in the Venture, the Company recognized a pre- and post-tax profit of NIS 129 million, which is included in the other income line item (in the health insurance segment - NIS 114 million, and in the pension and provident segment - NIS 15 million).
As of the report date, the Company recognized the fair value of the assets acquired and the liabilities assumed as part of the business combination according to a provisional measurement. As of the date of approval of the financial statements, a final valuation has not yet been received by an external appraiser in relation to the fair value of the identified assets acquired and the liabilities assumed. A final adjustment of the consideration for the acquisition as well as the fair value of the assets and liabilities purchased can be carried out up to 12 months from the date of purchase. At the time of the final measurement, the adjustments are made by way of a restating the comparison results previously reported according to the provisional measurement.
The Company has opted to measure the non-controlling interests in the acquired company according to the proportionate share of the non-controlling interests in the fair value of the net identified assets of the acquiree.
The fair value of FNX Private Partnerships' identified assets and identified liabilities as of the consolidation commencement date (June 30, 2023) is as follows:
| NIS thousand |
|
|---|---|
| Intangible assets | 103,277 |
| Liabilities in respect of deferred taxes | (35,310) |
| Total identifiable assets net of identifiable liabilities | 67,967 |
| Non-controlling interests | (27,309) |
| Profit from assuming control | (129,096) |
| Goodwill arising from the acquisition | 113,793 |
| Total acquisition cost | 25,355 |

According to the terms of the agreement, the total acquisition cost shall be paid by August 31, 2023. As stated above, the date on which control was assumed is June 30, 2023, and therefore the financial results of FNX Private Partnerships are included in the profits of investees accounted for by the equity method for the 3 months period ended on June 30, 2023.
In accordance with the Circular on Allocation of Non-Marketable Assets, in the first quarter of 2023, The Phoenix Insurance carried out a valuation of FNX Private's activity in relation to The Phoenix's self-directed insurance products; the valuation was conducted by an independent external appraiser. In accordance with the valuation, in the first quarter, The Phoenix Insurance recognized a pre-tax profit of NIS 114 million from revaluation of excess fair value of the illiquid assets against the LAT reserve in the health insurance segment. As a result of assuming control in the FNX Private, as stated above, the profit from revaluation of excess fair value in the second quarter was derecognized.
| As of June 30 | As of December 31 | |||
|---|---|---|---|---|
| 2023 | 2022 | 2022 | ||
| Unaudited | Audited | |||
| NIS thousand | ||||
| Investment property | 2,206,935 | 1,903,600 | 2,142,074 | |
| Financial investments: | ||||
| Liquid debt assets | 22,297,970 | 20,988,024 | 21,252,417 | |
| Illiquid debt assets | 8,131,412 | 8,685,245 | 8,306,926 | |
| Shares | 19,755,597 | 21,510,775 | 19,610,785 | |
| Other financial investments | 30,418,612 | 27,083,877 | 28,224,143 | |
| Total financial investments | 80,603,591 | 78,267,921 | 77,394,271 | |
| Cash and cash equivalents | 18,728,467 | 14,789,357 | 16,358,509 | |
| Other | 204,514 | 255,808 | 160,734 | |
| Total assets for yield-dependent contracts | 101,743,507 | 95,216,686 | 96,055,588 |
The following table presents
an analysis of assets held against insurance contracts and investment contracts presented at fair value through profit and loss. The different levels were defined as follows:
Level 1 - fair value measured using quoted prices (unadjusted) in an active market for identical instruments.
Level 2 - fair value measured using observable inputs, either directly or indirectly, that are not included in Level 1 above.
Level 3 - fair value measured using inputs that are not based on observable market inputs.
For financial instruments periodically recognized at fair value, the Company estimates, at the end of each reporting period, whether transfers have been made between the various levels of the fair value hierarchy.
During the reporting periods there were no material transfers between Level 1 and Level 2.
The Company holds the financial instruments measured at fair value according to the following classifications:
| June 30, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Financial investments: | ||||
| Liquid debt assets | 15,941,467 | 6,356,503 | - | 22,297,970 |
| Illiquid debt assets | - | 5,484,598 | 2,646,814 | 8,131,412 |
| Shares | 17,267,570 | 339,715 | 2,148,312 | 19,755,597 |
| Other financial investments | 10,485,451 | 1,096,654 | 18,836,507 | 30,418,612 |
| Total | 43,694,488 | 13,277,470 | 23,631,633 | 80,603,591 |

| June 30, 2022 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Financial investments: | ||||
| Liquid debt assets | 15,640,223 | 5,347,801 | - | 20,988,024 |
| Illiquid debt assets | - | 6,573,194 | 2,112,051 | 8,685,245 |
| Shares | 18,702,517 | 1,108,956 | 1,699,302 | 21,510,775 |
| Other financial investments | 9,241,380 | 1,695,516 | 16,146,981 | 27,083,877 |
| Total | 43,584,120 | 14,725,467 | 19,958,334 | 78,267,921 |
| As of December 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||||
| Audited | |||||||
| NIS thousand | |||||||
| Financial investments: | |||||||
| Liquid debt assets (*) | 15,871,715 | 5,380,702 | - | 21,252,417 | |||
| Illiquid debt assets | - | 6,390,528 | 1,916,398 | 8,306,926 | |||
| Shares | 17,047,803 | 686,686 | 1,876,296 | 19,610,785 | |||
| Other financial investments | 9,989,631 | 965,706 | 17,268,806 | 28,224,143 | |||
| Total | 42,909,149 | 13,423,622 | 21,061,500 | 77,394,271 |
(*) Reclassified
Assets measured at fair value - Level 3
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||
| Liquid | Illiquid | Other | |||
| debt | debt | financial | |||
| assets | assets | Shares | investments | Total | |
| NIS thousand | |||||
| Balance on January 1, | |||||
| 2023 (audited) | - | 1,916,398 | 1,876,296 | 17,268,806 | 21,061,500 |
| Total gains recognized | |||||
| in profit or loss (*) | - | 176,470 | 14,342 | 1,151,755 | 1,342,567 |
| Purchases | - | 709,408 | 349,235 | 1,917,563 | 2,976,206 |
| Proceeds from interest | |||||
| and dividend | - | (46,434) | (13,085) | (448,352) | (507,871) |
| Redemptions / sales | - | (574,341) | (78,476) | (1,053,265) | (1,706,082) |
| Transfers into Level 3 (**) | - | 569,646 | - | - | 569,646 |
| Transfers from Level 3 (**) | - | (104,333) | - | - | (104,333) |
| Balance as of June 30, | |||||
| 2023 (unaudited) | - | 2,646,814 | 2,148,312 | 18,836,507 | 23,631,633 |
| (*) Of which: Total unrealized | |||||
| gains for the period |
|||||
| recognized in profit and | |||||
| loss in respect of assets | |||||
| held as of June 30, 2023 | - | 108,850 | 847 | 802,446 | 912,143 |
| (**) Transfers into (from) Level 3 stem mainly from securities whose rating changed. |
NOTE 5 - FINANCIAL INSTRUMENTS (cont.)
Assets measured at fair value - Level 3 (cont.)
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | |||||
| Liquid debt assets |
Illiquid debt assets |
Shares | Other financial investments |
Total | |
| NIS thousand | |||||
| Balance on January 1, | |||||
| 2022 (audited) | - | 1,722,489 | 1,622,980 | 13,931,585 | 17,277,054 |
| Total gains recognized | |||||
| in profit or loss (*) | - | 15,268 | 144,922 | 1,766,457 | 1,926,647 |
| Purchases | - | 945,560 | 256,614 | 1,730,951 | 2,933,125 |
| Proceeds from | |||||
| interest and dividend | - | (15,949) | (11,330) | (362,043) | (389,322) |
| Redemptions / sales | - | (381,970) | - | (838,449) | (1,220,419) |
| Transfers into Level 3 (**) | - | 85,126 | - | - | 85,126 |
| Transfers from Level 3 (**) | - | (258,473) | (313,884) | (81,520) | (653,877) |
| Balance as of June 30, | |||||
| 2022 (unaudited) | - | 2,112,051 | 1,699,302 | 16,146,981 | 19,958,334 |
| (*) Of which: Total unrealized | |||||
| gains for the period |
|||||
| recognized in profit and | |||||
| loss in respect of assets | |||||
| held as of June 30, 2022 | - | 4,523 | 61,625 | 1,426,085 | 1,492,233 |
(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed and from securities issued for the first time.
| Liquid debt |
Illiquid debt |
Fair value measurement at the reporting date Financial assets at fair value through profit and loss Other financial |
|||
|---|---|---|---|---|---|
| assets | assets | Shares Unaudited |
investments | Total | |
| NIS thousand | |||||
| Balance as of April 1, 2023 Total gains recognized |
- | 2,251,160 | 1,798,085 | 17,973,706 | 22,022,951 |
| in profit or loss (*) | - | 104,840 | 22,357 | 809,367 | 936,564 |
| Purchases Proceeds from |
- | 441,207 | 342,815 | 956,352 | 1,740,374 |
| interest and dividend | - | (25,496) | (5,553) | (265,229) | (296,278) |
| Redemptions / sales | - | (422,539) | (9,392) | (637,689) | (1,069,620) |
| Transfers into Level 3 (**) | - | 297,642 | - | - | 297,642 |
| Balance on June 30, 2023 (*) Of which: Total unrealized gains for the period recognized in profit and loss in respect of assets |
- | 2,646,814 | 2,148,312 | 18,836,507 | 23,631,633 |
| held as of June 30, 2023 | - | 65,623 | 16,338 | 592,169 | 674,130 |
(**) Transfers into (from) Level 3 stem mainly from securities whose rating changed.
Assets measured at fair value - Level 3 (cont.)
Fair value measurement at the reporting date Financial assets at fair value through profit and loss

| Liquid debt |
Illiquid debt |
Other financial |
|||
|---|---|---|---|---|---|
| assets | assets | Shares | investments | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Balance as of April 1, 2022 | - | 1,909,722 | 1,474,869 | 14,455,133 | 17,839,724 |
| Total gains recognized | |||||
| in profit or loss (*) | - | 32,168 | 61,786 | 1,397,196 | 1,491,150 |
| Purchases | - | 594,942 | 172,984 | 789,410 | 1,557,336 |
| Proceeds from | |||||
| interest and dividend | - | (11,337) | (10,337) | (151,389) | (173,063) |
| Redemptions / sales | - | (240,097) | - | (343,369) | (583,466) |
| Transfers into Level 3 (**) | - | 85,126 | - | - | 85,126 |
| Transfers from Level 3 (**) | - | (258,473) | - | - | (258,473) |
| Balance on June 30, 2022 | - | 2,112,051 | 1,699,302 | 16,146,981 | 19,958,334 |
| (*) Of which: Total unrealized | |||||
| gains for the period |
|||||
| recognized in profit and | |||||
| loss in respect of assets | |||||
| held as of June 30, 2022 | - | 6,052 | 51,949 | 1,258,529 | 1,316,530 |
| (**) Transfers into (from) Level 3 stem mainly from securities whose rating changed. |
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss | ||||||
| Liquid debt assets |
Illiquid debt assets |
Shares | Other financial investments |
Total | ||
| 2,262,904 | ||||||
| Purchases | - | 1,538,352 | 283,383 | 4,239,798 | 6,061,533 | |
| Proceeds from interest | ||||||
| (782,653) | ||||||
| Transfers from Level 3 (**) | ||||||
| Balance as of January 1, 2022 Total gains recognized in profit or loss () and dividend Redemptions / sales Balance as of December 31, 2022 () Of which: Total unrealized gains (losses) for the period included in profit and loss in respect of assets - balance held as of December 31, 2022 (**) Transfers into (from) Level 3 stem mainly from securities whose rating changed and from |
- - - - - - - |
1,722,489 59,255 (42,028) (804,657) (557,013) 1,916,398 (11,021) |
Audited NIS thousand 1,622,980 324,560 (36,666) (4,077) (313,884) 1,876,296 228,762 |
13,931,585 1,879,089 (703,959) (1,982,255) (95,452) 17,268,806 1,332,466 |
17,277,054 (2,790,989) (966,349) 21,061,500 1,550,207 |
securities issued for the first time.
Composition:
| June 30, 2023 | |||
|---|---|---|---|
| Carrying amount | Fair value (**) | ||
| Unaudited | |||
| NIS thousand | |||
| Loans and receivables | |||
| Designated bonds and treasury deposits (*) | 8,808,980 | 11,439,046 | |
| Other non-convertible debt assets, excluding deposits with banks | 7,179,943 | 7,112,671 | |
| Deposits with banks | 1,298,519 | 1,306,702 | |
| Total illiquid debt assets | 17,287,442 | 19,858,419 |

| June 30, 2023 | |||
|---|---|---|---|
| Carrying amount | Fair value (**) | ||
| Unaudited | |||
| NIS thousand | |||
| Impairments carried to profit and loss (cumulative) (*) The fair value was calculated according |
69,365 |
to the contractual repayment date.
(**) The change in fair value in the reporting period is mainly attributed to the increase in the risk-free interest rate. See also Note 1D above.
| June 30, 2022 | |||
|---|---|---|---|
| Carrying | |||
| amount | Fair value (**) | ||
| Unaudited NIS thousand |
|||
| Loans and receivables | |||
| Designated bonds (*) | 8,477,307 | 11,917,819 | |
| Other non-convertible debt assets, excluding deposits with banks | 6,323,737 | 6,346,775 | |
| Deposits with banks | 2,392,191 | 2,419,840 | |
| Total illiquid debt assets | 17,193,235 | 20,684,434 | |
| Impairments carried to profit and loss (cumulative) (*) The fair value was calculated according |
53,108 |
| As of December 31, 2022 | |||
|---|---|---|---|
| Carrying | |||
| amount | Fair value (**) | ||
| Audited NIS thousand |
|||
| Loans and receivables | |||
| Designated bonds (*) | 8,562,862 | 11,336,672 | |
| Other non-convertible debt assets, excluding deposits with banks | 6,783,963 | 6,640,304 | |
| Deposits with banks | 1,114,675 | 1,128,407 | |
| Total illiquid debt assets | 16,461,500 | 19,105,383 | |
| Impairments carried to profit and loss (cumulative) | 50,454 |
(*) The fair value was calculated according
to the contractual repayment date.
(**) The change in fair value in the reporting period is mainly attributed to the increase in the risk-free interest rate. See also Note 1D above.
The tables below depict an analysis of the financial instruments presented at fair value. During the reporting periods there were no material transfers between Level 1 and Level 2.
| June 30, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets | 4,312,769 | 1,498,602 | - | 5,811,371 |
| Shares | 1,555,503 | 135,082 | 527,862 | 2,218,447 |
| Other | 506,941 | 377,009 | 4,752,796 | 5,636,746 |
| Total | 6,375,213 | 2,010,693 | 5,280,658 | 13,666,564 |

| June 30, 2022 | |||||
|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||
| Unaudited | |||||
| NIS thousand | |||||
| Liquid debt assets | 4,661,233 | 1,740,240 | - | 6,401,473 | |
| Shares | 1,650,443 | 371,416 | 491,931 | 2,513,790 | |
| Other | 670,203 | 347,871 | 3,453,113 | 4,471,187 | |
| Total | 6,981,879 | 2,459,527 | 3,945,044 | 13,386,450 |
| As of December 31, 2022 | ||||||
|---|---|---|---|---|---|---|
| Level 1 | Level 2 Level 3 |
|||||
| Total Audited |
||||||
| NIS thousand | ||||||
| Liquid debt assets (*) | 3,930,950 | 1,728,945 | - | 5,659,895 | ||
| Shares | 1,662,972 | 252,507 | 486,793 | 2,402,272 | ||
| Other | 585,574 | 305,766 | 4,111,483 | 5,002,823 | ||
| Total | 6,179,496 | 2,287,218 | 4,598,276 | 13,064,990 |
(*) Reclassified

| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
| Liquid debt |
Illiquid debt |
Other financial |
|||
| assets | assets | Shares | investments | Total | |
| NIS thousand | |||||
| Balance on January 1, 2023 (audited) | - | - | 486,793 | 4,111,483 | 4,598,276 |
| Total profits recognized: | |||||
| In profit and loss (*) | - | - | 1,958 | 125,125 | 127,083 |
| In other comprehensive income | - | - | 17,470 | 201,771 | 219,241 |
| Purchases | - | - | 23,168 | 605,450 | 628,618 |
| Proceeds from interest and dividend | - | - | (1,527) | (127,962) | (129,489) |
| Redemptions / sales | - | - | - | (163,071) | (163,071) |
| Balance as of June 30, 2023 (unaudited) | - | - | 527,862 | 4,752,796 | 5,280,658 |
| (*) Of which: Total unrealized gains (losses) for the | |||||
| period recognized in profit and loss in respect of | |||||
| assets held as of June 30, 2023 | - | - | (1,000) | (24,415) | (25,415) |
| Fair value measurement at the reporting date | ||||||
|---|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and | ||||||
| available-for-sale financial assets | ||||||
| Liquid | Illiquid | Other | ||||
| debt | debt | financial | ||||
| assets | assets | Shares | investments | Total | ||
| NIS thousand | ||||||
| Balance on January 1, 2022 (audited) | - | - | 498,033 | 2,863,064 | 3,361,097 | |
| Total gains (losses) recognized: | ||||||
| In profit and loss (*) | - | - | (3,649) | 37,612 | 33,963 | |
| In other comprehensive income | - | - | 26,345 | 331,780 | 358,125 | |
| Purchases | - | - | 87,481 | 463,217 | 550,698 | |
| Proceeds from interest and dividend | - | - | (55) | (71,305) | (71,360) | |
| Redemptions / sales | - | - | - | (153,902) | (153,902) | |
| Transfers from Level 3 (**) | - | - | (116,224) | (17,353) | (133,577) | |
| Balance as of June 30, 2022 (unaudited) | - | - | 491,931 | 3,453,113 | 3,945,044 | |
| (*) Of which: Total unrealized gains (losses) for the | ||||||
| period recognized in profit and loss in respect of | ||||||
| assets held as of June 30, 2022 | - | - | (3,699) | (42,895) | (46,594) | |
(**) Transfers from Level 3 stem primarily from securities issued for the first time.
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
| Liquid debt |
Illiquid debt |
Other financial |
|||
| assets | assets | Shares | investments | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Balance as of April 1, 2023 | - | - | 503,089 | 4,403,232 | 4,906,321 |
| Total gains (losses) recognized: | |||||
| In profit and loss (*) | - | - | (973) | 70,822 | 69,849 |
| In other comprehensive income | - | - | 7,660 | 127,554 | 135,214 |
| Purchases | - | - | 18,086 | 281,484 | 299,570 |
| Proceeds from interest and dividend | - | - | - | (78,214) | (78,214) |
| Redemptions / sales | - | - | - | (52,082) | (52,082) |
| Balance on June 30, 2023 | - | - | 527,862 | 4,752,796 | 5,280,658 |
| (*) Of which: Total unrealized gains (losses) for the period recognized in profit and loss in respect of |
|||||
| assets held as of June 30, 2023 | - | - | (1,000) | (7,930) | (8,930) |
| Fair value measurement at the reporting date | |||||
|---|---|---|---|---|---|
| Financial assets at fair value through profit and loss and available-for-sale financial assets |
|||||
| Liquid debt |
Illiquid debt |
Other financial |
|||
| assets | assets | Shares | investments | Total | |
| Unaudited | |||||
| NIS thousand | |||||
| Balance as of April 1, 2022 | - | - | 438,387 | 2,917,650 | 3,356,037 |
| Total gains (losses) recognized: | |||||
| In profit and loss (*) | - | - | (3,649) | (13,938) | (17,587) |
| In other comprehensive income | - | - | 22,140 | 320,192 | 342,332 |
| Purchases | - | - | 35,108 | 296,611 | 331,719 |
| Proceeds from interest and dividend | - | - | (55) | (22,981) | (23,036) |
| Redemptions / sales | - | - | - | (44,421) | (44,421) |
| Balance on June 30, 2022 | - | - | 491,931 | 3,453,113 | 3,945,044 |
| (*) Of which: Total unrealized gains (losses) for the period recognized in profit and loss in respect of |
|||||
| assets held as of June 30, 2022 | - | - | (3,699) | (34,401) | (38,100) |
Assets measured at fair value - Level 3 (cont.)

| Liquid debt |
Illiquid debt |
Other financial |
|||
|---|---|---|---|---|---|
| assets | assets | Shares | investments | Total | |
| Audited | |||||
| NIS thousand | |||||
| Balance as of January 1, 2022 | - | - | 498,033 | 2,863,064 | 3,361,097 |
| Total gains (losses) recognized: | |||||
| In profit and loss (*) | - | - | (804) | 154,348 | 153,544 |
| In other comprehensive income | - | - | 47,457 | 500,197 | 547,654 |
| Purchases | - | - | 60,189 | 1,211,807 | 1,271,996 |
| Proceeds from interest and dividend | - | - | (1,858) | (140,728) | (142,586) |
| Redemptions / sales | - | - | - | (459,852) | (459,852) |
| Transfers from Level 3 (**) | - | - | (116,224) | (17,353) | (133,577) |
| Balance as of December 31, 2022 | - | - | 486,793 | 4,111,483 | 4,598,276 |
| (*) Of which: Total unrealized losses for the period | |||||
| included in profit and loss in respect of assets - | |||||
| balance held as of December 31, 2022 | - | - | (8,321) | (75,807) | (84,128) |
(**) Transfers from Level 3 stem primarily from securities issued for the first time.
| As of June 30 | As of December 31 | |||
|---|---|---|---|---|
| 2023 | 2022 | 2022 | ||
| Unaudited | Audited | |||
| NIS thousand | ||||
| Trade receivables and checks for collection | 1,024,287 | 1,096,544 | 1,105,547 | |
| Credit vouchers | 18,866 | 19,601 | 17,064 | |
| Loans and checks for collection | 1,023,219 | 830,736 | 1,010,058 | |
| Credit vouchers for sale | 1,454,634 | 1,280,360 | 1,335,486 | |
| Provision for doubtful debts | - | (18,919) | (24,818) | |
| Loan loss provision (*) | (32,153) | - | - | |
| Total | 3,488,853 | 3,208,322 | 3,443,337 |
(*) See Note 2A and B regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.
| June 30, 2023 | ||
|---|---|---|
| Carrying amount |
Fair value |
|
| Unaudited NIS thousand |
||
| Financial liabilities presented at amortized cost: | ||
| Loans and credit from banking corporations (see Note 8K and 8O) | 815,705 | 815,705 |
| Loans from non-bank entities | 797,806 | 797,806 |
| Bonds (see Note 8C and 8N) | 2,141,941 | 2,051,986 |
| Subordinated bonds (1) | 3,679,246 | 3,547,009 |
| Additional Tier 1 capital subordinated bond (1) | 215,044 | 190,731 |
| Trade receivables for credit cards | 1,637,003 | 1,637,003 |
| Notes to the Condensed Consolidated Interim Financial Statements as of June 30, 2023 | ||
|---|---|---|
| REPO in respect of non-yield-dependent contracts (2) | 753,384 | 753,384 |
| Other (3) | 27,362 | 27,362 |
| Total financial liabilities presented at amortized cost | 10,067,491 | 9,820,986 |
| Financial liabilities presented at fair value through profit and loss: | ||
| Derivatives held for yield-dependent contracts | 1,501,978 | 1,501,978 |
| Derivatives held for non-yield-dependent contracts | 611,717 | 611,717 |
| REPO in respect of yield-dependent contracts (2) | 855,992 | 855,992 |
| Liability for short sale of liquid securities | 1,269,828 | 1,269,828 |
| Total financial liabilities presented at fair value through profit and loss | 4,239,515 | 4,239,515 |
| Lease liabilities (4) | 106,132 | |
| Total financial liabilities | 14,413,138 |
(1) The bonds were issued for the purpose of complying with the capital requirements.
A. See Note 8E regarding full early redemption of Series F Bonds.
B. See Note 8I regarding listing for trading of Series L Bonds.
(2) During the present quarter, The Phoenix Insurance entered into repo and reverse repo agreements with foreign banks. The term of those transactions was up to one year, against liquid debt assets of the Government of Israel; they include a mechanism for the adjustment of the value of the collateral that will be provided against the consideration that was received in the transaction.
(3) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.
(4) Disclosure of fair value was not required.

| June 30, 2022 | |||
|---|---|---|---|
| Carrying | Fair | ||
| amount | value | ||
| Unaudited | |||
| NIS thousand | |||
| Financial liabilities presented at amortized cost: | |||
| Short-term credit from banking corporations | 530,921 | 530,921 | |
| Loans from non-bank entities | 821,494 | 821,494 | |
| Bonds (see Note 8C) | 2,079,078 | 2,016,153 | |
| Subordinated bonds (1) | 3,675,910 | 3,693,530 | |
| Additional Tier 1 capital subordinated bond (1) | 206,145 | 191,479 | |
| Trade receivables for credit cards | 1,472,492 | 1,472,492 | |
| Other (2) | 34,612 | 34,612 | |
| Total financial liabilities presented at amortized cost | 8,820,652 | 8,760,681 | |
| Financial liabilities presented at fair value through profit and loss: | |||
| Derivatives held for yield-dependent contracts | 1,635,376 | 1,635,376 | |
| Derivatives held for non-yield-dependent contracts | 528,042 | 528,042 | |
| Liability for short sale of liquid securities | 2,319,030 | 2,319,030 | |
| Total financial liabilities presented at fair value through profit and loss | 4,482,448 | 4,482,448 | |
| Lease liabilities (3) | 128,901 | ||
| Total financial liabilities | 13,432,001 |
(1) The bonds were issued for the purpose of complying with the capital requirements.
(2) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.
(3) Disclosure of fair value was not required.

| As of December 31, 2022 | |||
|---|---|---|---|
| Carrying | Fair | ||
| amount | value | ||
| Audited | |||
| NIS thousand | |||
| Financial liabilities presented at amortized cost: | |||
| Short-term credit from banking corporations | 577,658 | 577,658 | |
| Loans from non-bank entities | 827,333 | 827,333 | |
| Bonds | 2,128,984 | 2,004,364 | |
| Subordinated bonds (1) | 4,074,461 | 3,946,156 | |
| Subordinated bonds - Additional Tier 1 capital (1) | 210,536 | 174,768 | |
| Trade receivables for credit cards | 1,571,513 | 1,571,513 | |
| REPO in respect of non-yield-dependent contracts (2) | 477,606 | 477,606 | |
| Other (3) | 35,477 | 35,477 | |
| Total financial liabilities presented at amortized cost | 9,903,568 | 9,614,875 | |
| Financial liabilities presented at fair value through profit and loss: | |||
| Derivatives held for yield-dependent contracts | 1,177,929 | 1,177,929 | |
| Derivatives held for non-yield-dependent contracts | 479,909 | 479,909 | |
| REPO in respect of yield-dependent contracts (2) | 244,764 | 244,764 | |
| Liability for short sale of liquid securities | 1,189,653 | 1,189,653 | |
| Total financial liabilities presented at fair value through profit and loss | 3,092,255 | 3,092,255 | |
| Lease liabilities (4) | 109,741 | ||
| Total financial liabilities | 13,105,564 | ||
(1) The bonds were issued for the purpose of complying with the capital requirements.
(2) In 2022, The Phoenix Insurance entered into repo and reversed repo agreements with foreign banks. The term of those transactions was up to one year, against liquid debt assets of the Government of Israel; they include a mechanism for the adjustment of the value of the collateral that will be provided against the consideration that was received in the transaction.
(3) Mainly provision in respect of an option to acquire an investee and an undertaking to acquire portfolios.
(4) Disclosure of fair value was not required.

| June 30, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liability for short sale of liquid securities | 1,269,828 | - | - | 1,269,828 |
| REPO in respect of yield-dependent contracts | 855,992 | 855,992 | ||
| Derivatives | 167,902 | 1,935,410 | 10,383 | 2,113,695 |
| Financial liabilities presented at fair value | 1,437,730 | 2,791,402 | 10,383 | 4,239,515 |
| June 30, 2022 | ||||
| Level 1 | Level 2 | Level 3 | Total | |
| Unaudited | ||||
| NIS thousand |
| Liability for short sale of liquid securities | 2,319,030 | - | - | 2,319,030 |
|---|---|---|---|---|
| Derivatives | 314,073 | 1,849,345 | - | 2,163,418 |
| Financial liabilities presented at fair value | 2,633,103 | 1,849,345 | - | 4,482,448 |
| As of December 31, 2022 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Audited | ||||
| NIS thousand | ||||
| Liability for short sale of liquid securities | 1,189,653 | - | - | 1,189,653 |
| REPO in respect of yield-dependent contracts | 244,764 | 244,764 | ||
| Derivatives | 313,204 | 1,333,978 | 10,656 | 1,657,838 |
| Financial liabilities presented at fair value | 1,502,857 | 1,578,742 | 10,656 | 3,092,255 |
The fair value of investments traded actively in regulated financial markets is determined based on market prices as of the reporting date. For investments where there is no active market, fair value is determined using valuation techniques. Such techniques include using transactions that were recently made at fair market value, reference to the current market value of another instrument which is substantially the same, discounting of cash flows, or other valuation methods.
A) Illiquid debt assets
The fair value of illiquid debt assets, which are measured at fair value through profit and loss, and the fair value of illiquid financial debt assets, for which fair value information is provided solely for disclosure purposes, is determined by discounting the estimated future cash flows from those assets. The discount rates are based primarily on yields on government bonds and spreads of corporate bonds as measured on the Tel Aviv Stock Exchange. The quoted prices and interest rates used for discounting purposes are determined by a company which won the tender, published by the Ministry of Finance, for the setting up and operating a database of quoted prices and interest rates for institutional entities.

The fair value of the investment in illiquid shares was estimated using the discounted cash flow model (DCF). The estimate requires management to make certain assumptions regarding the model's data, including expected cash flows, discount rates, credit risk and volatility. The probabilities in respect of the estimates in the range can be measured reliably, and management uses them to determine and evaluate the fair value of these investments in illiquid shares.
The Company enters into transactions involving derivative financial instruments with multiple parties, especially financial institutions. The derivatives were valued using valuation models with observable market inputs are mainly interest rate swap contracts and foreign currency forwards. The most frequently used valuation techniques include prices of forwards and swap models using present value calculations. The models combine a number of inputs, including the credit rating of the parties to the financial transaction, spot/forward exchange rates, prices of forward contracts and interest rate curves. All derivative contracts are fully back against cash; therefore, there is no counterparty credit risk and non-performance risk of the Company itself in respect thereof.

It is management's policy to maintain a strong capital base in order to retain Company's ability to continue its activities such that it will be able to generate returns to its shareholders and support future business activities. The Phoenix Insurance, The Phoenix Investment House group, pension and provident funds management company and other institutional entities consolidated in the financial statements are subject to capital requirements set by the Commissioner.
The Phoenix Insurance is subject to the Solvency II-based Economic Solvency Regime in accordance with implementation provisions as published in June 2017 and revised in October 2020 (hereinafter the "Economic Solvency Regime").
The economic solvency ratio is calculated as the ratio between the insurance company's recognized economic equity and the capital required for solvency purposes.
The recognized economic equity is determined as the sum of the core tier 1 capital derived from the economic balance sheet and debt instruments that include loss absorption mechanisms (Additional Tier 1 capital and Tier 2 capital instrument).
Economic balance sheet items are calculated based on economic value, with insurance liabilities calculated on the basis of a best estimate of all expected future cash flows from existing businesses, without conservatism margins, and plus a risk margin.
The solvency capital requirement (SCR) is designed to estimate the economic equity's exposure to a series of scenarios set out in the Economic Solvency Regime provisions, and which reflect insurance risks, market risks and credit risks as well as operational risks.
The Economic Solvency Regime includes, among other things, transitional provisions in connection with compliance with capital requirements, and which allow increasing the economic capital by deducting from the insurance reserves an amount calculated in accordance with the Economic Solvency Regime provisions (hereinafter - the "Deduction"). The Deduction will decrease gradually until 2032 (hereinafter - the "Transitional Period"). In addition to a reduced capital requirements, that will increase gradually until 2023, in respect of certain investment types.
In accordance with the provisions of the Economic Solvency Regime, the economic solvency ratio report as of the December 31 and June 30 data of each year shall be included in the first periodic report published after the calculation date.
Furthermore, further to Note 8I, in view of the listing of Additional Tier 1 capital for trading on the Tel Aviv Stock Exchange's main list, and in accordance with The Phoenix Insurance's undertakings under the deed of trust, as from 2023 the Company will publish to the public, in the framework of the Report of the Board of Directors, the estimated quarterly solvency ratio as of March 31 and September 30, as part of the periodic report published following the calculation date. The calculation of the estimated quarterly solvency ratio is not audited or reviewed by the independent auditor, and the controls conducted by The Phoenix Insurance for the purpose of publishing the estimated ratio are less in scope compared to those executed for the purpose of publishing the solvency ratio report, which is published in accordance with the Commissioner's directives.

According to the above, the Company made an estimate of its economic solvency ratio as of March 31, 2023 (hereinafter - the "Estimate"); the Estimate is not audited or reviewed by the independent auditor. The calculation (of the Estimate) was carried out in accordance with the guidelines of the Solvency IIbased Economic Solvency Regime, and in accordance with the provisions of Circular 2020-1-15 of the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") - "Amendment to the Consolidated Circular concerning Implementation of a Solvency II-Based Economic Solvency Regime for Insurance Companies" (hereinafter - the "Provisions of the Economic Solvency Regime"), which was published on October 14, 2020. The Company carries out the Estimate and publishes the quarterly disclosure in addition to the publication of a mandatory solvency ratio reports as required under the Provisions of the Economic Solvency Regime.
In accordance with the Solvency Ratio Report as of December 31, 2022, and the estimated quarterly solvency ratio as of March 31, 2023 as stated above, The Phoenix Insurance has surplus capital, both when calculation is made having no regard to the transitional provisions and when it is made taking into account the transition provisions.
The calculation As at December 31, 2022 made by The Phoenix Insurance was reviewed by The Phoenix Insurance's independent auditors, in accordance with International Standard on Assurance Engagements (ISAE 3400) - The Examination of Prospective Financial Information. This standard is relevant to audits of solvency calculations and does not constitute part of the auditing standards that apply to financial statements.
It should be emphasized that the projections and assumptions on the basis of which the economic solvency ratio report was prepared are based mainly on past experience as arising from actuarial studies conducted from time to time. In view of the reforms in the capital market, insurance and savings, and the changes in the economic environment, past data do not necessarily reflect future results. The calculation is sometimes based on assumptions regarding future events, steps taken by management, and the pattern of the future development of the risk margin, that will not necessarily materialize or will materialize in a manner different than the assumptions used in the calculation. Furthermore, actual results may materially vary from the calculation, since the combined scenarios of events may materialize in a manner that is materially different than the assumptions made in the calculation.
In their special report, the independent auditors noted that they did not review the appropriateness of the Deduction During the Transitional Period as of December 31, 2022, except for verifying that the Deduction amount does not exceed the expected discounted amount of the risk margin and the capital required for solvency in respect of life and health insurance risks arising from existing businesses during the Transitional Period in accordance with the pattern of future development of the required capital, which affects both the calculation of the expected capital release and the release of the expected risk margin as described in the provisions on calculation of risk margin. Furthermore, attention is drawn to what is stated in the economic solvency ratio report regarding the uncertainty derived from regulatory changes and exposure to contingent liabilities, the effect of which on the solvency ratio cannot be estimated.
For further details, please see Section 2.1 to the Report of the Board of Directors, and the Economic Solvency Ratio Report as of December 31, 2022 published on The Phoenix Insurance's website.

According to the letter published by the Commissioner, in October 2017, (hereinafter - the "Dividend Distribution Letter") an insurance company shall be entitled to distribute a dividend only if, following the distribution, the company has a solvency ratio - according to the provisions of the Economic Solvency Regime - of at least 100%, calculated without taking into account the transitional provisions and subject to the economic solvency ratio target set by the Company's Board of Directors. The aforesaid ratio shall be calculated without the relief granted in respect of the original difference attributed to the acquisition of the provident funds and management companies. In addition, the letter set out provisions for reporting to the Commissioner.
The Phoenix Insurance's Board of Directors has set a minimum economic solvency ratio target and target range based on Solvency II. The economic solvency ratio target range, within which the Company seeks to be during and at the end of the Transitional Period, taking into account the Deduction during the Transitional Period and its gradual reduction is 150%-170%. In addition, the minimum economic solvency ratio target, taking into account the transitional provisions, is set at 135%. In addition, on August 23, 2023, the Company's Board of Directors increased the minimum economic solvency ratio target by 4 percentage points without taking into account the provisions during the Transitional Period - from a rate of 111% to a rate of 115% beginning on June 30, 2023. This minimum economic solvency ratio target is expected to reach 135% at the end of the transitional period, in accordance with the Company's capital plan.
On October 27, 2020, The Phoenix Insurance's Board of Directors approval of the dividend distribution whereby, as from 2021, The Phoenix Insurance shall distribute an annual dividend at a rate of 30% to 50% of its distributable comprehensive income as per its audited annual consolidated financial statements for the relevant year, so long as The Phoenix Insurance meets the minimum economic solvency ratio targets in accordance with Solvency II, as described above.
On March 28, 2022, The Phoenix Insurance's Board of Directors approved a revision of the dividend distribution policy that will apply to future dividend distributions to be made in connection with The Phoenix Insurance's financial results for 2022 and thereafter. According to the update, the rate of dividend will not change, but The Phoenix Insurance will take steps to distribute a dividend twice a year: Dividend at the discretion of the Board of Directors on the approval date of the Financial Statements for the second quarter of each calendar year.
Supplementary dividend in accordance with the policy on the annual report's approval date of each calendar year.
It is hereby clarified that this policy should not be viewed as an undertaking by The Phoenix Insurance to distribute dividends, and that any actual distribution shall be individually subject to the Board of Directors' approval, at its sole discretion; the Board of Directors of The Phoenix Insurance may decide on actual distribution at different (higher or lower) rates, or not to distribute any dividend. Furthermore, the execution of any actual distribution shall be subject to compliance with the provisions of the law applicable to any dividend distribution, including, among other things, the provisions of the Companies Law, 1999, and to compliance with the financial covenants The Phoenix Insurance has undertaken or/or will undertake to comply with, to The Phoenix Insurance's having sufficient distributable profits on the relevant dates, to the condition that the distribution shall not adversely affect the terms of The Phoenix Insurance's bonds and/or its cash flows, and to the extent to which The Phoenix Insurance needs cash to finance its activities, including future investments, as shall be from time to time, and/or its expected and/or planned future activities.
The Board of Directors of The Phoenix Insurance may review the dividend distribution policy from time to time and decide, at any given time, taking into account business considerations and the legal and regulatory provisions applicable to The Phoenix Insurance, to change the dividend distribution policy, including the rate of dividend to be distributed.

On March 22, 2023, The Phoenix Insurance's Board of Directors approved a cash dividend distribution in the amount of NIS 205 million. This dividend distribution was taken into account in the results of the solvency ratio as of December 31, 2022.
In August 2023, concurrently with the approval of The Phoenix Insurance's Financial Statements as of June 30, 2023, The Phoenix Insurance's Board of Directors decided to distribute a NIS 350 million dividend, at a rate higher than that set in the distribution policy, without detracting from its long-term dividend policy, and given the amount of the distributable profits and the solvency ratio rate of The Phoenix Insurance, and after compliance with the solvency ratio targets and the distribution tests as per the Companies Law.
The dividend distributions described above were approved after the revision of the Company's capital management plan, and indicated that The Phoenix Insurance meets the minimum capital target set by the Board of Directors as of the distribution dates, net of the transitional provisions, and meet the 150%- 170% target range, in which The Phoenix Insurance seeks to be during and after the Transitional Period, given the Deduction During the Transitional Period and its gradual reduction. Therefore, The Phoenix Insurance was in compliance with the requirements of the letter regarding the restrictions on dividend distribution as published by the Commissioner.
The solvency ratio as of December 31, 2022 does not include the effect of the business activity of The Phoenix Insurance subsequent to December 31, 2022 until the report publication date, changes in the mix and amounts of insurance investments and liabilities, exogenous effects - including changes in the risk-free interest rate curve, and regulatory changes affecting the business environment.
On January 5, 2022, the Commissioner published an Amendment to the Provisions of the Consolidated Circular - "Reporting to the Commissioner of Capital Market" - Own Risk and Solvency Assessment of an Insurance Company (ORSA) was published (hereinafter - the "Amendment"); the Amendment stipulates that an insurance company shall report to the Commissioner about Own Risk and Solvency Assessment of an Insurance Company (ORSA) once a year - in January. In accordance with the Amendment, the Company shall provide the Commissioner with a report that will include a summary of its results, status of its business and interactions, risk exposure, assessment of solvency and capital requirement, forwardlooking valuation, scenarios and sensitivity analyses. The circular's effective date is January 1, 2023. In January 2023, the Company reported its Own Risk and Solvency Assessment of an Insurance Company to the Commissioner for the first time, in accordance with the requirements of the Amendment.

In recent years, there has been a significant increase in the number of motions to certify class actions filed against the group and in the number of lawsuits recognized as class actions. This is part of an overall increase in motions to certify class actions in general, including against companies engaged in the group's areas of activity, which stems mainly from the enactment of the Class Actions Law, 2006 (hereinafter - the "Class Actions Law"). This trend substantially increases the group's potential exposure to losses in the event of a ruling against the group companies in class actions.
Motions to certify class actions are filed through the hearing procedure mechanism set forth in the Class Actions Law. The hearings procedure for motions to certify class actions is divided into two main stages: The first stage is the motion to certify (hereinafter - the "motion to certify" or the "motion stage", respectively). Provided the motion to certify is rejected by the court, the hearing stage at the class action level ends. A ruling at the approval stage may be subject to a request for appeal to the appellate courts. In the second stage, if the motion to certify is accepted, the class action will be heard (hereinafter - the "class action stage"). A judgment at the class action stage can be appealed to the appellate courts. Within the mechanism of the Class Actions Law, there are, inter alia, specific settlement agreements, both in the approval stage and in the class action stage, as well as arrangements with regard to the plaintiff's withdrawal of the motion to certify or class action lawsuit.
In the State of Israel, filing class action lawsuits does not entail payment of a fee derived from the claim amount; therefore the amounts of such claims may be significantly higher than the actual exposure for that claim.
In Sections 1-9, 11-22, 24-29, 31-33, 35-41, 43-46, 48, 49, 56 to the following table; for such lawsuits, which, in management's opinion - that is based, inter alia, on legal opinions whereby the group's defense claims are more likely than not to be accepted and the petitions to approve the lawsuit as class actions will be rejected - no provision was included in the financial statements, except for petitions to approve class actions in which the group is willing to reach a settlement. For motions to certify lawsuits as class actions (including lawsuits certified as class actions and the approval of which is under appeal), in which the group's defense claims - in whole or in part - are more likely than not to be rejected, and in which the group is willing to reach a compromise, provisions were included in the financial statements to cover the exposure as assessed by the group or a provision in the amount for which the group is willing to settle, as the case may be.
Management's assessment, which is based, inter alia, on legal opinions received, is included in the financial statements under adequate provisions, where such provisions were required, to cover the exposure as assessed by the group or the amount for which the group is willing to settle, as the case may be.
Many of the motions to certify lawsuits as class actions have been filed against the group on various matters related to insurance contracts and the group's ordinary course of business, for which the group has allocated insurance reserves.
In petitions to approve lawsuits as class actions as set out in Sections 10, 23, 30, 34, 42, 47, 50-55, 57, 58 in the table below, at this preliminary stage, the chances of the petitions to approve lawsuits as class actions cannot be assessed and therefore no provision is included in respect thereof in the financial statements.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 1. | January 2008 | Unlawful collection of |
In May 2018, the Supreme Court granted the defendants' motion for leave to appeal and dismissed the |
| Tel Aviv District Court | payments known as "sub | plaintiffs' appeal, such that the District Court's judgment was quashed and the motion to certify of the | |
| annuals" for life insurance policies, in an amount that |
claim as a class action was denied. | ||
| The Phoenix Insurance and other | exceeds the permitted one. | In July 2019, the Supreme Court upheld the plaintiffs' request for a further hearing on the question set | |
| insurance companies | forth in the Judgment regarding the regulator's position filed with the court regarding its instructions, | ||
| Approximately NIS 1.67 billion of all | and on the question of de minimis defense in a monetary class action. | ||
| defendants, with about NIS 277 million | In July 2021, the Supreme Court handed down its judgment in respect of the further hearing by the | ||
| Insurance.4 attributed to The Phoenix |
Supreme Court (which was concluded at a 4 to 3 majority), whereby the Supreme Court's judgment will be canceled and the District Court's judgment will be reinstated, the motion to certify will be allowed and the class action will be heard by the District Court, excluding the specific claims that were raised against The Phoenix Insurance (and another insurance company) regarding the collection of "sub annuals" in an amount that exceeds the amount permitted by law - claims which were rejected by the court and therefore will not be discussed again by the District Court, and the legal proceedings in respect thereof has ended. The class action continues to be heard in the District Court. |
||
| The parties are in mediation. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
4 The amounts were assessed by the plaintiffs in the class action statement of claim. It should be noted that the amounts in the motion to certify the claim as a class action were different and higher; those amounts also referred to the claim of collecting handling fees on policies and interest on annual premium, which is paid in installments, at a rate higher than the rate permitted by law, which, as stated, has been rejected.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 2. | February 2010 Central District Court The Phoenix Insurance (and other insurance companies in a parallel case, in light of filing a consolidated class action statement of claim) Approximately NIS 1.47 billion of all defendants (including the defendants in the corresponding case), of which approximately NIS 238 million is attributed to The Phoenix Insurance.4 |
The cause of the lawsuit, as approved by the District Court (in the corresponding case) was breach of insurance policies due to unlawful collection of "policy factor" commission in a manner that reduced the saving amount accrued in favor of the policyholder for a period starting seven years before the claim was filed. |
In November 2016, the District Court - in a parallel case filed against several other insurance companies - partially certified motions to approve the claims as class actions. The class action - both in the corresponding case and in the case heard against The Phoenix Insurance - continues to be heard jointly by the District Court. In June 2023, the parties filed with the Court a motion to approve a settlement agreement. According to the settlement agreement that was filed, the considerations paid to the class members (as defined in the settlement agreement), are: Refund at the rate of 42% in respect of the past for the "policy factor"; future discount of 50% in respect of the "policy factor"; and payment of compensation and legal fees to the class action plaintiff and his attorney (for more information, see immediate report of June 21, 2023, Ref No.: 2023-01-057877). The settlement agreement is subject to the Court's approval. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
4 The amounts are the amounts assessed by the plaintiffs in the consolidated class action statement of claim filed in March 2019 against the defendant insurance companies sued in the corresponding case and against The Phoenix. It should be noted that the amounts in the motion to certify of the claim as a class action were different and higher.

1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
4 The amounts are those amounts that were estimated by the plaintiff in the class action statement of claim - NIS 220 million (if it was ruled that interest should be calculated from the date of occurrence of the insured event) and NIS 90 million (if it is ruled that interest should be calculated starting 30 days from the delivery date of the claim). It should be noted that the amounts in the motion for approval of the class action lawsuit were different and higher and also related to the linkage claim, which was rejected.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 5. | June 2015 Beer Sheva District Court The Phoenix Insurance Approximately NIS 125 million. |
The cause of action, as approved by the District Court, is a violation of the provisions of the policy regarding special compensation (reimbursement) for performing surgery in a private hospital funded by "additional insurance services" (SHABAN) and the questions common to the class members are: what is the value of the commitment form on behalf of a health maintenance organization in respect of a privately-owned hospital (Form 17), according to which the amount to be reimbursed to the policyholder is calculated; how The Phoenix Insurance in effect calculated the amount reimbursed to policyholders who underwent surgeries as part of SHABAN; and whether The Phoenix Insurance violated the provisions of the policy, and did not reimburse the full amount to the policyholders. |
In December 2019, the District Court certified the claim as a class action lawsuit. The group on whose behalf the class action will be conducted will include all policyholders who were insured under a health insurance policy with The Phoenix Insurance, which included a reimbursement arrangement for performing surgery at a private hospital funded by SHABAN, based on a commitment form/Form 17, and in respect of whom an insured event occurred from June 25, 2012 through June 25, 2015. In January 2023, the parties filed with the Court a settlement agreement approval motion at amounts which are immaterial for The Phoenix Insurance. The settlement agreement is subject to the Court's approval. |
| 6. | September 2015 Tel Aviv District Court The Phoenix Pension (currently - The Phoenix Pension and Provident Fund Ltd.) and management companies of additional pension funds Approximately NIS 300 million per year since 2008 of all the defendants. |
The claim is that the defendants pay agents fees and commissions calculated as a percentage of the management fees charged by them, thus allegedly violating their fiduciary duties, and that, as a result, the management fees that planholders are charged are higher than the appropriate rate. |
In November 2022, the Court rejected the motion to certify the claim as a class action. In January 2023, the plaintiffs filed an appeal to the Supreme Court. An appeal hearing is scheduled for November 9, 2023. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 7. | December 2015 Tel Aviv District Court |
Alleged unlawful collection of "sub-annuals" in life insurance at a rate that is higher than the permitted one. |
In May 2020, the court issued a ruling rejecting the motion to certify of the claim as a class action, on the grounds that the plaintiffs do not have a cause of action. |
| The Phoenix Insurance and another insurance company |
In September 2020, the plaintiff filed an appeal with the Supreme Court. |
||
| Approximately NIS 100 million from all defendants, of which NIS 50 million is attributed to The Phoenix Insurance. |
In July 2023, the position of the Capital Market, Insurance and Savings Authority was filed to the Supreme Court, which is consistent with the position of The Phoenix Insurance. The appeal continues to be heard in the Supreme Court. |
||
| 8. | February 2016 | The plaintiffs argue that The Phoenix Insurance does | In May 2023, the parties filed with the Court a settlement |
| Central District Court | not link the payments it is required to pay policyholders under life insurance policies (which it issued until July |
agreement approval motion at amounts which are immaterial for The Phoenix Insurance. |
|
| The Phoenix Insurance NIS 100 million. |
19 1984) to the base index due to an insured event or due to the redemption of the policy, to the correct base index in accordance with the linkage terms and conditions set out in the policies; i.e., the latest CPI published before the first of the month in which the insurance term begins; the plaintiffs argue that this has a significant effect on the benefits to which the policyholders will be entitled. |
The settlement agreement is subject to the Court's approval. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details | |
|---|---|---|---|---|
| The motions to approve the lawsuits as class actions that appear in Sections 9-12 below were submitted on the grounds of unlawful collection of investment management expenses which are not sanctioned by the policies or bylaws. |
||||
| 9. | November 2016 Jerusalem Regional Labor Court Excellence Nessuah Gemel Ltd. (currently: The Phoenix Pension and Provident Fund Ltd.) Approximately NIS 215 million. |
The plaintiffs argue that under the rules and regulations of the Excellence Gemel provident fund, which were in effect until January 1, 2016, and according to the rules and regulations of the Excellence Advanced Education fund, Excellence Gemel may not collect investment management expenses from planholders, since collection of such expenses had to stipulated clearly and expressly in the rules and regulations of the funds. |
The court approved the hearing arrangement filed by the parties, according to which the hearings to certify the claim as a class action will be postponed until a decision has been made in connection with the motion for leave to appeal against the May 2019 District Court decision to certify as class actions claims filed for similar causes of action against The Phoenix Insurance, among others. In June 2023, the Supreme Court handed down its judgment (hereinafter the "Judgment"), whereby the motion for leave to appeal was allowed, and the motions to certify the claims as class actions were dismissed (see Section B(2) below). According to the Court's decision, The Phoenix announced its position, whereby the motion to certify should be disallowed in view of the Judgment. |
|
| 10. | June 2019 Tel Aviv Regional Labor Court The Phoenix Insurance Approximately NIS 351 million. |
According to the plaintiff, The Phoenix Insurance charges policyholders of insurance policies which combine a life insurance component and a pension saving component (executive insurance) for investment management expenses without such charges being included in the terms and conditions of the policy. |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action lawsuit. In October 2022, the Court stayed the proceedings until after a judgment is rendered in the motion to appeal described in Section B(2) below. In June 2023, a judgment was rendered, as outlined in Section 9 above and in Section B(2) below. The Phoenix informed the Court that the Judgment was handed down, and that its position is that the motion to certify should be disallowed in view of the Judgment. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 11. | June 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) NIS 17.5 million. |
The statement of claim alleges that IBI Provident and Study Fund Management Company Ltd. (which was merged with Halman Aldubi on July 1, 2018) charged the plaintiff and the other planholders of the advance education fund under its management, investment management expenses, in addition to the fund management fees, contrary to the fund's by laws. |
Halman Aldubi has yet to submit its response to the motion to certify the class action lawsuit. In March 2022, the Court stayed the proceedings until after a judgment is rendered in the motion to appeal described in Section B(2) below. In June 2023, a judgment was rendered, as outlined in Section 9 above and in Section B(2) below. |
| 12. | July 2019 Jerusalem Regional Labor Court Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) No estimate was provided, but it was noted that the damage to all class members exceeds NIS 3 million. |
According to the statement of claim, Halman Aldubi charged the plaintiff and the other planholders of the Halman Aldubi comprehensive pension fund (hereinafter - the "Fund") investment management expenses, in addition to the management fees charged by the Fund, contrary to the Fund's bylaws; the practice continued until May 2017, at which time the Fund's bylaws were changed so as to include the specific provision for charging direct investment management expenses. |
Halman Aldubi has yet to submit its response to the motion to certify the class action lawsuit. In March 2022, the Court stayed the proceedings until after a judgment is rendered in the motion to appeal described in Section B(2) below. In June 2023, a judgment was rendered, as outlined in Section 9 above and in Section B(2) below. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 13. | January 2017 Central District Court The Phoenix Insurance and other insurance companies At least approximately NIS 12.25 million in respect of each of the defendants. |
According to the plaintiffs, insurance companies overcharge insurance premiums since they do not disclose to policyholders a "practice" in the motor insurance subsegment that allows updating the age of the young driver insured under the policy and/or the years of driving experience when moving into another age bracket and/or years of driving experience bracket which can potentially result in a reduction of the insurance premium. |
On March 2022, the Court stayed the proceedings in this case until a judgment is handed down in the appeal that has been filed in a similar class action lawsuit against another insurance company that was rejected (to which the plaintiffs referred in the certification motion). |
| It should be noted that the plaintiffs refer in their claim to a decision approving a motion to certify of a claim as a class action dealing with the same issue and filed against another insurance company, in which the said practice had allegedly been proven. |
|||
| 14. | June 2017 Central District Court The Phoenix Insurance The amount of the claim was not estimated. |
The lawsuit is concerned with a claim that service level agreements are marketed and sold, either directly or through agents on behalf of The Phoenix Insurance, in violation of the provisions of the law regarding the marketing and sale procedure of such agreements. |
In August 2021, the District Court issued a ruling approving the motion to certify the claim as a class action. The group on behalf of which the class action will be conducted is anyone who had purchased from The Phoenix Insurance, whether directly or through its agents, service level agreements as part of the comprehensive car insurance policy, with The Phoenix Insurance violating the law regarding the marketing and sale of service level agreements, in the period ranging from June 30, 2016 until the date of the ruling. |
| The class action continues to be heard in court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 15. | June 2017 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction). The National Insurance Institute (hereinafter - the "National Insurance Institute"). The Phoenix Insurance and additional insurance companies (hereinafter, jointly: the "Official Respondents") The amount of the claim was not estimated. |
According to the plaintiffs, the National Insurance Institute collects national insurance contributions and health insurance contributions illegally from the tax-exempt income of class members as defined below, in addition to collecting the minimum rate of health insurance contributions from class members' disability annuity. According to the plaintiffs, the National Insurance Institute overcharges class members for these contributions through the pension fund, the employer or any other third party. The plaintiffs point out that the Official Respondents are entities through which the insurance premiums were collected from the plaintiffs, and clarify that any employer and any entity paying an early pension and any entity paying a PHI benefit in Israel may be in a similar position to that of the Official Respondents. According to the plaintiffs, it is impossible to add all the parties as respondents and the court is asked to consider the Official Respondents that were added and which are related to the |
The motions to certify the claim as a class action lawsuit continues to be heard in court. |
| plaintiffs' case as class action defendants. The plaintiffs also stated that no operative remedy is requested in the case of the Official Respondents in the framework of the above claim. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 16. | August 2017 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) Excellence Gemel & Hishtalmut Ltd. (currently: The Phoenix Pension and Provident Fund Ltd.) The claim amount was not estimated but it was stated as more than NIS 2.5 million. |
Increasing management fees in 2007 without sending prior notice as required by law. |
In March 2022, the court certified the claim as a class action. As part of the certification decision, it is decided that the group on behalf of which the class action will be conducted is as requested in the certification motion. In June 2022, Excellence Gemel filed a motion for leave to appeal against the decision approving the lawsuit as class action to the National Labor Court. The hearing of the class action by the Regional Court was delayed until a decision is made regarding the motion for leave to appeal. At the same time, the parties conduct a mediation process. |
| 17. | January 2018 Central District Court The Phoenix Insurance and other insurance companies Approximately NIS 82.2 million per year from all the defendants, of which approximately NIS 22.3 million per year is attributed to The Phoenix Insurance. |
According to the plaintiff, The Phoenix Insurance unlawfully refrains from paying its policyholders and third parties the VAT component applicable to the cost of damages when the damages have not been effectively repaired. |
In January 2022, the District Court issued a judgment rejecting the motion to certify of the claim as a class action lawsuit. In April 2022 the plaintiff filed an appeal to the Supreme Court. A hearing was scheduled for September 27, 2023. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 18. | May 2018 Haifa Regional Labor Court The Phoenix Pension and Provident Fund Ltd.4 NIS 200 million. |
According to the plaintiffs, contrary to that which is stated in its rules and regulations, The Phoenix Pension has refrained from paying or from paying in full the partial contributions towards benefits to anyone who does not receive a full disability pension. In any case, The Phoenix Pension refrained from reporting to policyholders - either in pay slips or in annual statements - about the payments it made, to the extent that it did, indeed, make such payments. |
In August 2021, the Regional Labor Court issued a resolution approving the motion to certify of the claim as a class lawsuit. As part of the above resolution, the Court approved causes of action in connection with the failure to pay contributions towards benefits in respect of planholders receiving a partial disability pension during the period from May 1, 2012 through May 1, 2019; the Court ordered a remedy whereby the rules and regulations should be abided by and the planholders' accumulated balance should be credited with current monthly contributions towards benefits based on a value date as of the original entitlement date, plus the yield accrued on the fund as from the said date. The Court also ruled that no separate pecuniary damages has been proven in addition to what is stated above, and that no monetary damages should be paid. The class action continues to be heard in court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
4 The motion to certify the claim as a class action lawsuit was originally filed against The Phoenix Insurance. The plaintiffs filed an amended motion to certify the claim as a class action lawsuit, in which they changed the identity of the defendant and also added to their previous allegations and to the definition of the class they seek to represent.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 19. | June 2018 Jerusalem District Court The Phoenix Insurance and another insurance company The amount of the claim was not estimated. |
According to the plaintiff, the claim deals with the defendants' unjustified refusal to recognize a surgical procedure that had medical justification as an insured event according to the health policies issued, by claiming that it is a "preventive surgical procedure". |
In January 2022, the District Court issued a ruling approving the motion to certify the claim as a class action. As part of the certification decision it was determined that the group on whose behalf the class action will be conducted will include any person who engaged in an health insurance contract with the defendants, including insurance coverage for surgical procedures, whose claim to have such procedure done was rejected for the reason that it is a preventative procedure which is not covered by |
| the policy (even if the reason was presented differently in the letter rejecting the claim), and the joint questions for the class members are: Did the defendants breach the insurance contracts when they rejected the claims for insurance coverage by stating that the surgical procedure is a "preventative" one, and the remedies to which class members are entitled due to that. |
|||
| In May 2022, The Phoenix Insurance filed a motion for leave to appeal to the Supreme Court against the decision approving the class action lawsuit. At the same time, the class action continues to be heard in the District Court, and the parties are concurrently conducting a mediation process. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 20. | December 2018 Tel Aviv District Court |
According to the plaintiffs, the claim deals with unlawful overcharging of insurance premiums for unnecessary building insurance policies issued to building owners (who took out a mortgage loan and were |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| The Phoenix Insurance, other insurance companies and banks NIS 280 million from all defendants. |
required to insure the building with a building policy in favor of the lending bank), despite the fact that at the time of issuance of such policies, there was already and insurance policy covering that building, regardless of whether that policy was taken out with the same insurance company or with another insurance company. |
||
| 21. | March 2019 | According to the plaintiff, the claim deals with The Phoenix Insurance's practice to delay the repayment of the relative portion of insurance |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A pre-trial |
| Central District Court | premiums upon cancellation of compulsory motor and property insurance policies rather than paying it within the period set by law; |
hearing is scheduled for November 22, 2023. | |
| The Phoenix Insurance | the plaintiff also claims that The Phoenix Insurance repays the said amount without adding linked interest. The defendant also claims that |
||
| Approximately NIS 2.6 million. | The Phoenix Insurance refrains from repaying full linkage when refunding the relative portion of the insurance premiums. |
||
| 22. | May 2019 | According to the plaintiff, the claim deals with The Phoenix Insurance's not paying policyholders in participating life insurance policies which |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| Tel Aviv District Court | include an Rm formula their full share of the profits and full payments to which they are entitled under the insurance contracts; the plaintiff |
It should be noted that the plaintiff stated that a similar motion to certify of a claim as class |
|
| The Phoenix Insurance | also claims that The Phoenix Insurance does not fulfill its reporting and disclosure obligations towards policyholders regarding their policies and |
action, which was filed against another insurance company, had recently been |
|
| Approximately NIS 766.8 million. | rights. | approved. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 23. | July 2019 Tel Aviv District Court The Phoenix Insurance and other insurance companies Approximately NIS 264.5 million from all the defendants, of which approximately NIS 67.5 million is attributed to The Phoenix Insurance. |
The plaintiffs claim that the defendants do not pay their policyholders interest as required by law in respect of insurance benefits for the period starting 30 days after the date of delivery of the claim until the date of actual payment. |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action lawsuit. It should be noted that according to the plaintiffs, this claim is based on the same cause of action as the class action described in Section 3 above in the table; however, it was nevertheless decided to file this claim for the sake of caution only, given the doubt as to whether the class of plaintiffs seeking the approval of this motion is included in the previous class action. In light of this, the proceedings in this claim were stayed until a judgment |
| 24. | August 2019 Central District Court The Phoenix Insurance and other insurance companies The claim amount was not estimated, but it was stated that it was in the tens of millions of shekels or more. |
The plaintiffs claim that in case of vehicle theft or total loss as a result of an accident, the defendants refuse to reimburse policyholders for the proportionate share of the insurance premiums (the premium) paid for service contracts (road recovery services, windscreen repair, towing, etc.) in respect of the period subsequent to the theft or total loss, despite the fact that the service contract is canceled and the risk it covers no longer exists. |
is rendered in the previous claim. The motion to certify the claim as a class action lawsuit continues to be heard in court. In February 2020, the position of the Capital Market, Insurance and Savings Authority was submitted, which is not in line with the plaintiffs' position. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 25. | December 2019 Central District Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance The amount of the claim was not estimated. |
According to the plaintiff, the defendants sell travel insurance without informing their customers - at the time of issuing the insurance policy - about the fact that the "search and rescue" component can be excluded if it is not required by the customers; the plaintiff also claims that the defendants do not inform customers about price changes they make in insurance policies' components; furthermore, the defendants do not inform customers in a clear manner about the right to reimbursement of a proportionate share of the insurance premiums in the event that the actual trip is shorter than planned, and in the event that the insurance period is shortened for any reason whatsoever (including due to cancellation of the insurance policy). |
In April 2023, the Court approved a settlement agreement between The Phoenix Insurance and the plaintiff in relation with The Phoenix Insurance's travel insurance policy, according to which The Phoenix Insurance will make a donation to a dedicated fund set up pursuant to the Class Actions Law; The Phoenix Insurance will regulate its future conduct as set out in the settlement agreement and in the judgment, and pay the lead plaintiff's compensation and his counsels' legal fees at amounts which are immaterial to The Phoenix Insurance. The motion to certify of the claim as a class action lawsuit against PassportCard in connection with its policies continues to be heard by the Court. |
| The plaintiff also claims that even when the defendants reimburse insurance premiums to policyholders who shortened their travel period and at the same time also shortened the insurance period for any reason whatsoever, they do not reimburse the full insurance premium for the shortened insurance period, contrary to law and the insurance policy. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 26. | January 2020 Central District Court The Phoenix Insurance, other insurance companies and a road recovery and towing services company. The claim amount was not estimated but it was stated that it significantly exceeds NIS 2.5 million. |
The plaintiff claims that, in cases where vehicles' windscreens broke, the defendants had provided and still provide alternative windscreens, which do not meet Israeli standards and are not manufactured by the same maker as the car; by doing so, the defendants allegedly breach their obligations under the insurance policies and coverage contracts. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| 27. | February 2020 Central District Court The Phoenix Insurance The claim amount was not estimated, but it was stated that it is in the millions of shekels or more. |
The plaintiff claims that starting in early 2016 or thereabouts, The Phoenix Insurance ceased to fulfill its obligation in health insurance policies marketed prior to February 1, 2016, in which it undertook to provide insurance coverage, at no additional cost, to all children born to the principal policyholder (starting with the fourth child), until they reach the age of 21. |
In January 2023, a decision was issued, granting the motion to certify the claim as a class action. Under the approval decision, the class on whose behalf the class action will be administered is all The Phoenix Insurance policyholders who had joined the health insurance plan, as, with respect to that plan, The Phoenix Insurance pledged that from the fourth child they have, they will have insurance coverage for no extra charge, and The Phoenix Insurance did not provide such a coverage or it provided it for a fee; it was also found that the issue all class members have in common is whether The Phoenix Insurance is obligated to continue to allow the primary policyholders to buy policies for children from their fourth oldest child and after for free even after January 31, 2016, or if it could have canceled this acquisition option for the primary policyholders' children, as it had, even though they had entered into the insurance contract with it before the termination. The class action continues to be heard in the District Court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 28. | February 2020 Tel Aviv Regional Labor Court (the hearing was transferred from the Tel Aviv District Court) Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) NIS 335 million (alternatively NIS 58 million, and alternatively 36 million). |
The claim is that Halman Aldubi allegedly violated its duty to the plaintiff and to all beneficiaries in the provident funds of Halman Aldubi, of deceased planholders, and any planholder of the Halman Aldubi provident funds with whom contact was lost, to locate and inform the said beneficiaries, as well as the planholders with whom contact was lost, that they are entitled to funds in the Halman Aldubi funds, on the dates set forth to that effect in the Supervision of Financial Services Regulations (Provident Funds) (Locating Planholders and Beneficiaries), 2012, in the period beginning on January 1, 2013 until the date of the ruling in the lawsuit. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| 29. | April 2020 Tel Aviv District Court The Phoenix Insurance, other insurance companies and the managing corporation of the Compulsory Motor Insurance Pool (the "Pool") Ltd. Approximately NIS 1.2 billion of all the defendants, of which NIS 145 million is attributed to The Phoenix Insurance or, alternatively, NIS 719 million of all the defendants, of which NIS 113 million is attributed to The Phoenix Insurance. |
The subject matter of the lawsuit4 is that the defendants unjustly profited, allegedly, by failing to reduce car insurance premiums (for compulsory and/or comprehensive and/or third-party policies) during the mobility restrictions imposed due to the Covid-19 pandemic. This was done, argued the plaintiffs, despite a decrease in mileage traveled and the level of risk to which the defendants are exposed. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for January 10, 2024. It should be noted that a motion to certify a similar claim as a class action, which was filed against The Phoenix Insurance and other insurance companies was rejected in August 2021, and another motion to certify a similar claim as a class action, which was filed against The Phoenix Insurance and other insurance companies was concluded by its withdrawal by the plaintiffs in February 2023. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
4 The motion to certify the claim as a class action includes two motions to certify claims as class actions filed against The Phoenix Insurance and other defendants, which were merged into a single claim in February 2021 by the Tel Aviv District Court (see Note 42(a)(1) in Sections 42 and 44 of the class actions table in the Company's financial statements as of December 31, 2020, published on March 25, 2021 (Ref. No. 2021-01-044709).

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 30. | May 2020 Tel Aviv District Court Phoenix Excellence Pension and Provident Funds Ltd. (currently - The Phoenix Pension and Provident Fund Ltd.), Halman Aldubi Provident and Pension Funds Ltd. (which was merged into The Phoenix Pension and Provident Fund Ltd.) and additional management companies The claim amount was not estimated, but it was stated that it is estimated, at a minimum, in the hundreds of millions of shekels. |
According to the plaintiffs, the claim deals with the defendants' classifying some of the contributions transferred to an advanced education fund on behalf of their customers as taxable provisions, even though they are not taxable. |
In accordance with the Court ruling, the government - the Israel Tax Authority, was added as a further defendant to the motion to certify the lawsuit as a class action. The motion to certify the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for January 21, 2024. At the same time, the parties agreed to conduct a mediation procedure. |
| 31. | June 2020 Tel Aviv District Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance At least NIS 10 million. |
According to the plaintiff, the claim deals with non payment of insurance benefits in respect of cancellation of a trip due to a pandemic (the Covid-19 pandemic) under travel insurance that the plaintiff purchased through PassportCard. |
In September 2022, the Court handed down a ruling approving the agreed motion for the plaintiff's withdrawing the motion to certify the lawsuit as a class action lawsuit in relation to The Phoenix Insurance's travel insurance policies. The motion to certify of the claim as a class action lawsuit against PassportCard in connection with its policies continues to be heard by the Court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 32. | June 2020 Tel Aviv Regional Labor Court The Phoenix Insurance The amount of the claim was not estimated. |
According to the claim, after a policyholder passes away, The Phoenix Insurance links the funds accrued in the policy to the consumer price index, instead of linking them to the investment track selected by the policyholder, as it previously did. |
In March 2023, the parties filed with the Court a settlement agreement approval motion at amounts which are immaterial for The Phoenix Insurance. The settlement agreement is subject to the Court's approval. |
| 33. | June 2020 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) The Phoenix Insurance and another insurance company Approximately NIS 10.5 million for each defendant. |
According to the claim, the defendants overcharge customers in loan agreements they enter into with their customers; overcharging takes place due to a one-way linkage mechanism, which is in place under those agreements, whereby if the CPI increases above the base index, the defendants collect the linkage differences due to the increase; however, if the CPI decreases below the base index, the defendants do not credit their customers for the said decrease. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| 34. | July 2020 Haifa Magistrate Court PassportCard Israel General Insurance Agency (2014) (hereinafter - "PassportCard") and The Phoenix Insurance NIS 1.84 million. |
According to the claim, when travel insurance benefits are paid late, the defendants do not pay interest in respect of the delay; the plaintiff also claims that the defendants usually pay the insurance benefits according to the exchange rate on the day of the insured event rather than the exchange rate on repayment date. In addition, it was argued that the disclosure duty regarding the deductible and the limitation of the insurer's liability with regard to the "winter sports" component is violated as part of a representation made prior to entering into the insurance contract. |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action lawsuit. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 35. | July 2020 Central District Court The Phoenix Insurance and other insurance companies |
According to the claim, the defendants must charge reduced insurance premiums in cases of insurance policies with exclusions due to an existing medical condition compared to policies in which no such exclusion is present, since exclusions mitigate the defendants' insurance risk. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for September 13, 2023. |
| About 1.9 billion of all defendants, with the share of each of the defendants being in accordance with its market segment; according to the plaintiffs, The Phoenix's share is approximately 19%. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details | ||||
|---|---|---|---|---|---|---|---|
| 36. | September 2020 | According to the claim, The Phoenix Insurance | In September 2022, the District Court partially certified the | ||||
| Tel Aviv District Court | does not pay policyholders insured under a As part of the approval long-term care policies the full amount due to them under their policies, since it offsets these |
motion to approve the action as a class action lawsuit. ruling, the Court dismissed the class |
|||||
| The Phoenix Insurance | action approval motion in connection with the claim that The Phoenix Insurance does not indemnify policyholders under their |
||||||
| NIS 92.7 million. | amounts against proceeds received from the National Insurance Institute; it is also claimed |
long-term care policies for certain medical treatments, and | |||||
| that The Phoenix Insurance does not indemnify policyholders for certain medical treatments. |
allowed the class action approval motion in connection with offsetting of funds the policyholders receive from the National |
||||||
| Insurance Institute. | |||||||
| The group in whose name the class action shall be conducted comprises all policyholders holding long-term care insurance |
|||||||
| policies of The Phoenix Insurance (or their successors for that purpose), who did not receive the compensation payable to them |
|||||||
| due to offsetting of National Insurance proceeds they received due to their long-term care needs; that the limitation period is 7 years; and that the joint question raised by class members is whether, under the terms of the policy, one may take into account the funds the policyholder receives from the National Insurance Institute and deduct them from the proceeds The Phoenix Insurance pays the policyholder. |
|||||||
| The class action continues to be heard in the District Court. | |||||||
| The parties agreed to refer the proceeding to mediation. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 37. | September 2020 Central District Court The Phoenix Insurance and another insurance company NIS 84 million from all the defendants, of which NIS 67.2 million is attributed to The Phoenix Insurance (a total of NIS 16.8 million in respect of critical illness insurance and a total of NIS 50.4 million in respect of permanent health insurance). |
According to the claim, the defendants acted in violation of the provisions of critical illness insurance policies when they continued to charge policyholders the full amount of the monthly premium even after the first insured event had occurred. It was also alleged against The Phoenix Insurance that contrary to its obligations, it charges its policyholders a monthly PHI insurance premium, even after the period of insurance coverage has ended. |
In October 2022, the parties filed with the Court a motion to certify a settlement agreement at amounts which are immaterial for The Phoenix Insurance. In view of the clarifications and supplementary information requested by the court in connection with the settlement agreement, the parties are considering the amendment of the settlement agreement. |
| 38. | December 2020 Central District Court The Phoenix Insurance The aggregate claim amount was not estimated but it was stated that it exceeds NIS 2.5 million. |
According to the plaintiff, The Phoenix Insurance allegedly does not indemnify its policyholders in motor insurance policies relating to vehicles other than private and commercial cars weighing up to 3.5 tons (such as trucks, taxis, etc.), in respect of the damage caused to their vehicle due to the insured event - which, the plaintiff claims, is in breach of the policy and the law. It is further claimed that The Phoenix Insurance does not provide its policyholders with an appraiser's report, which includes an estimate of the impairment to the vehicle's value due to the insured event nor its manner of calculation. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 39. | March 2021 Tel Aviv District Court |
The subject matter of the claim, according to the plaintiffs, is that the defendants refuse to pay for the policyholders' expenses for the purchase of medical cannabis, contrary to the provisions of the policy to cover drugs excluded from the Healthcare Services Basket, and since medical |
The parties are in a mediation procedure. |
| The Phoenix Insurance and other insurance companies |
cannabis is recognized for medical use in Western countries. | ||
| Approximately NIS 79 million from all defendants. |
|||
| 40. | March 2021 Central District Court The Phoenix Insurance No estimate was provided for the claim amount, but it was stated that the damage exceeds NIS 2.5 million. |
The subject matter of the claim, according to the plaintiff, is that The Phoenix Insurance allegedly unlawfully rejects claims by its policyholders in "personal accident" policies to pay for hospitalization at a "non-general hospital", claiming that a "hospital", as defined in the policy, is a medical institution whose underlying meaning is a "general hospital only". |
The parties are in a mediation procedure. |
| 41. | April 2021 Central District Court The Phoenix Insurance, banks, investment houses, credit card companies and other insurance companies The claim amount was not estimated but it was stated that it amounts to millions of shekels. |
According to the plaintiffs, when using the defendants' digital services (while browsing their personal accounts), customers' private, personal and confidential information is transferred to third parties without the customers' consent, violating their privacy. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A hearing was scheduled for September 14, 2023. At the same time, the parties conduct a mediation process. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 42. | July 2021 Tel Aviv District Court The Phoenix Insurance The claim amount was not estimated, but it was stated that it exceeds NIS 2.5 million. |
According to the plaintiffs, the subject matter of the claim is that the defendants deduct interest at the rate of 2.5% (or any other rate) from the monthly yield accrued for policyholders to whom a monthly benefit is paid under participating life insurance policies issued in 1991-2004; according to the plaintiffs, such a deduction is not established in the contractual terms of the relevant insurance policies. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| 43. | December 2021 Tel Aviv District Court The Phoenix Insurance The claim amount was not estimated, but it was stated that it was in the millions of shekels or more. |
The plaintiff argues that in claims pertaining to damages caused to vehicles (of a policyholder or a third party), The Phoenix Insurance allegedly reduces the insurance benefits unlawfully due to failure to fix the vehicles or transfer the damaged parts to The Phoenix Insurance. |
The parties agreed to conduct a mediation procedure. |
| 44. | January 2022 Central District Court The Phoenix Insurance The claim amount was not estimated but it was stated as being more than NIS 2.5 million. |
The plaintiff claims that in 2019 The Phoenix Insurance renewed a group health insurance policy to members of the Secondary Schools and Colleges Teachers Union and their families, while making changes, reducing the scope of the insurance coverage and increasing the premium, allegedly without informing policyholders and obtaining their consent. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A hearing is scheduled for December 10, 2023. At the same time, the parties agreed to subject the proceeding to mediation. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 45. | January 2022 Central District Court |
According to the plaintiffs, the defendants renewed a home insurance policy automatically while increasing the premium, allegedly without obtaining policyholders' consent. |
The parties are in a mediation procedure. |
| The Phoenix Insurance and another insurance company |
|||
| The claim amount was not estimated but it was stated that it exceeds NIS 3 million. |
|||
| 46. | April 2022 | The lawsuit deals with the claim that The Phoenix Insurance has collected and is still collecting from policyholders an additional premium |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action |
| Tel Aviv District Court | for the expansion of insurance coverage in respect of preventative surgical procedures, despite the fact that those procedures are |
lawsuit. A pre-trial hearing is scheduled for December 28 2023. |
|
| The Phoenix Insurance | allegedly covered by the basic tier of The Phoenix Insurance's health insurance policies. |
The motion filed by The Phoenix Insurance to | |
| The claim amount was not estimated but it was stated as being (much) more than NIS 2.5 million. |
According to the lawsuit, the plaintiff's claim is based on a decision of the Jerusalem District Court, to approve a lawsuit against The Phoenix Insurance and another insurance company as a class action (see Section 19 in the table above). |
stay the proceeding until a decision is made regarding the class action against The Phoenix Insurance and another insurance company (see Section 19 to the table) has not been allowed by the Court. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 47. | May 2022 Tel Aviv Regional Labor Court (the hearing was transferred from the Central District Court due to substantive jurisdiction) The Phoenix Pension and Provident (formerly - "The Phoenix Excellence Pension and Provident Funds Ltd.") and another management company The claim amount was not estimated but it was stated that it exceeds NIS 3 million. |
The lawsuit deals with the claim that with regard to CPI-linked loans, the defendants adopted a practice of a one-way linkage mechanism, whereby when the CPI increases compared with the base index, the customer's monthly payment is increased accordingly, and when the CPI decreases, the monthly payment does not change; the plaintiffs claim that this practice was adopted despite the fact that this is not mentioned in the provisions of the agreement. The plaintiffs noted that three motions to certify lawsuits as class actions are pending, which they claim give rise to joint issues against three other companies, including The Phoenix Insurance (see Section 33 in the table above). |
The Phoenix Pension and Provident has yet to submit its response to the motion to certify the class action lawsuit. |
| 48. | June 2022 Haifa Regional Labor Court The Phoenix Insurance NIS 5 million. |
The subject matter of the lawsuit is the claim that The Phoenix Insurance breached its contractual obligation with regard to the insurance period in a permanent health insurance, as reflected in the insurance offer, in contrast to the policy's provisions regarding "age for insurance purposes"; the lawsuit also deals with the claim that as part of the engagement, The Phoenix Insurance did not provide fair disclosure regarding the insurance end date. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. |
| 49. | September 2022 Tel Aviv District Court Excellence Nessuah Brokerage Services Ltd. (Currently: Excellence Investment Management and Securities Ltd.) NIS 26.5 million. |
The lawsuit deals with a claim of overcharging 2 agorot above the conversion rate in respect of conversion of shekels into foreign currency, and without such overcharging being set in an agreement between the parties. |
The motion to certify the claim as a class action lawsuit continues to be heard in court. A pre-trial hearing is scheduled for November 1, 2023. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 50. | October 2022 Tel Aviv District Court The Phoenix Insurance and other insurance companies |
The lawsuit deals with alleged discrimination of the defendants against male policyholders, who have a health insurance policy, based solely on their sex. According to the plaintiffs, the defendants prevent men who pay an additional premium for the ambulatory insurance appendix from receiving reimbursement in connection with amounts they expensed in connection with their babies, claiming |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action lawsuit. A pre-trial hearing is scheduled for November 15, 2023. |
| The claim amount was not estimated but it was stated as being more than NIS 2.5 million. |
that only women are entitled to reimbursement of expenses in connection with babies. |
||
| 51. | November 2022 Haifa District Court |
According to the plaintiff, The Phoenix Insurance rejected a claim filed by a policyholder with a "Long-Term Care Gift" long-term care policy, under which insurance benefits are payable upon the occurrence of a long-term care event, with the reason for rejecting the claim being that the policy is an "indemnity" |
The parties agreed to conduct a mediation procedure. |
| The Phoenix Insurance | policy rather than a "compensation" policy; the plaintiff also claimed that The Phoenix Insurance allegedly made the payment of the insurance benefits |
||
| The claim amount was not estimated but it was stated as being more than NIS 2.5 million. |
conditional on the presentation of receipts in respect of actual payments made. | ||
| 52. | April 2023 | The lawsuit concerns the claim that when a policyholder of a comprehensive motor insurance policy has an insured event, due to which they file insurance claims |
The Phoenix Insurance has yet to submit its response to the motion |
| Central District Court | and/or demands and/or request for insurance benefits, and decides to repair his/her car at an auto-repair shop that is not among the auto-repair shops that |
to certify the class action lawsuit. A pre-trial hearing is scheduled |
|
| The Phoenix Insurance | "participate" in The Phoenix Insurance's arrangement, The Phoenix Insurance offsets various amounts from the insurance benefits even though it had authorized |
for January 8, 2024. | |
| The claim amount was not estimated but it was stated as being more than NIS 2.5 million. |
the appraiser's assessment, claiming that the auto-repair shop can purchase spare parts from its own vendors for a lower price than these spare parts' consumer prices, and thus, the policyholder allegedly ends up receiving insurance compensation that does not cover the true cost of the damage they incurred as |
||
| determined in the appraiser's assessment. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 53. | April 2023 Central District Court |
The lawsuit concerns the claim that in an insured event in which the policyholder's and/or a third party's vehicle is damaged, The Phoenix Insurance underpays the appraiser's fees, as paid by the policyholder and/or the third party. |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action lawsuit. A hearing date has not yet been scheduled. |
| The Phoenix Insurance The claim amount was not estimated but it was |
|||
| stated as being more than NIS 2.5 million. | |||
| 54. | April 2023 | The lawsuit concerns the claim that in work disability policies, the defendants collected monthly insurance fees immediately prior to the |
The Phoenix Insurance has yet to submit its response to the motion to certify the class action |
| Haifa District Court | stipulated insurance end date, for the last several months that overlap with the duration of the last possible waiting period stipulated in every |
lawsuit. A pre-trial hearing is scheduled for October 23, 2023. |
|
| The Phoenix Insurance and another insurance company |
work disability insurance contract, a period in which, allegedly, according to the insurance contracts, the defendants are under no |
||
| obligation to pay any insurance benefit. | |||
| No estimate was provided for the claim amount, but it was stated that the damage amounts to millions of shekels. |
|||
| 55. | July 2023 | The lawsuit concerns the plaintiffs' claim, whereby starting on January 1, 2012, when Amendment 190 to the Income Tax Ordinance [New |
The Phoenix Insurance and The Phoenix Pension and Provident have yet to submit their response |
| Tel Aviv District Court | Version] came into effect, as alleged, the defendants did not ensure that the recipients of annuities from one of the new pension funds |
to the motion to certify the class action lawsuit. A pre-trial hearing is scheduled for March 17, 2024. |
|
| The Phoenix Insurance, The Phoenix Pension and | and/or provident funds and/or insurance funds they manage would | ||
| Provident and additional companies | receive the tax exemption for those entitled due to the component | ||
| known as a "recognized annuity," as defined in the Income Tax | |||
| NIS 297 million from all defendants | Ordinance. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 |
Main arguments | Details |
|---|---|---|---|
| 56. | July 2023 Tel Aviv District Court The Phoenix Insurance NIS 3.18 million |
The lawsuit concerns the claim that callers to The Phoenix Insurance's call center to purchase comprehensive motor / third party insurance were allegedly treated differently than other callers due to their ethnic background, in that they had been asked to submit a no claims confirmation, while other callers allegedly had the option to present the confirmation retroactively, after entering into the insurance policy. |
On July 16, 2023, concurrently with the filing of the motion to certify the claim as a class action, the parties filed with the Court a motion to certify a settlement agreement at amounts which are immaterial for The Phoenix Insurance. The settlement agreement is subject to the Court's |
| approval. | |||
| 57. | August 2023 Tel Aviv Regional Labor Court The Phoenix Insurance and The Phoenix Pension and Provident The claim amount was not estimated but it was stated as being more than NIS 2.5 million. |
The lawsuit concerns the claim that the defendants allegedly act contrary to the provisions of the law by transferring the redemption funds of their policyholders or planholders under a pension fund and/or executive insurance and/or annuity provident fund to an annuity after the stipulated date for this purpose under the law. Thus, the defendants are unjustly enriched, overcharge management fees, and do not compensate their policyholders / planholders with the interest on arrears plus the returns with respect to the alleged delay. |
The Phoenix Insurance and The Phoenix Pension and Provident have yet to submit their response to the motion to certify the class action lawsuit. A pre-trial hearing is scheduled for February 18, 2024. |
| 58. | August 2023 | The claim deals with a claim that in cases where customers had a credit balance, | The Phoenix Insurance's response to the motion |
| Central District Court | The Phoenix Insurance has allegedly acted unlawfully by not transferring those funds to the customers - whether by transferring the funds to the customers by way of a check that was not paid-in, rather than by way of bank transfer or by |
to certify the claim as a class action has yet to be filed. A hearing date has not yet been scheduled. |
|
| The Phoenix Insurance | crediting the amount to the customer's credit card, or due to any other reason; by not informing the customers of the funds they are entitled to; and by not |
||
| The claim amount was not estimated but | acting to recover those funds. It was further claimed that damage was allegedly | ||
| it was stated that it is higher than NIS 3 |
caused to customers to whom The Phoenix Insurance transferred funds in | ||
| million (potentially tens of millions of NIS). |
respect of a credit balance through checks that were paid-in, rather than by way of bank transfer or by crediting the amount to the customer's credit card. |
||
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details |
|---|---|---|---|
| 1. | June 2021 Tel Aviv District Court The Phoenix Holdings, The Phoenix Insurance, the Chairman of the Board of Directors of The Phoenix Holdings and The Phoenix Insurance, serving board members of The Phoenix Holdings and The Phoenix Insurance and a long-serving manager in The Phoenix Insurance (hereinafter - the "Defendants"). NIS 137 million. |
This lawsuit relies on the facts as presented in a motion to certify a derivative lawsuit that was filed against the Defendants and which deals with events that took place at the beginning of the 1990s and was concluded with the plaintiff's withdrawal (see Section 3 in Chapter C below under Legal and Other Proceedings). According to the plaintiffs, the subject matter of the claim is an alleged misleading report and non-disclosure by the Company of material facts that caused damage to buyers of the share. According to the plaintiffs, at the beginning of the 1990s, the Company took steps, in which it managers were involved, to recruit customers and help them to benefit from guaranteed return policies; such steps were allegedly carried out in breach of guidance. |
On May 15, 2023, the Court handed down a judgment approving the plaintiffs' withdrawal from the motion to certify the claim as a class action. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

| No. | Date,1 court,2 defendants and claim amount3 | Main arguments | Details | |
|---|---|---|---|---|
| 2. | September 2016 | Collecting investment |
In May 2019, the District Court certified the motion to certify as a class action the | |
| Central District Court | management expenses in the individual saving policy Excellence Invest in addition to collecting management fees, without a provision in the policy expressly permitting to do so. |
claim filed against The Phoenix Insurance and three other insurance companies (hereinafter - the "Defendants"), for breaching the provisions of the insurance |
||
| The Phoenix Insurance | policy due to unlawful collection of investment management expenses. The class | |||
| NIS 14.7 million. | on whose behalf the class action lawsuit against The Phoenix Insurance will be conducted includes all policyholders of the individual savings policy Excellence Invest issued by The Phoenix Insurance at present and in the seven years prior to the date of submission of the motion to certify as class action. The remedies claimed are the reimbursement of the investment management expenses that were overcharged in addition to interest differentials; and an order directing the defendants to stop collecting such fees. |
|||
| In September 2019, The Phoenix Insurance (along with the other defendants) filed a motion for leave to appeal to the Supreme Court against the decision approving the class action lawsuit. |
||||
| In June 2023, the Supreme Court allowed the defendants' motion for leave to appeal and dismissed the motions to certify the claims as class actions. |
||||
| It should be noted that requests for approval of class actions regarding investment management expenses are also pending against Excellence Gemel (please see Section A(9) above in the table), The Phoenix Insurance (see Section A(10) above in the table) and Halman Aldubi Provident and Pension Funds Ltd. (see Sections A(11-12) above in the table). |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

| Date,1 court,2 defendants and claim amount3 No. Main arguments |
Details |
|---|---|
| 3. April 2017 According to the plaintiffs, until the regulator intervened and legislative changes were made in connection with this issue, Tel Aviv Regional Labor Court (the hearing was managers of pension arrangements in general and the defendants transferred from the Tel Aviv District Court due to in particular, provided employers with operating services involving substantive jurisdiction) preparing and managing pension insurance for employees without the employers paying any consideration in respect thereof Shekel Insurance Agency (2008) Ltd. (hereinafter - to the pension arrangement managers, and that all costs "Shekel"), Agam Leaderim (Israel) Insurance Agency pertaining to the operating services are paid by the employees (2003) Ltd. (hereinafter - " Agam Leaderim"), second through management fees they pay for the products marketed to tier companies of The Phoenix Holdings, and other them by the managers of the pension arrangement. insurance agencies. Approximately NIS 357 million of all defendants, of which NIS 47.81 million is attributed to Agam Leaderim and NIS 89.64 million to Shekel. |
In August 2020, the Regional Court issued a ruling rejecting the motion to certify of the claim as a class action. In September 2022, the National Court dismissed the plaintiffs' appeal. In December 2022, the plaintiffs filed a petition to the Supreme Court, in its capacity as the High Court of Justice, requesting the reversal of the judgment that dismissed the appeal. In June 2023, the Supreme Court, sitting as the High Court of Justice, denied the plaintiffs' petition to reverse the judgment. |
1 The date on which the motion to certify the claim as a class action was originally filed.
2 The court with which the motion to certify the claim as a class action lawsuit was originally filed.
3 The claim amount as assessed (if assessed) by the plaintiff(s) in the motion to certify the claim as a class action lawsuit.
* For additional claims concluded between January 1, 2023 and March 23, 2023, please see Note 43A.2, Sections 11-13 of the table of concluded claims in the Company's financial statements as of December 31, 2022, published on March 23 (Ref. No. 2023-01-026428).

Set forth below is a description of legal and other proceedings against the group. For proceedings where, in the opinion of management - which is based, among other things, on the legal opinion it has received - it is more likely than not that the group's defense claims will be allowed and the proceeding will be dismissed, no provision was included in the financial statements.
For proceedings where it is more likely than not that the group's defense claims will be dismissed, in whole or in part, the financial statements include provisions to cover the exposure estimated by the group. In management's opinion, which is based, among other things, on legal opinions it received, the financial statements include adequate provisions, where provisions were required, to cover the exposure estimated by the group.
In the statement of claim, the Court is requested to order the defendants, jointly and severally, to compensate the plaintiffs for the damage caused to them, according to the claim, due to the impairment of Pilat Group's value, in the total amount of NIS 35.9 million; in addition, declaratory reliefs are requested against Oracle Group and Hadas Provident. In June 2023, the Court approved a mediation agreement between the plaintiffs and all of the other defendants other than Halman Aldubi. The lawsuit against Halman Aldubi continues to be heard in court. A hearing is scheduled for October 24 2023.

The letter states that it was sent, among other things, against the backdrop of a legal proceeding currently being conducted against another insurance company in connection with this issue. On April 28, 2022, The Phoenix Insurance responded in writing to this letter. The Authority's decision has yet to be issued.
In June 2023, The Phoenix Insurance responded to the letter and to the draft audit report. In July 2023, The Phoenix Insurance added upon its response. The Authority's decision has yet to be issued.
Complaints are filed against the group from time to time, including complaints to the Commissioner of the Capital Market, Insurance and Savings (hereinafter - the "Commissioner") in relation to policyholders' rights under insurance policies and/or the law. These complaints are handled on an ongoing basis by the group's Public Complaints Department. The Commissioner's decisions with regard to these complaints, to the extent that a decision has been made in respect thereof, are sometimes issued as sweeping decisions relating to a group of policyholders. Before issuing a final version of his decisions, the Commissioner usually issues a draft decision.
Furthermore, as part of the Commissioner's inquiries with the group, following complaints and/or audits on his behalf, demands are made from time to time to receive various data regarding the group's handling of insurance policies in the past and/or a demand to reimburse funds to groups of policyholders and/or other guidelines. In addition, the Commissioner has the power, among other things, to impose monetary sanctions on the group in accordance with the data that was and/or will be transferred thereto following inquiries as described above. In addition to the motions to certify lawsuits filed against the group as class actions.
and the legal and other proceedings, there is a general exposure, which cannot be assessed and/or quantified, due to, among other things, the complexity of the services provided by the group to its policyholders. The complexity of these services inevitably leads to interpretive claims and other claims due to information gaps between the group and third parties to the insurance contracts in connection with a long list of commercial and regulatory terms. This exposure is reflected, among other things, in the areas of pension savings and long-term insurance, including health and long-term care insurance, in which the group operates. Insurance policies in these areas of activity are assessed over many years in which policies, regulation and legislation change and new court rulings are issued. These changes are implemented by automated systems that undergo frequent changes and adjustments. The complexity of these changes and the application of the changes over many years lead to an increased operational exposure. In addition, allowing new interpretations for the provisions of insurance policies and long-term pension products sometimes affects the group's future profits in respect of its existing portfolio, in addition to the exposure embodied in claims for compensation for customers in respect of past activity.

It is impossible to anticipate the types of claims that will be raised in this area or the exposure arising from these and other claims in connection with insurance contracts - claims which are raised through, among other things, the procedural mechanism set forth in the Class Actions Law.
In addition, some of the group's products have long terms and are particularly complex in light of the various legislative arrangements both in the field of product management and in the field of taxation, attribution of contributions, investment management, the policyholder's employment status, his contributions and more.
The Wage Protection Law, 1958 imposes a liability on the group's institutional entities, in accordance with the circumstances specified in the law, in respect of employers' debts to the institutional entities, where such debts have not been repaid on time. The group is in the process of improving the data on employers' debts and policyholders' rights, during the course of which lawsuits were filed against employers and the debts of other employers were rescheduled. Once this process is completed, the group will complete the handling of employers' debts in accordance with the provisions of the law.
The following table summarizes the amounts claimed in pending motions to certify claims as class actions, claims certified as class actions and other material claims against the group, as noted by the plaintiffs in the statements of claim filed on their behalf. It is hereby clarified that the amount claimed does not necessarily constitute a quantification of the exposure amount assessed by the group, since these are assessments on behalf of the plaintiffs which will be resolved as part of the legal proceedings. It is further clarified that the table below does not include proceedings that have been concluded, including proceedings that concluded after a compromise agreement was approved in respect thereof.
| Type | No. of claims |
The amount claimed in NIS thousand |
|---|---|---|
| Claims certified as a class actions: | ||
| A specific amount was attributed to the Company | 6 | 1,152,743 |
| The claim pertains to several companies and | ||
| no specific amount was attributed to the Company | 1 | 48,000 |
| The amount of the claim was not specified | 4 | - |
| Pending motions to certify lawsuits as class actions: A specific amount was attributed to the Company The claim pertains to several companies and no specific amount was attributed to the Company The amount of the claim was not specified |
18 6 23 |
2,691,892 3,067,875 - |
| Other material claims: A specific amount was attributed to the Company The claim pertains to several companies and |
- | - |
| no specific amount was attributed to the Company | 1 | 35,900 |
| The amount of the claim was not specified | - | - |
| Claims and other demands | 20 | 24,725 |
The total provision amount in respect of class actions, legal proceedings and others, filed against the Group as specified above as of June 30, 2023 and December 31, 2022, amounted to approximately NIS 380,596 thousand (of which a total of approximately NIS 2,370 thousand is for concluded class actions) and approximately NIS 354,703 thousand, respectively.

A decrease (increase) in long-term interest rates may increase (decrease) the paid pension reserve and the supplementary retirement pension reserve is deferred due to the use of a lower (higher) discount rate, to the extent that a change in the discount rate is required due to changes in market interest rates.
In addition, the supplementary retirement pension reserve for deferred pensions is affected by future income expectations (using K factor), so that the decrease (increase) in interest rates may decrease (increase) the expected future income, and if according to the new projection it will be impossible to continue funding the provisions to the reserve, the Company will increase the reserve in order to reduce future provision amounts (or vice versa).
| June 30, 2023 2022 Unaudited % |
December 31, 2022 Audited |
|||
|---|---|---|---|---|
| In respect of guaranteed return insurance policies | - | - | - | |
| In respect of yield-dependent insurance policies | 0.85 | 0.85 | 0.85 |
The Company tests the adequacy of the reserves for life insurance and LTC and where necessary, increases the reserves. Testing is performed according to the regulatory guidelines and on the basis of actuarial assumptions and a risk-free yield curve plus an illiquidity premium. To the extent that there are changes in these assumptions, the supplement required according to the test will change.
A decrease (increase) in the risk-free interest rate curve and/or in the rate of illiquidity premium will increase (decrease) the supplement for the reserves required according to the LAT test (to the extent that a supplement is required).

| For the 6 months ended June 30 |
For the 3 months ended June 30 |
For the year ended December 31 |
|||
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | |
| Unaudited | Audited | ||||
| Life insurance segment: Effect of updating assumption regarding rates of annuity uptake |
- | (462) | - | NIS million (462) |
(462) |
| Effect of updating other assumptions on the supplementary retirement pension reserve and paid pensions |
- | - | - | - | (12) |
| The effect of the changes in the assumptions regarding the cost of claims in long-term health insurance |
(59) | - | (59) | - | - |
| Effect of updating assumptions on the expense rates | - | - | - | - | (1) |
| Effect of updating assumptions on the mortality rates | - | 364 | - | 364 | 364 |
| Change in the discount rate used in the calculation of the supplementary retirement pension reserve and paid pensions |
17 | (397) | 43 | (119) | (560) |
| Total decrease in liabilities on retention in life insurance segment |
(42) | (495) | (16) | (217) | (671) |
| Health insurance segment: Effect of updating of assumptions on the cancellation rates: |
|||||
| LAT Other |
- - |
- - |
- - |
- - |
(16) 25 |
| Effect of updating assumptions on the expense rates: LAT Other |
- - |
- - |
- - |
- - |
(21) (63) |
| Effect of updating assumptions on the mortality and morbidity rates: Other |
- | - | - | - | 38 |
| Change in LAT reserve following a change in the discount rate (*) |
81 | (753) | 187 | (133) | (919) |
| Total increase (decrease) in liabilities on retention in health insurance segment |
81 | (753) | 187 | (133) | (956) |
| P&C insurance segment: Change in discount rate (*) |
5 | (68) | 23 | (70) | (264) |
| Total decrease in liabilities on retention in P&C insurance segment |
5 | (68) | 23 | (70) | (264) |
| Total decrease in liabilities on retention before tax | 44 | (1,316) | 194 | (420) | (1,891) |
Total decrease in liabilities on retention, after tax 29 (869) 128 (277) (1,244) (*) This effect includes the change in the excess of value of illiquid assets, and the effect of the classification of excess value illiquid assets. For further details, please see Note 41 (5.2.2.5) A to the Consolidated Annual Financial Statements, and Note 4B(3).
Furthermore, in the first quarter of 2023, the Company revised the estimate of the insurance liabilities in the guarantees under the Sale Law line of business under the property and casualty insurance subsegment, such that the liabilities shall reflect the policyholders' weighted credit risks. As a result of the said revision, the pre-tax profit from property and casualty insurance increased by NIS 40 million, and post-tax comprehensive income increased by NIS 26 million.


For further details regarding the above, please see immediate reports dated January 19, 2023 and July 2, 2023 (Ref. Nos.: 2023-01-009285 and 2023-01-061972).
As of June 30, 2023, The Phoenix Investment House paid the entire consideration amount to Psagot Securities, and paid a NIS 160 million advance to Psagot Funds; this advance was recorded under the receivables line item in the Company's balance sheet. For said acquisitions, the Company advanced a NIS 149 million loan to The Phoenix Investment House for the acquisition of the activities as stated above. This loan was advanced against the expansion of the Company's Series 6 bonds. For further details regarding the above, please see immediate report dated January 19, 2023 (Ref. No.: 2023-01-009285). In addition, KSM and a bank entered into a loan agreement for the purpose of paying the outstanding consideration amount.

bonds on the main list of the TASE, such that in May 2023, trading of the subordinated bonds on the main list started. In accordance with the provisions of the deed of trust, the interest in respect of the subordinated bonds was reduced by 0.2%. As part of the listing on the main list, The Phoenix Insurance undertook to publish data in connection with its economic solvency ratio on a quarterly basis in respect of the quarter preceding the reporting date.
For further details in connection with the issuance of the subordinated bonds and their listing on the main list, see the Company's immediate reports dated August 2, 2021, August 3, 2021 August 8, 2021, April 24, 2023 and May 3, 2023 (Ref. Nos.: 2021-01-060658, 2021-01-061159, 2021- 01-062515, 2023-01-038554 and 2023-01-040573, respectively).

M. On June 27, 2023, the Company's Board of Directors approved - after obtaining the approval of the Compensation Committee - the allocation to employees of the Company and its subsidiaries, some of whom are Company officers (including the Company's CEO), and to service providers of the Company (hereinafter- the "Offerees") of up to 3,211,588 unlisted options (including options that were awarded in a private placement that was approved by the Board of Directors on August 1, 2023), which are offered without cash consideration (but in consideration of work or services provided to the Company by the Offerees), under the theoretical assumption of all allocatable options being exercised taking into consideration the cap price and the cashless exercise mechanism under the outline, immediately after exercise thereof and taking into account the issued and paid-up capital of the Company, the shares arising from the exercise of the options as of the Board of Directors' approval, shall constitute approximately 0.37% of the issued and paid-up capital of the Company and approximately 0.37% of its voting rights (and approximately 0.36% and 0.36%, respectively, fully diluted). The fair value at the Award Date is calculated based on an appraisal received from an external appraiser who used the binomial model. The average value of one option was estimated at approximately NIS 6.1, and the total value of the options allotted was estimated at that date at approximately NIS 20 million.
In accordance with the Board of Directors' decision, out of the amount of 3,211,588 options allotted to offerees a total of 57,190 options were allotted to the Company's CEO. The award of options to the Company's CEO was approved in an extraordinary general meeting of the Company held on August 2, 2023 (hereinafter - the "Meeting").
For further details regarding the vesting terms and conditions, see Note 37B to the Consolidated Annual Financial Statements. In addition, please see the immediate reports dated June 28, 2023, July 26, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060307, 2023-01-060334, 2023-01- 072205513 and 2023-01-088974, respectively).

The fair value at the Award Date is calculated based on an appraisal received from an external appraiser, which amounted to approximately NIS 23 million. The vesting period shall be spread over 4 years.
Out of the total number of options allocated as described above, 63,321 options were allocated to the Chairman of the Company's Board of Directors, and 78,771 options were allocated to the Company's CEO. The award of options to the Company's Chairman and CEO was approved in an extraordinary general meeting of the Company held on August 2, 2023. For further details, please see the immediate reports dated June 28, 2023 and August 2, 2023 (Ref. Nos.: 2023-01-060334 and 2023-01-088974, respectively).
F. In connection with class actions filed and developments in lawsuits subsequent to the balance sheet date, please see Note 7 above.

| June 30, 2023 | ||||
|---|---|---|---|---|
| Presented at fair value |
||||
| through profit and loss |
Available for-sale |
Loans and receivables |
Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets (a1) | 220,947 | 5,425,161 | - | 5,646,108 |
| Illiquid debt assets | - | - | 15,276,930 | 15,276,930 |
| Shares (a2) | 18,086 | 1,891,720 | - | 1,909,806 |
| Other (a3) | 298,160 | 5,214,619 | - | 5,512,779 |
| June 30, 2022 | ||||
|---|---|---|---|---|
| Presented at fair value |
||||
| through profit and loss |
Available for-sale |
Loans and receivables |
Total | |
| Unaudited | ||||
| NIS thousand | ||||
| Liquid debt assets (a1) | 380,954 | 5,931,293 | - | 6,312,247 |
| Illiquid debt assets | - | - | 14,106,324 | 14,106,324 |
| Shares (a2) | - | 2,144,175 | - | 2,144,175 |
| Other (a3) | 433,597 | 3,924,439 | - | 4,358,036 |
| Total | 814,551 | 11,999,907 | 14,106,324 | 26,920,782 |
| As of December 31, 2022 | ||||
|---|---|---|---|---|
| Presented at fair value |
||||
| through profit | Available | Loans and | ||
| and loss | for-sale Audited |
receivables | Total | |
| NIS thousand | ||||
| Liquid debt assets (a1) | 394,299 | 5,132,051 | - | 5,526,350 |
| Illiquid debt assets | - | - | 14,696,915 | 14,696,915 |
| Shares (a2) | - | 1,869,608 | - | 1,869,608 |
| Other (a3) | 311,906 | 4,578,276 | - | 4,890,182 |
| Total | 706,205 | 11,579,935 | 14,696,915 | 26,983,055 |

| June 30, 2023 | |||
|---|---|---|---|
| Carrying amount | Amortized cost | ||
| Unaudited | |||
| NIS thousand | |||
| Government bonds | 2,242,513 | 2,406,740 | |
| Other debt assets: | |||
| Other non-convertible debt assets | 3,182,648 | 3,436,603 | |
| Other convertible debt assets | 220,947 | 239,606 | |
| Total liquid debt assets | 5,646,108 | 6,082,949 | |
| Impairments carried to profit and loss (cumulative) | 499,998 |
| June 30, 2022 | |||
|---|---|---|---|
| Carrying amount | Amortized cost | ||
| Unaudited | |||
| NIS thousand | |||
| Government bonds | 2,717,777 | 2,805,869 | |
| Other debt assets: | |||
| Other non-convertible debt assets | 3,213,516 | 3,230,546 | |
| Other convertible debt assets | 380,954 | 410,952 | |
| Total liquid debt assets | 6,312,247 | 6,447,367 | |
| Impairments carried to profit and loss (cumulative) | 356,873 |
| As of December 31, 2022 | |||
|---|---|---|---|
| Carrying amount Amortized cost |
|||
| Audited | |||
| NIS thousand | |||
| Government bonds | 1,814,653 | 1,628,926 | |
| Other debt assets: | |||
| Other non-convertible debt assets | 3,317,398 | 3,367,254 | |
| Other convertible debt assets | 394,299 | 441,759 | |
| Total liquid debt assets | 5,526,350 | 5,437,939 | |
| Impairments carried to profit and loss (cumulative) | 357,288 |

| June 30, 2023 | |||
|---|---|---|---|
| Carrying amount | Cost | ||
| Unaudited | |||
| NIS thousand | |||
| Liquid shares | 1,410,317 | 1,500,481 | |
| Illiquid shares | 499,489 | 333,657 | |
| Total shares | 1,909,806 | 1,834,138 | |
| Impairments carried to profit and loss (cumulative) | 338,101 |
| June 30, 2022 | ||
|---|---|---|
| Carrying amount | Cost | |
| Unaudited | ||
| NIS thousand | ||
| Liquid shares | 1,671,274 | 1,365,837 |
| Illiquid shares | 472,901 | 288,885 |
| Total shares | 2,144,175 | 1,654,722 |
| Impairments carried to profit and loss (cumulative) | 280,643 |
| As of December 31, 2022 | ||
|---|---|---|
| Carrying amount | Cost | |
| Audited | ||
| NIS thousand | ||
| Liquid shares | 1,407,424 | 1,173,073 |
| Illiquid shares | 462,184 | 289,471 |
| Total shares | 1,869,608 | 1,462,544 |
| Impairments carried to profit and loss (cumulative) | 345,963 |

| June 30, 2023 | ||
|---|---|---|
| Carrying amount | Cost | |
| Unaudited | ||
| NIS thousand | ||
| Total liquid financial investments | 550,952 | 509,214 |
| Total illiquid financial investments | 4,961,827 | 3,841,533 |
| Total other financial investments | 5,512,779 | 4,350,747 |
| Impairments carried to profit and loss (cumulative) | 255,228 |
| June 30, 2022 | |||
|---|---|---|---|
| Carrying amount | Cost | ||
| Unaudited | |||
| NIS thousand | |||
| Total liquid financial investments | 572,658 | 514,615 | |
| Total illiquid financial investments | 3,785,378 | 2,651,937 | |
| Total other financial investments | 4,358,036 | 3,166,552 | |
| Impairments carried to profit and loss (cumulative) | 205,570 |
| As of December 31, 2022 | ||
|---|---|---|
| Carrying amount | Cost | |
| Audited | ||
| NIS thousand | ||
| Total liquid financial investments | 511,235 | 443,876 |
| Total illiquid financial investments | 4,378,947 | 3,172,645 |
| Total other financial investments | 4,890,182 | 3,616,521 |
| Impairments carried to profit and loss (cumulative) | 245,426 |

Standalone Financial Data from the Consolidated Interim Financial Statements Attributed to the Company


Page

Kost Forer Gabbay & Kasierer Menachem Begin Road 144A, Tel Aviv 6492102
Tel. +972-3-6232525 Fax +972-3-5622555 ey.com
To The Shareholders of The Phoenix Holdings Ltd.
Dear Madam/Sir,
We have reviewed the separate interim financial information disclosed in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports), 1970 of The Phoenix Holdings Ltd. ( "the Company") as of June 30, 2023 and for the six and three-months periods then ended. The company's board of directors and management are responsible for the separate interim financial information. Our responsibility is to express a conclusion regarding the separate interim financial information based on our review.
We did not review the separate interim financial information taken from the interim information of investees, in which the total amounted to approximately NIS 951,675 thousand as of June 30, 2023, and the Company's share in of their earnings amounted to approximately NIS 60,082 thousand and NIS 14,240 thousand for the six and three-months periods then ended, respectively. The separate interim financial statements of these companies were reviewed by other auditors, whose review reports have been furnished to us, and our conclusion, insofar as it relates to financial statements in respect of these companies, is based on the review reports of the other auditors.
We conducted our review in accordance with Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and of applying analytical and other review procedures. A review is substantially less in scope than an audit performed pursuant to Israeli GAAP and, as a result, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we are not express an audit opinion.
Based on our review and the review reports of other auditors, nothing has come to our attention that causes us to believe that the accompanying separate interim financial information is not prepared, in all material respects, in accordance with Regulations 38D to the Securities Regulations (Periodic and Immediate Reports), 1970.
Tel Aviv, Kost Forer Gabbay & Kasierer August 23, 2023 Certified Public Accountants

| As of | ||||||
|---|---|---|---|---|---|---|
| June 30, 2023 | June 30, 2022 | December 31, 2022 | ||||
| Unaudited | Audited | |||||
| NIS thousand | ||||||
| Assets | ||||||
| Investments in investees | 9,162,290 | 9,381,481 | 9,842,459 | |||
| Loans and capital notes to investees | 881,387 | 689,681 (*) | 805,201 (*) | |||
| Total non-current assets | 10,043,677 | 10,071,162 | 10,647,660 | |||
| Investments and capital notes for investees | 1,038,168 | 985,155 (*) | 1,009,673 (*) | |||
| Other financial investments | 10,610 | 11,194 (*) | 10,603 (*) | |||
| Receivables and debit balances | 10,452 | 10,565 | 10,791 | |||
| Dividend receivable (see Note 2F) | 486,031 | - | - | |||
| Current tax assets | - | 31 | 31 | |||
| Deferred tax assets | 11,511 | - | - | |||
| Cash and cash equivalents | 15,174 | 105,710 | 16,959 | |||
| Total current assets | 1,571,946 | 1,112,656 | 1,048,057 | |||
| Total assets | 11,615,623 | 11,183,818 | 11,695,717 | |||
| Equity attributable to Company's shareholders | ||||||
| Share capital | 313,168 | 310,514 | 311,640 | |||
| Premium on shares and capital reserves | 858,022 | 845,296 | 851,918 | |||
| Treasury shares | (167,733) | (155,628) | (155,628) | |||
| Capital reserves | 1,210,070 | 934,615 | 1,123,705 | |||
| Surplus | 7,841,012 | 7,773,062 | 8,013,123 | |||
| Total equity | 10,054,539 | 9,707,859 | 10,144,758 | |||
| Liabilities | ||||||
| Non-current liabilities | - | - | - | |||
| Bonds | 1,506,993 | 1,417,883 | 1,495,505 | |||
| Current liabilities | ||||||
| Liability in respect of current taxes | 5,556 | - | - | |||
| Payables and credit balances | 12,262 | 4,796 | 10,362 | |||
| Liability in respect of deferred taxes | - | 18,600 | 9,689 | |||
| Short-term bonds | 36,273 | 34,680 | 35,403 | |||
| Total current liabilities | 54,091 | 58,076 | 55,454 | |||
| Total liabilities | 1,561,084 | 1,475,959 | 1,550,959 | |||
| Total equity and liabilities | 11,615,623 | 11,183,818 | 11,695,717 |
(*) Reclassified.
| Benjamin Gabbay | Eyal Ben Simon | Eli Schwartz |
|---|---|---|
| Chairman of the Board | CEO | EVP, CFO |
Date of approval of the financial statements - August 23, 2023

| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | ||||
| Unaudited | Unaudited | Audited | ||||||
| NIS thousand | ||||||||
| Company's share in the profits | ||||||||
| (losses) of investees, net of tax | (38,264) | 840,839 | 28,917 | 172,613 | 1,216,360 | |||
| Investment income, net and finance income | 53,199 | 55,302 | 28,573 | 31,351 | 101,271 | |||
| Income from management fees of investees | 1,500 | 1,500 | 750 | 750 | 3,000 | |||
| Total income | 16,435 | 897,641 | 58,240 | 204,714 | 1,320,631 | |||
| General and administrative expenses | 6,654 | 5,437 | 2,770 | 2,415 | 9,897 | |||
| Finance expenses | 23,787 | 32,241 | 5,628 | 17,433 | 62,710 | |||
| Total expenses | 30,441 | 37,678 | 8,398 | 19,848 | 72,607 | |||
| Profit (loss) before taxes on income | (14,006) | 859,963 | 49,842 | 184,866 | 1,248,024 | |||
| Income tax expenses | (15,600) | - | (8,800) | - | (9,100) | |||
| Profit for the period attributable | ||||||||
| to the Company's owners | 1,594 | 859,963 | 58,642 | 184,866 | 1,257,124 |

| ended June 30 | For the six months | ended June 30 | For the three months | For the year ended December 31 |
|
|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | |
| Unaudited | Audited | ||||
| NIS thousand | |||||
| Profit for the period | 1,594 | 859,963 | 58,642 | 184,866 | 1,257,124 |
| Other comprehensive income: | |||||
| Amounts that will be or that have | |||||
| been reclassified to profit or loss | |||||
| when specific conditions are met | |||||
| Net change in fair value of financial | |||||
| assets classified as available for sale, | |||||
| carried to capital reserves | - | (673) | - | (710) | (754) |
| Net gains from disposal of financial | |||||
| assets classified as available for sale, | |||||
| carried to the income statement | - | 87 | - | 9 | (111) |
| Gain on impairment of financial | |||||
| assets classified as available for sale, | |||||
| carried to the income statement | - | 110 | - | 110 | 208 |
| The Group's share in other comprehensive | |||||
| income (loss) of investees | 296,914 | (323,030) | 158,733 | (323,623) | (230,419) |
| Taxes on income relating to components | |||||
| of other comprehensive income | - | (121) | - | 137 | 152 |
| Total components of income | |||||
| (loss) items, subsequently | |||||
| reclassified to profit or loss | 296,914 | (323,627) | 158,733 | (324,077) | (230,924) |
| Amount that will not be subsequently | |||||
| reclassified to profit or loss | |||||
| The Group's share in other comprehensive | |||||
| income of equity-accounted investees | - | 597 | - | 324,121 | 97,707 |
| Other comprehensive income | |||||
| (loss) for the period, net | 296,914 | (323,030) | 158,733 | 44 | (133,217) |
| Total comprehensive | |||||
| income for the period | 298,508 | 536,933 | 217,375 | 184,910 | 1,123,907 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance on January 1, 2023 (audited) | 311,640 | 851,918 | (155,628) | 8,013,123 | (56,503) | 11,000 | 62,920 | 224,054 | (14,435) | 896,669 | 10,144,758 |
| Effect of first-time application of IFRS 9 (*) | - | - | - | 1,522 | - | - | - | - | - | (1,522) | - |
| Balance as of January 1, 2023 after | |||||||||||
| first-time application of IFRS 9 | 311,640 | 851,918 | (155,628) | 8,014,645 | (56,503) | 11,000 | 62,920 | 224,054 | (14,435) | 895,147 | 10,144,758 |
| Net profit | - | - | - | 1,594 | - | - | - | - | - | - | 1,594 |
| Other comprehensive income (loss) | - | - | - | - | - | - | - | - | 25,734 | 271,180 | 296,914 |
| Total comprehensive income (loss) | - | - | - | 1,594 | - | - | - | - | 25,734 | 271,180 | 298,508 |
| Share-based payment | - | (216) | - | - | - | - | 9,489 | - | - | - | 9,273 |
| Acquisition of treasury shares | - | - | (12,105) | - | - | - | - | - | - | - | (12,105) |
| Exercise of employee options | 1,528 | 6,320 | - | - | - | - | (7,848) | - | - | - | - |
| Transfer from revaluation reserve in | |||||||||||
| respect of revaluation of property, | |||||||||||
| plant, and equipment, at the | |||||||||||
| depreciation amount |
- | - | - | 1,945 | - | - | - | (1,945) | - | - | - |
| Dividend Acquisition of minority interests |
- - |
- - |
- - |
(177,172) - |
- (10,848) |
- - |
- - |
- - |
- - |
- - |
(177,172) (10,848) |
| Allocation of shares of a consolidated | |||||||||||
| company to minority interests | - | - | - | - | 1,730 | - | - | - | - | - | 1,730 |
| Transaction with minority interest | - | - | - | - | (199,605) | - | - | - | - | - | (199,605) |
| Balance as of June 30, 2023 (unaudited) | 313,168 | 858,022 | (167,733) | 7,841,012 | (265,226) | 11,000 | 64,561 | 222,109 | 11,299 | 1,166,327 | 10,054,539 |
(*) See Note 2B to the condensed consolidated financial statements regarding first-time application of IFRS 9 (Financial Instruments) regarding financial instruments that do not relate to The Phoenix Insurance, which falls within the scope of the definition of insurer. According to the transition method that was selected, the comparative figures were not restated.

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance on January 1, 2022 (audited) | 310,323 | 849,309 | (99,769) | 7,331,992 | (45,655) | 11,000 | 51,652 | 131,354 | (41,946) | 1,155,104 | 9,653,364 |
| Profit for the period | - | - | - | 859,963 | - | - | - | - | - | - | 859,963 |
| Other comprehensive income (loss) | - | - | - | 593 | - | - | - | - | 18,823 | (342,446) | (323,030) |
| Total comprehensive income (loss) | - | - | - | 860,556 | - | - | - | - | 18,823 | (342,446) | 536,933 |
| Share-based payment | (4,993) | - | - | - | - | 10,035 | - | - | - | 5,042 | |
| Acquisition of treasury shares | - | - | (55,859) | - | - | - | - | - | - | - | (55,859) |
| Dividend | - | - | - | (421,000) | - | - | - | - | - | - | (421,000) |
| Exercise of employee options Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, at the |
191 | 980 | - | - | - | - | (1,171) | - | - | - | - |
| depreciation amount Allocation of shares of a consolidated |
- | - | - | 1,514 | - | - | - | (1,514) | - | - | - |
| company to minority interests | - | - | - | - | 1,379 | - | - | - | - | - | 1,379 |
| Acquisition of non-controlling interests Balance as of June 30, 2022 |
- | - | - | - | (12,000) | - | - | - | - | - | (12,000) |
| (unaudited) | 310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available-for sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of April 1, 2023 | |||||||||||
| (unaudited) Net profit |
311,817 - |
851,225 - |
(161,926) - |
7,781,449 (*) 58,642 |
(135,725) - |
11,000 - |
67,407 - |
223,030 - |
1,395 - |
1,017,498 (*) - |
9,967,170 58,642 |
| Other comprehensive | |||||||||||
| income (loss) | - | - | - | - | - | - | - | - | 9,904 | 148,829 | 158,733 |
| Comprehensive | |||||||||||
| income (loss) | - | - | - | 58,642 | - | - | - | - | 9,904 | 148,829 | 217,375 |
| Share-based payment Treasury shares |
- - |
1,428 - |
- (5,807) |
- - |
- - |
- - |
3,874 - |
- - |
- - |
- - |
5,302 (5,807) |
| Exercise of | |||||||||||
| employee options | 1,351 | 5,369 | - | - | - | - | (6,720) | - | - | - | - |
| Transfer from revaluation | |||||||||||
| reserve in respect of | |||||||||||
| revaluation of property, plant, and equipment, at |
|||||||||||
| the depreciation amount | - | - | - | 921 | - | - | - | (921) | - | - | - |
| Acquisition of | |||||||||||
| minority interests | - | - | - | - | (9,985) | - | - | - | - | - | (9,985) |
| Allocation of shares of a | |||||||||||
| consolidated company to | |||||||||||
| minority interests Transaction with |
- | - | - | - | 896 | - | - | - | - | - | 896 |
| minority interest | - | - | - | - | (120,412) | - | - | - | - | - | (120,412) |
| Balance as of June 30, 2023 | |||||||||||
| (unaudited) | 313,168 | 858,022 | (167,733) | 7,841,012 | (265,226) | 11,000 | 64,561 | 222,109 | 11,299 | 1,166,327 | 10,054,539 |
(*) Reclassified.

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as of April 1, 2022 (unaudited) | 310,366 | 851,131 | (155,628) | 7,587,379 | (45,408) | 11,000 | 56,835 | 130,657 | (39,539) | 829,030 | 9,535,823 |
| Profit for the period | - | - | - | 184,866 | - | - | - | - | - | - | 184,866 |
| Other comprehensive income (loss) | - | - | - | - | - | - | - | - | 16,416 | (16,372) | 44 |
| Total comprehensive income (loss) Transfer from revaluation reserve in respect of revaluation of property, |
- | - | - | 184,866 | - | - | - | - | 16,416 | (16,372) | 184,910 |
| plant and equipment, at the | |||||||||||
| depreciation amount | - | - | - | 817 | - | - | - | (817) | - | - | - |
| Share-based payment | - | (6,568) | - | - | - | - | 4,562 | - | - | - | (2,006) |
| Acquisition of non-controlling interests | - | - | - | - | (12,000) | - | - | - | - | - | (12,000) |
| Exercise of employee options | 148 | 733 | - | - | - | - | (881) | - | - | - | - |
| Allocation of shares of a consolidated | |||||||||||
| company to minority interests | - | - | - | - | 1,132 | - | - | - | - | - | 1,132 |
| Balance as of June 30, 2022 (unaudited) |
310,514 | 845,296 | (155,628) | 7,773,062 | (56,276) | 11,000 | 60,516 | 129,840 | (23,123) | 812,658 | 9,707,859 |

| Share capital |
Premium and capital reserves in respect of shares |
Treasury shares |
Retained earnings |
Capital reserve from transactions with non controlling interests |
Capital reserve from transaction with controlling shareholder NIS thousand |
Capital reserve from share based payment |
Revaluation reserve |
Reserve from translation differences |
Capital reserve in respect of available for-sale financial assets |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance on January 1, 2022 (audited) | 310,323 | 849,309 | (99,769) | 7,331,992 | (45,655) | 11,000 | 51,652 | 131,354 | (41,946) | 1,155,104 | 9,653,364 |
| Profit for the year | - | - | - | 1,257,124 | - | - | - | - | - | - | 1,257,124 |
| Other comprehensive income (loss) | - | - | - | 2,097 | - | - | - | 95,610 | 27,511 | (258,435) | (133,217) |
| Total comprehensive income (loss) | - | - | - | 1,259,221 | - | - | - | 95,610 | 27,511 | (258,435) | 1,123,907 |
| Share-based payment | - | (2,362) | - | - | - | - | 17,556 | - | - | - | 15,194 |
| Acquisition of treasury shares | - | - | (55,859) | - | - | - | - | - | - | - | (55,859) |
| Exercise of employee options | 1,317 | 4,971 | - | - | - | - | (6,288) | - | - | - | - |
| Dividend | - | - | - | (581,000) | - | - | - | - | - | - | (581,000) |
| Transfer from revaluation reserve in respect of revaluation of property, plant, and equipment, |
|||||||||||
| at the depreciation amount | - | - | - | 2,910 | - | - | - | (2,910) | - | - | - |
| Transaction with minority interest | - | - | - | - | (14,435) | - | - | - | - | - | (14,435) |
| Allocation of shares of a consolidated company to minority interests |
- | - | - | - | 3,587 | - | - | - | - | - | 3,587 |
| Balance on December 31, 2022 (audited) | 311,640 | 851,918 | (155,628) | 8,013,123 | (56,503) | 11,000 | 62,920 | 224,054 | (14,435) | 896,669 | 10,144,758 |
| Condensed Separate Interim Financial Inform ation of Cash Flows of the Com pany as of June 30, 2022 | For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||
|---|---|---|---|---|---|---|---|
| 2023 2022 Unaudited |
2023 2022 |
2022 | |||||
| Appendix | Unaudited | Audited | |||||
| NIS thousand | |||||||
| Cash flows for | |||||||
| operating activities | |||||||
| Profit | 1,594 | 859,963 | 58,642 | 184,866 | 1,257,124 | ||
| Adjustments required to | |||||||
| present cash flows for | |||||||
| operating activities | (a) | 14,409 | (869,932) | (42,331) | (199,048) | (1,271,235) | |
| Net cash used for operating | |||||||
| activities of the Company | 16,003 | (9,969) | 16,311 | (14,182) | (14,111) | ||
| Cash flows from investing | |||||||
| activities: | |||||||
| Loans and capital notes repaid | |||||||
| by subsidiaries | 61,922 | 5,125 | 18,708 | 5,125 | 5,125 | ||
| Dividend from investees | 255,000 | 500,000 | 255,000 | 500,000 | 615,000 | ||
| Sales (acquisitions) of | |||||||
| financial investments by | |||||||
| the Company, net | 346 | 10,627 | (5,588) | 3,622 | 22,652 | ||
| Investment in investees | (1,750) | (14,925) | (1,750) | (14,925) | (16,675) | ||
| Loans and capital notes | |||||||
| provided to subsidiaries | (149,405) | - | - | - | (109,500) | ||
| Net cash from investing | |||||||
| activities | 166,113 | 500,827 | 266,371 | 493,822 | 516,602 | ||
| Cash flows from | |||||||
| financing activities | |||||||
| Dividend paid to shareholders | (177,172) | (421,000) | (177,172) | (421,000) | (581,000) | ||
| Acquisition of Company shares | (12,105) | (55,859) | (5,807) | - | (55,859) | ||
| Repayment of bonds | (143,015) | (315,159) | (143,015) | (34,220) | (356,564) | ||
| Issuance of bonds (less | |||||||
| issuance expenses) | 148,391 | 296,948 | - | - | 397,968 | ||
| Net cash used in financing | |||||||
| activities | (183,901) | (495,070) | (325,994) | (455,220) | (595,455) | ||
| Increase (decrease) in | |||||||
| cash and cash equivalents | (1,785) | (4,212) | (43,312) | 24,420 | (92,963) | ||
| Balance of cash and | |||||||
| cash equivalents at | |||||||
| beginning of period | 16,959 | 109,922 | 58,486 | 81,290 | 109,922 | ||
| Balance of cash and | |||||||
| cash equivalents at | |||||||
| end of period | 15,174 | 105,710 | 15,174 | 105,710 | 16,959 |
| For the six months ended June 30 |
For the three months ended June 30 |
For the year ended December 31 |
||||||
|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2022 | ||||
| Unaudited | Audited | |||||||
| NIS thousand | ||||||||
| Adjustments required to present | ||||||||
| cash flows (for) from operating | ||||||||
| (a) | activities: | |||||||
| Items not involving cash flows: | ||||||||
| Profits from financial investments, net | (353) | (695) | (477) | 268 | 367 | |||
| Income and expenses not | ||||||||
| involving cash flows: | ||||||||
| Accrued interest and | ||||||||
| appreciation of bonds | 6,982 | 25,263 | (3,513) | 12,534 | 43,992 | |||
| Tax expenses (income) | (15,600) | - | (8,800) | - | (9,100) | |||
| Company's share in the losses | ||||||||
| (profits) of investees, net | 38,264 | (840,839) | (28,917) | (172,613) | (1,216,361) | |||
| Changes in other balance | ||||||||
| sheet line items, net: | ||||||||
| Change in receivables | ||||||||
| and debit balances | 245 | 6,318 | (5,348) | (6,647) | 7,948 | |||
| Change in payables | ||||||||
| and credit balances | 2,070 | (6,652) | (72) | (1,658) | (1,086) | |||
| Change in loans to investees | (17,199) | (53,327) | 4,796 | (30,932) | (96,995) | |||
| Total cash flows for | ||||||||
| operating activities | 14,409 | (869,932) | (42,331) | (199,048) | (1,271,235) | |||
| Significant non-cash activities: | ||||||||
| Dividend receivable from subsidiaries | 486,031 | - | - | - | - |
Additiona l Informa tion to the Condense d Interim F inancia l Informa tion
The Interim Separate Financial Information is presented in accordance with Regulation 38D of the Securities Regulations (Periodic and Immediate Reports), 1970 and does not include all the information required under Regulation 9C and the Tenth Addendum to the Securities Regulation (Periodic and Immediate Reports), 1970, "Separate Financial Information of the Corporation".
This separate financial information should be read in conjunction with the separate financial information as of the date and year ended December 31, 2022 and in conjunction with the Condensed Consolidated Interim Financial Statements as of June 30, 2023 (hereinafter - the "Consolidated Financial Statements").
Further to that detailed in Note 2 to the condensed consolidated financial statements, as of January 1, 2023, the Company applies to the condensed interim separate financial information IFRS 9, Financial Instruments (hereinafter - "IFRS 9") excluding the financial data related to The Phoenix Insurance, which meets the definition of an insurer.
The "Company" - The Phoenix Holdings Ltd.
"Investee companies"- Consolidated companies and companies the Company's investment in which is included, whether directly or indirectly, in the financial statements based on the equity method.

Tel. +972-3-6232525 Fax +972-3-5622555 ey.com

Dear Madam/Sir,
We hereby inform you that we agree to the inclusion (including by way of reference) of our reports, as listed below, in a shelf offering based on the Shelf Prospectus in the subject:
Kost Forer Gabbay & Kasierer Certified Public Accountants

Report on the Effectiveness of Internal Control over Financial Reporting and Disclosure


Management, under the supervision of the Board of Directors of The Phoenix Holdings Ltd. (hereinafter the "Corporation") is responsible for establishing and maintaining adequate internal control over financial reporting and disclosure in the Corporation.
For this matter, the members of management are as follows:
The internal control over financial reporting and disclosure consists of the Corporation's existing controls and procedures that have been planned by the chief executive officer and the most senior financial officer or under their supervision, or by the equivalent acting officers, under the supervision of the Corporation's Board of Directors, designed to provide reasonable assurance about the reliability of financial reporting and the preparation of the financial statements in compliance with applicable laws, and ensure that all information that the Company is required to disclose in the financial statements its publishes pursuant to law is collected, processed, summarized and reported in a timely manner and according to the format prescribed by law.
Among other things, internal controls include controls and procedures planned to ensure that all information that the Corporation is required to disclose as aforesaid is collected and transferred to the Corporation's management, including the chief executive officer and the most senior financial officer, or the equivalent acting officers, in order to allow decision making on a timely basis with respect to the disclosure requirements.

Due to its inherent limitations, internal control over financial reporting and disclosure is not designed to provide absolute assurance that misstatements or omissions of information in the financial statements shall be prevented or detected.
The Phoenix Insurance Ltd., a subsidiary of the Corporation, is an institutional entity which is subject to the directives of the Commissioner of the Capital Market, Insurance and Savings in the Ministry of Finance regarding the assessment of the effectiveness of internal controls over financial reporting.
With respect to the internal control of the said subsidiary, the Corporation implements the following provisions:
Institutional Entities Circular 2009-9-10, "Management's Responsibility for Internal Controls over Financial Reporting"; Institutional Entities Circular 2010-9-6, "Management's Responsibility for internal control over financial reporting - Amendment"; Circular 2010-9-7, "internal control over financial reporting - Statements, Reports and Disclosures"; and Circular 2015-9-15, "internal control over financial reporting - Statements, Reports, Disclosures and Management's Responsibility for internal control over financial reporting - Amendments".
In the quarterly report on the effectiveness of internal control over financial reporting and the disclosure attached to the quarterly report for the period ended March 31, 2023 (hereinafter - the "Last Quarterly Internal Control Report"), the internal control was found to be effective.
As of the report date, the Board of Directors and management have not been informed of any event or matter that may alter the assessment of the effectiveness of internal control, as presented in the Most Recent Annual Report Over Internal Control.
As of the report date, based on the Most Recent Quarterly Report over Internal Control and based on information brought to the attention of management and the Board of Directors as stated above, the internal control is effective.

Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 23, 2023 ___________________________________________
Eyal Ben Simon, CEO

I, Eli Schwartz, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 23, 2023 ___________________________________________

Statements Regarding Controls and Procedures in respect of Disclosure in the Financial Statements of The Phoenix Insurance Company Ltd.


I, Eyal Ben Simon, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 23, 2023
______________________________________ Eyal Ben Simon, Chief Executive Officer

I, Eli Schwartz, hereby certify that:
Nothing in the foregoing shall derogate from my responsibility or the responsibility of any other person, under any law.
August 23, 2023
______________________________________________ Eli Schwartz, EVP, CFO
1 As defined in the provisions of the institutional entities circular titled "Internal Controls over Financial Reporting - Statements, Reports and Disclosures".
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.